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Science knows no country, because knowledge belongs to humanity, and is the torch which 
illuminates the world.
  -Louis Pasteur
As quoted in Free Lance of Science (1960), René Dubos
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ABSTRACT
 Yersinia pestis, the causative agent of plague, is estimated to have claimed the lives of 
30-50% of the European population in five years. Although it can now be controlled through 
antibiotics, there are still lurking dangers of outbreaks from biowarfare and bioterrorism; 
therefore, ongoing research to further our understanding of its strong virulence factors is 
necessary for development of new vaccines. Many Gram-negative bacteria, including Y. 
pseudotuberculosis, the evolutionary ancestor of Y. pestis, produce a hexa-acylated lipid A/LPS 
which can strongly trigger innate immune responses via activation of Toll-like receptor 4 
(TLR4)-MD2. In contrast, Y. pestis grown at 37oC generates a tetra-acylated lipid A/LPS that 
poorly induces TLR4-mediated immune activation. We have reported that expression of E. coli 
lpxL in Y. pestis, which lacks a homologue of this gene, forces the biosynthesis of a hexa-
acylated LPS, and that this single modification dramatically reduces virulence in wild type mice, 
but not in mice lacking a functional TLR4. This emphasizes that avoiding activation of innate 
immunity is important for Y. pestis virulence. It also provides a model in which survival is 
strongly dependent on innate immune defenses, presenting a unique opportunity for evaluating 
the relative importance of innate immunity in protection against bacterial infection. TLR 
signaling is critical for the sensing of pathogens, and one implication of TLR4 engagement is the 
induction of the pro-forms of the potent inflammatory cytokines IL-1β and IL-18. Therefore Y. 
pestis is able to suppress production of these which are generated through caspase-1-activating 
nucleotide-binding domain and leucine-rich repeat (NLR)-containing inflammasomes. For my 
thesis, I sought to elucidate the role of NLRs and IL-18/IL-1β during bubonic and pneumonic 
vii
plague infection. Mice lacking IL-18 signaling led to increased susceptibility to wild type Y. 
pestis, and an attenuated strain producing a Y. pseudotuberculosis-like hexa-acylated lipid A. I 
found that the NLRP12, NLRP3 and NLRC4 inflammasomes were important protein complexes 
in maturing IL-18 and IL-1β during Y. pestis infection, and mice deficient in each of these NLRs 
were more susceptible to bacterial challenge. NLRC4 and NLRP12 also directed interferon-
gamma production via induction of IL-18 against plague, and minimizing inflammasome 
activation may have been a central factor in evolution of the high virulence of Y. pestis. This is 
also the first study that elucidated a pro-inflammatory role for NLRP12 during bacterial 
infection. 
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PREFACE to CHAPTER 1
This section includes segments of a review accepted for publication in Current Opinions in 
Microbiology, January 2013: Inflammasomes and host defenses against bacterial infections.
Gregory I. Vladimer1, Robyn Marty-Roix1, Shubhendu Ghosh1, Dan Weng1, Egil Lien1,2
1Division of Infectious Diseases and Immunology, Department of Medicine, UMass Medical 
School, Worcester, MA 01605, USA; 2NTNU, Dept of Cancer Research and Molecular 
Medicine, 7491 Trondheim, Norway.
G.I.V. created all of the figures as outlines from published work, and was the principal writer and 
coordinator of the manuscript text.
Co-authors contributed the following data:
R.M.R. created Table 1.1 and collected information and wrote sections on bacterial recognition 
by NLRP3. D.W. wrote the section on cell death after inflammasome activation. S.G. and E.L. 
assisted in editing and organization of the manuscript.
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CHAPTER 1: Introduction
2
The Innate Immune System
 The germline-encoded innate immune system is the first line of defense against invading 
pathogens. Innate immunity is comprised of a number of pattern recognition receptors (PRRs) 
recognizing conserved pathogen-associated molecular patterns (PAMPs) and danger-associated 
molecular patterns (DAMPs). PRRs sense extracellular and intracellular pathogens and are 
specific for various classes of molecules including proteins, lipids, carbohydrates and nucleic 
acids (Janeway and Medzhitov, 2002; Ye and Ting, 2008; Kawai and Akira, 2010). PAMPs are 
molecular patterns specific to invading pathogens while DAMPs are host cell-danger signals 
elicited by pathogen assault.  PRRs are largely divided into four types based on structural 
homology: Toll-like receptors (TLRs), RIG (retinoic acid-inducible)-I-like receptors (RLRs), and 
NOD (nucleotide oligomerization domain)-like receptors (NLRs), and an emerging family that 
broadly encompasses intracellular DNA sensors (Kawasaki et al., 2011; Keating et al., 2011). 
Ligand binding by these receptors leads to the activation a battery of immune effector 
mechanisms which facilitate the eradication of the pathogen (Janeway and Medzhitov, 2002). 
These include signaling pathways that culminate in the induction of type-one interferons (IFNs) 
or pro-inflammatory responses mediated by various cytokines and chemokines. This cytokine 
and chemokine response leads to local tissue inflammation at the site of the PAMP or DAMP, 
which includes the production of antimicrobial peptides, reactive oxygen species (ROS), and 
further cellular recruitment. The reaction elicited during the innate immune response directs 
inflammatory cell recruitment and elicits activation of humoral immunity (Vallabhapurapu and 
Karin, 2009; Kawasaki et al., 2011).
3
 An important class of cytosolic immune sensors is the inflammasome: multi-protein 
complexes comprised of a subset of NLRs, activated after detection of specific PAMPs and 
DAMPs. Upon activation, they form higher-order structures that, with or without an adapter 
protein ASC (apoptosis-associated speck-like protein containing a CARD (caspase activation and 
recruitment domain)), recruits the zymogen pro-caspase-1 (Franchi et al., 2009). Upon 
recruitment, pro-caspase-1 is cleaved into active caspase-1 which can catalytically activate the 
potent pro-inflammatory cytokines pro-IL (interleukin)-1β and pro-IL-18, whose expression is 
upregulated prior to inflammasome activation in an NF-κB dependent manner (Stutz et al., 
2009).
 Mounting evidence indicates that inflammatory responses can be a double-edged-sword 
as innate receptors can also be activated in the absence of infection by self-molecules that appear 
during disease conditions. “Sterile inflammation” is thought to underlie the symptoms associated 
with inflammatory responses in crystal-based diseases, e.g. gout caused by crystals of uric acid 
(Martinon et al., 2006). Thus, our understanding of these systems will not only assist in fighting 
disease, but also allow us to combat inflammatory syndromes from self-processes gone rogue.
 It is the culmination of this multi-pathway based innate immune response the host 
depends on to yield pathogen spread until the adaptive immune system can be initiated.
Toll-like Receptors (TLRs)
 The TLR family is an extensively studied innate immune PRR and its members are 
believed to be the system’s primary sensor (Janeway and Medzhitov, 2002). The Toll receptor 
was originally discovered in flies; its importance embryonic patterning, anti-bacterial, and anti-
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fungal responses lead to the discovery of its mammalian homologues (Lemaitre et al., 1996). 
TLRs recognize different conserved PAMPs and activate innate immune function through a 
variety of pathways (Kawai and Akira, 2007; 2010). TLRs are type-I transmembrane proteins 
with ectodomains that are localized either to the plasma membrane (TLRs 1, 2, 4, 5, and 6) or the 
endolysosome (TLR 3, 7, and 9) (Figure 1.1) (Takeda and Akira, 2004). Each consists of a C-
terminal leucine-rich repeat domain (LRRs), which is tasked with PAMP-recognition, 
transmembrane domains, and intracellular Toll-interleukin receptor (TIR) domains required for 
downstream signaling (Gazzinelli et al., 2004; Kawai and Akira, 2007; 2010). Crystal structures 
and mechanistic studies have provided some insight into the TLRs in their active and inactive 
forms - a conserved “m-shape” when bound with specific ligand (two TLRs together), or a 
“horseshoe-like” shape when unbound (one TLR).
 So far, 12 functional TLRs have been identified in mice and 10 in humans; TLR1-TLR9 
are conserved between each species, while murine TLR10 is an inactive pseudogene caused by a 
retrovirus insertion and TLR11-TLR13 have been lost from the human genome (Guan et al., 
2010; Kawai and Akira, 2010). Studies of single TLR knockout (KO) mice have shown that each 
TLR is responsible for recognizing specific PAMPs dependent on their LRR structure or binding 
partners. The diverse group of bacterial and viral PAMPs which are recognized include 
lipoproteins, lipids, proteins and multiple nucleic acid species. The TLRs recognizing nucleic 
acid are localized to the endolysosome while the others are localized to the outer membrane 
(Takeda and Akira, 2004); their locations define the two general categories.
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Extracellular TLRs: ligands, structure, and function
 The extracellular TLR group is comprised of TLRs1, 2, 4, 5, and 6. These cell surface-
expressed TLRs recognize proteins, lipoproteins, and lipids, mostly from bacteria. They are 
thought to sample the extracellular space for possible PAMPs (Takeda and Akira, 2004). 
TLR4
 TLR4 is the most extensively studied TLR, and has been identified as the receptor for 
bacterial lipopolysaccharide (LPS) (Figure 1.1) (Nagai et al., 2002), an extracellular lipid which 
decorates the cell-wall of Gram-negative bacteria, and the cause of septic shock (Battafaraono et 
al., 1995; Poltorak et al., 2000). In the presence of the lipid A component of LPS, TLR4 forms a 
tetrameric complex on the cell surface, consisting of two TLR4s, along with two molecules of 
the co-adapter, MD2. (Figure 1.1) (Shimazu et al., 1999; Park et al., 2009). In the absence of 
lipid A, a single TLR4 and MD2 can associate, but the tetrameric complex cannot form. 
 In the TLR4-MD2 dimer, TLR4 forms hydrophobic and hydrophilic interactions with the 
LPS and with Phe126 and Leu87 of MD2. A crystal structure of the TLR4-MD2 in complex with 
hexa-acylated lipid A shows that five of the acyl-chains are positioned inside the β-cup fold 
structure of the MD2 hydrophobic pocket and the remaining is exposed to the MD2 surface that 
is hydrophobically bound with TLR4 (Park et al., 2009). The six acyl-chains push the negatively 
charged phosphate group on the glucosamine-backbone up, to ionically interact with positively 
charged TLR4/MD2 clusters (Park et al., 2009). The resulting complex that forms initiates signal 
transduction intracellularly by recruiting adapter molecules to the TIR domain (Kawai and Akira, 
2007).  Eritoran, a drug used to counteract extreme sepsis in patients (Shahzad G Raja, 2007), is 
a TLR4 antagonist (Shimamoto et al., 2006), as is lipid IVa, a lipid A precursor (Saitoh S, 2004). 
Eritoran and lipid IVa contain the same glucosamine-backbone with charged phosphate groups at 
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positions 1 and 4; however, only four acyl chains are present and therefore the structure falls too 
deep within the MD2 binding pocket (Park et al., 2009). Therefore, the charged phosphate 
groups do not interact with either TLR4 due to a ~5Å shift and a almost 180o rotation of the 
ligand and this prevents downstream signaling (Park et al., 2009). Interestingly, Park et al. 
showed that Phe126 of MD2 is exposed to the solvent, instead of the TLR4 binding partner, 
when an antagonist was bound; thus it is this structural change that is necessary for dimerization 
and subsequent downstream signaling. Point mutation studies of the Phe126 loop also support 
this finding (Motshwene et al., 2009). 
 To note, lipid IVa does activate mild pro-inflammatory responses via rodent TLR4, but 
not by mammalian TLR4 (Meng et al., 2010). This is due to an interaction between the 
negatively charged 4’ phosphate on lipid IVa with two positively charged residues on the mouse 
TLR4; these residues are absent from human TLR4 (Meng et al., 2010).
 Many bacterial pathogens, such as Yersinia pestis and Francisella tularensis, limit TLR4 
signaling by expressing lipid A/LPS that is antagonist (i.e. tetra-acylated) to TLR4 (Montminy et 
al., 2006; Schilling B, 2007). This is described in detail in the Y. pestis section. 
 Other proteins that play a role in LPS recognition including LPS-binding protein (LBP), a 
soluble protein which binds LPS (Tobias et al., 1997) and CD14, a glycosylphosphatidylinositol 
(GPI)-linked LRR-containing receptor which binds LBP and delivers it to the TLR4-MD2 
complex (Wright et al., 1990; Becker et al., 2000) (Figure 1.1).
TLR2
 TLR2 is unique as it recognizes a wide range of PAMPs via heterodimerization with two 
TLR binding partners (TLR1 and TLR6) (Jin et al., 2007; Kawai and Akira, 2010) (Figure 1.1). 
These PAMPs include bacterial lipopeptides, Gram-positive specific peptidoglycan and 
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lipoteichoic acid, lipoarabinomannan from mycobacteria, zymosan from fungi, and others (Akira 
et al., 2003; Kang et al., 2009). Major recognized ligands for the TLR2-TLR1 heterodimer are 
triacylated lipopeptides (Pam3Cys4) from Gram-negative bacteria and mycoplasma, and the 
TLR2-TLR6 heterodimer recognizes diacylated lipopeptides (Pam2Cys4) from Gram-positive 
bacteria (Kawai and Akira, 2010) (Figure 1.1). 
 In the TLR2-TLR1-Pam3Cys4 crystal structure, two of the three lipid chains (the ester 
bound lipids) locate inside the TLR2 pocket while the third (amide bound lipid) binds inside the 
hydrophobic channel of TLR1 (Kang et al., 2009). The hydrophilic binding channel of TLR6 is 
half as long as TLR1 due to the bulky side-chains of Phe343 and Phe365, therefore the TLR2-
TLR6 complex discriminates against triacylated lipopeptides, and recognizes diacylated 
lipopeptides based on this feature (Kang et al., 2009). 
TLR5 and TLR11
 TLR5 recognizes flagellin, a protein component of the bacterial flagellum (Hayashi et al., 
2001) (Figure 1.1). Flagellin is highly conserved among motile bacteria and is readily accessible 
by the innate immune system, thus serving as the perfect target for innate immune activation 
(Hayashi et al., 2001). TLR11, a relative of TLR5, is also suspected of recognizing bacterial 
components and profilin-like molecular patterns (Yarovinsky et al., 2006; Kawasaki et al., 2011). 
Intracellular TLRs: ligands, structure, and function
 Intracellular TLRs are expressed mainly in the endocytic compartments and primarily 
recognize nucleic acid PAMPs (ss/dsRNA or ss/dsDNA) derived from various viruses and 
bacteria (Figure 1.1).
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TLR3
 TLR3 recognizes dsRNA and was discovered by its ability to bind a synthetic ligand, 
polyinosinic-polycytidylic acid (poly(I:C)) (Alexopoulou et al., 2001) (Figure 1.1). Poly(I:C) 
can induce prototypical antiviral immune responses including type-I interferons and pro-
inflammatory cytokine production. The crystal structure of the human TLR3 ectodomain has 
been described(Choe et al., 2005). It is the binding of dsRNA to TLR3 that induces dimerization 
and downstream signaling. TLR3 mainly recognizes the genomic RNA of retroviruses, and the 
dsRNA produced during the replication of ssRNA viruses such as respiratory syncytial virus and 
West Nile Virus (Akira et al., 2003; Kalali et al., 2008).
TLR7 and TLR8
 TLR7, originally identified as recognizing the anti-viral, immune modulating compound, 
resiquimond (R-848) (Jurk et al., 2002), activates innate immune responses after detection of 
ssRNA from RNA viruses such as influenza A and human immunodeficiency virus (HIV) 
(Figure 1.1) (Heil et al., 2004; Barchet et al., 2005). Recognition of ssRNA viruses by TLR7 
occurs in a replication-independent manner after internalization and recruitment of the pathogen 
to the endolysosome where anti-viral immune responses are triggered. TLR7 induction can also 
occur when virus replication intermediates are internalized via autophagy, the processes of self-
degradation of cellular proteins (Manuse et al., 2010). 
 Human TLR8, which also recognizes ssRNA and R-848, is phylogenetically most similar 
to TLR7, though mice deficient in TLR8 respond normally to these ligands(Jurk M, 2002; Jurk et 
al., 2002).
TLR9
 Unmethylated 2’-deoxyribo(cytidine-phosphate-guanosine) (CpG) are small DNA motifs 
that are frequently present in bacteria and viruses but are rare in mammalian cells. These are 
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recognized by TLR9 to elicit an IFN-based immune response (Figure 1.1) (Bauer et al., 2001; 
Hornung and Latz, 2010). The 2’ deoxyribose backbone of the CpG determines the TLR9 
activating ability (Haas et al., 2008). These CpGs can directly activate dendritic cells (DCs) and 
macrophages, which then drive a strong Th1 response (Hornung and Latz, 2010). 
 TLR9 is localized to the endoplasmic reticulum (ER) of DCs and macrophages under 
resting conditions, and relocates to early endosomes that contain CpG DNA (Latz et al., 2004). 
Though the crystal structure of TLR9 has yet to be elucidated, the mechanism of downstream 
pathway activation via CpG DNA binding to the receptor has been worked out. Binding of CpG 
changes the TLR9 ectodomain conformation and decreases spacial separation of the TIR domain 
of TLR9 homodimers (Latz et al., 2007). The TLR9 dimer is not sufficient for activation and 
requires ligand induced conformational changes (Latz et al., 2007). 
 TLR9 recognizes DNA viruses such as murine cytomegalovirus (MCMV), HSV-1, and 
HSV-2 (Lund J, 2003; Kumar et al., 2011). TLR7 and TLR9 have been linked to autoimmune 
disorders such as systemic lupus erythematous (SLE), since self-nucleic acid can, in unusual 
circumstances, act as immune-stimulating ligands (Celhar et al., 2012).
TLR sub-cellular localization and trafficking
 Nucleic acid-sensing TLRs localize to various intracellular compartments such as the ER, 
endosome, and endolysosome; and blocking of endosome acidification prevents TLR9-induced 
signaling due to a failure of TLR9 prototypic cleavage (Park et al., 2008). This suggests that 
intracellular delivery of internalized nucleic acids to the TLR-containing compartments is pivotal 
for their interaction. TLR3, 7, an 9 are sequestered to the ER via retention signals and are rapidly  
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trafficked to endolysosomes by the ER-localization protein UNC93B, a 12-membrane-spanning 
protein (Latz et al., 2004; Kim et al., 2008). Mice deficient in UNC93B (3d mice) cannot signal 
though TLR3, 7, or 9. The intracellular localization of these TLRs is thought help prevent 
activation by self-DNA as stated above.
 It is not only the intracellular TLRs which traffic, but signaling via TLR4 is also 
dependent on movement, and cellular responsiveness to LPS is partly regulated by the physical 
amount of TLR4 present on the cell surface (Kalis et al., 2003) (Figure 1.1). In resting human 
monocytes, TLR4 is located at the golgi, and LPS-bound MD2 is necessary for correct 
intracellular distribution of the TLR4 from the golgi to the plasma membrane as well as TLR4 
activation (Latz E, 2002; Husebye et al., 2006). It has been demonstrated that the TLR4-MD2-
CD14 complex, when engaged with LPS, rapidly traffics to and from the plasma membrane and 
the golgi in a process that is distinct from downstream signal transduction (Latz et al., 2002). 
Additionally, after LPS engagement of TLR4-MD2, the complex is recruited into the endosome 
(Tanimura et al., 2008) (Figure 1.1). This relocation of the complex has been linked to 
downstream signaling via separate adapter proteins, discussed below, then utilized at the surface 
membrane. The movement of the LPS-detection complex has been linked to CD14 signaling, 
which is required for, and mediates the endocytosis (Zanoni et al., 2011).
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Figure 1.1: Surface and endolysosome localized TLRs and their cognate antigens 
with simplified signaling pathways
TLRs 1, 2, 4, 5, and 6 are mainly localized to the cell surface, while TLRs 3, 7, 8, and 9 are 
mainly localized in the endolysosome. CD14 and LBP assist in TLR4 signaling. The signaling 
pathways of TLRs are mediated through the adapter proteins MAL/MyD88 (yellow lines) or 
TRAM/TRIF (red lines) to downstream signaling cascades. The culmination of these pathways 
results in the activation of the transcription factors NF-κB and IRFs which promote the 
expression of type-I IFNs and pro-inflammatory cytokines. Solid arrows depict direct pathways 
while dotted lines depict simplified pathways.
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TLR adapter pathways - Downstream responses
 After TLR-ligand engagement, specific biological processes, determined by the adapters 
recruited to the intracellular TIR domains of the activate TLR, are triggered. These TIR-
containing adapter proteins include MyD88, Mal, TRIF and TRAM; adapter usage determines 
downstream effects (Figure 1.1) (Wesche et al., 1997; Fitzgerald et al., 2001; Yamamoto M, 
2003; Yamamoto et al., 2003b). TLR3 is the only TLR that solely uses TRIF and TRAM whereas 
TLR4 is the only TLR able to utilize all 4 adapters for signaling (Akira et al., 2003). TLR4 
initially recruits Mal and MyD88 at the plasma membrane (Kagan and Medzhitov, 2006) and 
activates early NF-κB genes (Andrade et al., 2010). Activated TLR4 then undergoes dynamin-
dependent endocytosis and is trafficked to the endosome (as described above) where it associates 
with TRIF and TRAM to activate late NF-κB (nuclear factor kappa-light-chain-enhancer of 
activated B cells) genes as well as IRF-dependent type I IFNs (Fitzgerald Ka, 2003; Yamamoto 
et al., 2003b; Rowe et al., 2006). Therefore, TLR4 has a two-tiered activation mechanism of 
innate immunity, which could explain why LPS is such a potent innate immune activator.
MyD88-dependent pathway
 Once a TLR, with the exception of TLR3, recognizes its PAMP, MyD88 is recruited to 
the intracellular TIR, which then engages members of the IRAK family (IL-1 receptor-associated 
kinase) (Akira et al., 2003). IRAK4 is activated first and leads to the subsequent interaction with 
TRAF6 (tumor necrosis factor receptor - associate factor), an E3 ligase responsible for 
downstream signaling (Cao et al., 1996). TRAF6 catalyzes the addition of polyubiquitin K63 
(Lys63)-linked chains on target proteins with assistance from E2 ubiquitin-conjugating 
enzymes(Xia et al., 2009). K63-linked chains are added to TAB2 and TAB3, the regulatory 
components of the kinase TAK1 (transforming growth factor-β-activated kinase 1); activation of 
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IKKɣ (also called NEMO (NF-κB essential modulator)), a component of IKK (IκB (inhibitor of 
NF-κB) kinase) is also necessary for activation. Activated TAK1 subsequently phosphorylates 
IKKβ, another component of the IKK complex, which leads to the ubiquitination and 
degradation of IκB and finally NF-κB activation and nuclear localization (Takaesu et al., 2000; 
Vallabhapurapu and Karin, 2009; Fan et al., 2010). 
 NF-κB is an essential, and highly-regulated, pro-inflammatory transcription factor, its 
activation leads to the expression of a number of antimicrobial defense systems and cytokines 
such as IL-6 and TNF (tumor necrosis factor) which control downstream immune effects (Figure 
1.1) (Li and Verma, 2002; Kawai and Akira, 2007). 
TRIF-dependent pathway
 The TRIF/TRAM-dependent pathway is downstream of TLR3 (located at the 
endolysosome) and late-phase TLR4 activation (Fitzgerald et al., 2003; Yamamoto et al., 2003a), 
this activates IRF3 (interferon regulatory factors) and NF-κB-based immune responses. Internal 
TIR domains of TLR3 and TLR4 draft TRAM and TRIF, which leads to the recruitment of 
TRAF6 and the subsequent K63-ubiquitination of TAK1 for NF-κB activation. TRIF also 
recruits RIP1, which is required for NF-κB activation downstream of TLR3 (Tatematsu et al., 
2010). TRIF-dependent pathways also lead to phosphorylation, and subsequent activation, of 
IRFs, and type-1 IFN production via TRAF3 (Figure 1.1) (Sato S, 2003).
TLR signaling summary
 Tremendous research has been performed to elucidate the roles and importance of TLRs 
in pathogen recognition during infection. TLRs, after detection of their cognate antigen, initiate 
downstream pathways that culminate in the activation of IRFs, NF-κB, and MAPK (mitogen-
activated protein kinase) transcription factors to elicit a potent pro-inflammatory milieu. The 
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known crystal structures of a handful of TLRs have elucidated the exact mechanisms of ligand 
interactions, though more work must be done to solve all structures. It is the understanding of 
these complex pathways which further our knowledge in order to create better anti-microbial 
compounds and therapies.
Cytosolic Receptors
 Extracellular and endolysosome TLRs are absolutely necessary for tissue surveillance 
and pro-inflammatory responses, however, pathogens have developed ways to subvert TLR 
signaling and hide in the cell cytosol. During the past decade, a large focus of innate immune 
research has been focused on families of cytosolic innate-immune receptors and their importance 
in host defense signaling. From DAMP sensing, such as crystal-associated inflammation 
(Duewell et al., 2010), PAMPs such as bacterial secretion systems, toxins, flagellin, LPS, 
peptidoglycan (PGN) (Averette et al., 2009; Miao et al., 2010), and pathogen nucleic acid 
(Ablasser et al., 2009; Hornung et al., 2009; Poeck et al., 2009; Sander et al., 2011), cytosolic 
receptors have been described to recognize diverse ligands which initiate strong pro-
inflammatory pathways.  Cytosolic surveillance is compulsory for cellular and host survival 
as many bacterial and viral pathogens replicate in the relatively safe niche of this cellular area. 
Once a pathogen has escaped lysosomal degradation, or has been phago- or pinocytosed, it 
would have unlimited access to the host cell machinery for replication. The cytosolic receptors 
fall into multiple classes: RIG (retinoic acid inducible gene)-like receptors (RLRs), which detect 
RNA, and NOD (nucleotide-binding domain and leucine-rich repeat containing)-like receptors 
(NLRs) which respond to various PAMPs and DAMPs, as further explained below.
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NOD-Like Receptors and the Inflammasome
 The NLR family of proteins has emerged as important and necessary receptors in 
pathogen detection and innate immune activation, and much evidence has been provided to 
indicate roles for the NLR family members in host inflammatory disorders. NLRs have been 
shown to complement and synergize with TLR signals arising from pathogen recognition, and 
are not necessarily separate pathways. Evolutionarily, NLR orthologs can be found in plants (R-
genes / R-proteins), and are required for anti-pathogen responses (Ronald and Beutler, 2010). 
The detection of avirulence (avr) proteins delivered by pathogenic bacteria trigger rapid host 
defenses in plants. The detection of avr proteins by R-proteins can occur by direct binding or by 
detection of altered cellular function caused by the avr proteins (guardian hypothesis vs receptor-
ligand model) (Ronald and Beutler, 2010). 
 The NLR family can be divided into two groups, one group which activates NF-κB- and 
MAPK-dependent responses, and the other group which signals through pro-inflammatory 
caspases (such as caspase-1) to activate idle pro-inflammatory cytokines. The latter group is 
termed the inflammasome-forming NLRs. To date, the NLR family is comprised of 23 human 
genes, and 34 in the mouse - and although these are primarily expressed in immune cells, a few 
are expressed in other tissues, such as epithelial cells (Shaw et al., 2008). 
 NLRs are comprised of, and characterized by, three domains: the first, located at the N-
terminus, is a pyrin domain (PYD), CARD, or a baculovirus inhibitor of apoptosis protein repeat 
(BIR) (Stutz et al., 2009) (Figure 1.2). The CARD and PYD domains are part of the death 
domain superfamily of proteins, classified by their fold: 6 to 7 tightly packed α-helices. The BIR 
belongs to the zink-finger domain family. The central domain is a NBD (nucleotide-binding 
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domain) responsible for binding ribonucleotides and possibly involved in NLR-
oligomerization(Duncan et al., 2007). Finally, NLRs contain an LRR domain at the C-terminus 
which is believed to play a role in the recognition of DAMPs and PAMPs (Stutz et al., 2009). 
 NLR proteins are sub-classified by the differences in their varying N-terminal domains. 
The largest group shares an N-terminal PYD, termed NLRP, and contains proteins such as 
hNLRP1, NLRP3, NLRP6, NLRP7, and NLRP12 (Figure 1.2). Another group expresses an N-
terminal CARD domain and is termed NLRC. The NLRC group contains the proteins NOD1 and 
NOD2 as well as NLRC4 (IPAF). Other NLR families have emerged containing a BIR domain 
such as NAIP5 (apoptosis inhibitory protein 5).
NOD1 and NOD2
 NOD1 (also called CARD4) and NOD2 (CARD15) have been demonstrated as important 
cytosolic receptors for microbial pathogens(Chamaillard et al., 2003; Girardin et al., 2003a; 
Meinzer et al., 2007), and activate downstream NF-κB and MAPK responses (Shaw et al., 2008). 
NOD1 is ubiquitously expressed in all cells while NOD2 is expressed only in monocytes, 
macrophages, dendritic cells and some epithelial cells. It has been shown that NOD1 and NOD2 
recognize different structures of core motifs from various PGN (peptidoglycan) structures, a 
component of bacterial cell walls. NOD1 is activated by y-D-glutamyl-meso-diaminopimelic 
acid (meso-DAP) (Chamaillard et al., 2003; Girardin et al., 2003a), which is unique to PGN 
structures from all Gram-negative and some Gram-positive bacteria. NOD2 is activated by MDP 
(muramyl dipeptide), which is present in all Gram-positive and -negative PGN (Girardin et al., 
2003b).
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Figure 1.2: Inflammasome design and activators
Inflammasome design and activators. Inflammasome-forming NLRs share the same general 
features, although mechanisms for ligand recognition may differ. NLRP3, NLRP6, NLRP7 and 
NLRP12 all share a C-terminal leucine-rich-repeat (LRR) region, an internal nucleotide-binding-
domain (NBD), and an N-terminal Pyrin domain (PYD), which recruits the adapter protein ASC 
– a caspase recruitment and activation domain (CARD) and PYD containing protein which links 
the NLR or AIM2 to caspase-1. The ASC adapter is believed to be an integral part of NLRP3, 
NLRP6, NLRP7 and NLRP12 inflammasomes. NLRC4 contains an N-terminal CARD domain 
which can recruit caspase-1 directly, though ASC involvement may increase caspase-1 
processing activity. NLRP1b, like NLRC4, has a N-terminal CARD domain, but has an internal 
LRR and a C-terminal NBD domain. Lastly, AIM2 has a HIN200 DNA binding domain and a 
PYD for ASC recruitment. Different types of stimuli signal inflammasome activation via the 
various NLRs or AIM2, some of which are depicted.
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The Inflammasome
 A relatively new and interesting PRR-containing complex in innate immunity is the 
inflammasome, a multi-protein complex that acts as a platform for the activation of the pro-
inflammatory caspase-1 (originally called ICE (IL-1-converting enzyme))(Martinon et al., 2002). 
Upon activation, caspase-1 proteolytically cleaves the cytosolic-sequestering leader sequence 
from pro-IL-1β, and pro-IL-18 (Wang et al., 1998; Davis et al., 2011b; Franchi et al., 2012b) to 
generate mature cytokines which are released from the cell to mediate downstream inflammatory 
effects (Figure 1.2). Pro-IL-1β and pro-IL-18 are upregulated downstream of TLR stimulation 
and NF-κB activation (Watari et al., 2000). The mature IL-1β is a potent pyrogen with 
pleiotropic function including inciting tissue inflammation by activating epithelial cells 
(Dinarello, 2009). IL-18 can induce IFNɣ, a type-II IFN expressed by T-cells and NK (natural 
killer) cells, and other pro-inflammatory cytokines (Okamura et al., 1995).
 Inflammasomes are constructed of pro-caspase-1 and proteins in the cytosolic NLR 
family, or AIM2; some require the adapter protein ASC that mediates interaction between the 
NLR and pro-caspase-1 (Stutz et al., 2009). NLR composition is outlined in Figure 1.2. The 
LRR is thought to be responsible for the recognition of the specific activating signal (Stutz et al., 
2009). Inflammasome-mediated cytokine release follows a multi-step activation pathway: first an 
NF-κB-dependent upregulation of the inactive pro-forms of IL-1β and IL-18, and also of some 
NLRs, like NLRP3 (Bauernfeind et al., 2009), and second, activation of the NLR itself resulting 
in inflammasome formation. Recently, a 3-step activation pathway has been described for some 
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Gram-negative bacteria that involves caspase-11 and TLR4/TRIF (Rathinam et al., 2012b) 
(Figure 1.3). It should be noted that some cells may have a simpler activation process due to 
higher basal levels of pro-forms of caspase-1 and/or pro-cytokines (Netea et al., 2009). 
 Some NLRs have been well characterized and shown to form inflammasomes (NLRC4, 
NLRP3, AIM2), whereas details are emerging for others (NLRP1, NLRP6, NLRP7, NLRP12). 
Great amounts of evidence have shown the importance of the inflammasome in pathogen 
clearance, however, the inflammasome is also responsible for many host disorders that lead to 
detrimental effects (Dinarello, 2009). Inflammasome activation has also been linked to cell death 
pathways (e.g., pyroptosis), which may be a novel anti-pathogen pathway (Miao et al., 2011).
NLRP3 Inflammasome
 The NLRP3 inflammasome is involved in host responses to a wide variety of pathogenic 
microorganisms (Table 1.1), is expressed by myeloid cells, and is upregulated in response to 
TLR stimulation (Bauernfeind et al., 2009). NLRP3 contains a C-terminal LRR, internal NBD, 
and a N-terminal PYD domain (Figure 1.3). NLRP3 activation and subsequent inflammatory 
damage has also been linked to the pathogenesis of diseases characterized by crystal-mediated 
sterile inflammation, e.g., atherosclerosis caused by the deposition of cholesterol crystals 
(Duewell et al., 2010). Other examples of exogenous NLRP3 activators include silica and 
asbestos, leading to silicosis and asbestosis (Cassel et al., 2008; Hornung et al., 2008).
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 Pathogen Putative 
Bacterial 
Activator
Inflammasome Proposed 
Mechanism
Role in 
host defense 
in vivo
References
Bacillus anthracis Lethal toxin NALP1b/NLRP1b phospho-PKR, 
ATP leakage/K+ 
efflux, pyroptosis
Yes 19, 40, 58, 59
Burkholderia 
pseudomallei
BsaK NLRP3,  NLRC4 nd Yes 23, 60
Burkholderia 
thailandensis
BsaK NLRC4/NAIP2 Ligand binding to 
NAIP
nd 22
Chlamydia 
pneumoniae
nd NLRP3 oxidized mtDNA, 
K+ efflux, 
lysosomal 
acidification, 
cathepsin B release
nd 16, 61
Chromobacterium 
violaceum
CprI NLRC4/human 
NAIP
Ligand binding to 
NAIP
nd 22
Citrobacter 
rodentium
mRNA NLRP3 TLR4/TRIF, 
Caspase-11
nd 5
Escherichia coli mRNA NLRP3 TLR4/TRIF, 
Caspase-11, 
lysosomal rupture
Yes 5, 13
nd NLRP3 phospo-PKR Yes 19
EprJ, Escl NLRC4/NAIP5, 
NLRC4, 
nd Yes 23, 30
Franciscella 
tularensis
DNA AIM2 K+ efflux, 
lysosomal 
acidification
yes 35, 36
Group B 
Streptococcus
β-hemolysin NLRP3 K+ efflux Yes 12
Legionella 
pneumophila
Flagellin NLRC4/NAIP5 Ligand binding to 
NAIP, cPLA2, 
eicosanoid release, 
caspase-7 
activation
Yes 22, 27, 31
Listeria 
monocytogenes
nd NLRP3 GBP5 Yes 18
LLO, DNA? NLRP3, AIM2 nd nd 57
Mycobacterium 
tuberculosis
DNA AIM2 nd Yes 62
ESX-1, 
ESAT-6
NLRP3 pore formation nd 63
ASC/Caspase-1 dependent in vitro, 
not in vivo
yes 66
Pseudomonas 
aeruginosa
PscL NLRC4 nd nd 23
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Flagellin NLRC4/NAIP5 Ligand binding to 
NAIP
nd 22
Salmonella enterica 
serovar Typhimurium
nd NLRP3, NLRC4 GBP5, phospo-
PKR
nd 18, 19
PrgJ NLRC4, NLRC4/
NAIP2
Ligand binding to 
NAIP
Yes 23, 22, 26
T3SS, 
Flagellin
NLRP3, NLRC4 phospho-Ser533, 
PKCδ, TLR4/TRIF, 
Caspase-11
Yes 28, 30, 33, 4
Shigella flexneri Mxil NLRC4 nd nd 23
Staphylococcus 
aureus
α-hemolysin NLRP3 K+ efflux Yes 64
Streptococcus 
pneumoniae
pneumolysin NLRP3 K+ efflux Yes 65
Treponema denticola Td92 NLRP3 ATP leakage/K+ 
efflux
nd 67
Vibrio cholera cholera toxin 
B
NLRP3 Caspase-11 
dependent
nd 53
Yersinia pestis T3SS NLRP3, NLRC4 ND Yes 24
YopJ NLRP3 K+ efflux nd 68
T3SS, YopJ NLRP12, NLRP3 nd Yes 46
   
Table 1.1: Bacterial pathogens, ligands, and their known signaling 
inflammasomes.
The table contains upstream, and in some cases, downstream inflammasome effects after 
pathogen activation.
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 Three models of NLRP3 activation in response to microbial ligands have been proposed 
(Davis et al., 2011b). The channel model suggests that extracellular ATP (adenosine triphosphate) 
from microbial pathogens activates the P2X7 receptor (P2X7R) and allows the efflux of 
intracellular potassium ion (K+) resulting in NLRP3 activation (Figure 1.3) (Franchi et al., 2007; 
Arlehamn et al., 2010). A number of bacterial pore-forming toxins (e.g. Group B Streptococcus 
β-hemolysin (Costa et al., 2012)) can also cause cellular ion dysregulation and subsequent 
NLRP3 activation (Table 1.1). As well LRR-mediated binding of regulatory proteins, such as 
ubiquitin ligase–associated protein SGT1 and heat shock protein 90 (HSP90) may assist in 
controlling NLRP3 activity before activation (Mayor et al., 2007).
 Escape from the lysosome after phagocytosis is an important step during the movement 
of many pathogens, toxins, and cholesterol-dependent cytolysins. The lysosomal rupture model 
for NLRP3 activation posits that the release of lysosomal enzymes, such as cathepsin B, into the 
cell cytoplasm during lysosomal destabilization leads to NLRP3 activation (Figure 1.3) (Davis 
et al., 2011b). Recent studies have shown that prokaryotic mRNA (messenger RNA) released 
from the lysosome into the cytosol during degradation of phagocytosed live bacteria can activate 
NLRP3 (Sander et al., 2011), thus, bacterial RNA may be a key trigger of the NLRP3 
inflammasome during many infections, either by direct binding or though an adapter.
 Reactive oxygen species (ROS) released from the mitochondria are considered to be a 
cellular stress-induced alarms and may trigger NLRP3 inflammasomes. The ROS model is based 
on observations showing that NLRP3 is activated upon mitochondrial damage and release of 
ROS (Zhou et al., 2011). Oxidized mitochondrial DNA (mtDNA) from mitochondria damaged 
by bacterial infection or other means was suggested to bind and activate NLRP3 (Shimada et al., 
25
2012) (Figure 1.3). This phenomenon was negatively regulated by the anti-apoptotic protein 
Bcl2, suggesting a link between apoptosis and inflammasome activation. The idea that the 
NLRP3 inflammasome senses mitochondrial dysfunction could also help in understanding the 
prior observations suggesting an association of mitochondrial damage with inflammatory 
diseases (Beal, 2003).
 Recently, GBP5 (guanylate-binding protein 5) and PKR (dsRNA-dependent protein 
kinase) have been proposed to play integral roles in NLRP3 activation (Figure 1.3). GBP5 
interacts with the pyrin domain of NLRP3 and aids in the oligomerization of the inflammasome 
complex (Shenoy et al., 2012). Importantly, GBP5 promotes a role in NLRP3 activation by live 
bacteria, but not during sterile inflammation in vitro. Infection of GBP5-deficient mice had 
higher uncontrolled infection and faster disease progression in comparison to wild type mice. 
 PKR has also been shown to autophosphorylate upon macrophage stimulation with 
NLRP3 ligands, and active PKR can bind NLRP3 (as well as NLRP1b, NLRC4 and AIM2) (Lu 
et al., 2012). This study proposes that PKR can directly activate the NLRP3 inflammasome and 
mediate the release of pro-inflammatory cytokines when stimulated with many ligands including 
bacterial pathogens. It is, however, unclear how the PKR phosphorylation leading to NLRP3 
inflammasome activation is triggered during infection. 
 Since many of the NLRP3 stimuli lead to inhibition of protein synthesis, it has also been 
found that direct blocking of ribosomal function leads to inflammasome activation (Vyleta et al., 
2012). 
 Methods of controlling inflammasome function are also now just being discovered: 
NLRP3 inflammasome activation triggers autophagosome formation via the G protein RalB 
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which targets ubiquitinated inflammasome for lysosome degradation (Shi et al., 2012). 
Moreover, blocking autophagy increased inflammasome activity and inducing autophagy limited 
it. The post-translational modifications of NLRP3 may also control activation as the 
deubiquitination of NLRP3 by BCRR3 regulates inflammasome activity (Py et al., 2012). 
 Although multiple ways may lead to NLRP3 activation, the array of ligands which trigger 
the NLRP3 inflammasome indicates that common denominators exist.
 The NLRP3 inflammasome can also be activated by host/self molecules, such as ATP, 
monosodium urate (MSU), cholesterol crystals, and amyloid-β - these are associated with cell 
death, tissue damage, or danger (Martinon et al., 2006; Halle et al., 2008; Duewell et al., 2010). 
These have been important findings in human health and disease. For instance, cholesterol 
crystals deposited within arteries are the cause, not the result of, inflammation in an NLRP3 
dependent matter  and therefore provide new insights into the pathogenesis of atherosclerosis and 
may indicate targets for therapy (Duewell et al., 2010). Moreover, MSU deposits within joints is 
indicative of the inflammatory disorder gout, which is also linked to NLRP3-dependent activity 
(Martinon et al., 2006). 
 Genetic predisposition for auto-activation of the NLRP3 inflammasome is associated 
with many inflammatory disorders called cryopyrin-associated periodic fever syndromes (CAPS) 
(Ozkurede and Franchi, 2012). These disorders include familial cold-induced auto-inflammatory 
syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal onset multi-system 
inflammatory disorder (NOMID); all of these present with varying disease severity and 
symptoms include reoccurring fevers, rashes, chills and arthralgia. NOMID, the most severe, can 
cause neurological  problems including aseptic meningitis and deafness (Posch et al., 2012). 
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Patients with CAPS usually have mutations within the NBD domain of NLRP3, and a small 
percentage within the LRR (Hoffman and Brydges, 2011). Mice with FCAS and MWS NLRP3 
mutation knock-ins mimicked clinical manifestations and treatment of these animals with anti-
IL-1β partially yielded the disease progression (Brydges et al., 2009). However, Brydges et al. 
found that cells from these animals did not spontaneously secrete IL-1β but did respond the 
lower concentrations of PAMPs then WT.
 The crystal structure of the NLRP3 PYD domain has been solved and shows 6 α-
helicases that form the canonical anti-parallel folds that are constant though the PYD domain 
family (Bae and Park, 2011). The protein contains two hydrophobic regions, one in the center 
which the helicases are packed around, and a second which is essential for stabilization. Both of 
these patches are necessary for interaction with ASC (Bae and Park, 2011).
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Figure 1.3: Model of NLRP3 activation
Model of NLRP3 activation. Activation of caspase-1 by the NLRP3 inflammasome is a multi-
signal process. Signal 1 occurs when TNF or a TLR ligand binds its cognate receptor resulting in 
the translocation of NF-κB into the nucleus where expression of NLRP3 and the immature (pro-) 
forms of IL-1β and IL-18 are induced. Signal 2 is the activation of NLRP3 resulting in 
recruitment and cleavage of pro-caspase-1 to its active form leading to cleavage of the immature 
inflammatory cytokines. At least three distinct NLRP3 activation pathways have been identified. 
Phagocytosis of extracellular particulates and pathogens results in lysosomal destabilization and 
release of cathepsin B and bacterial mRNA which trigger NLRP3 activation. A decrease in 
intracellular K+ has been shown to result in activation of NLRP3. K+ efflux occurs by 
engagement of extracellular ATP with the P2X7R or directly through bacterial pore-forming 
toxins. ROS generated during mitochondrial damage and oxidized mitochondrial DNA (mtDNA) 
produced during apoptosis lead to activation of NLRP3. Td92, a surface protein of Treponema 
denticola, can interact with the α5β1 integrin resulting in ATP release and K+ efflux. Inhibition 
of ribosomal function and protein synthesis can also direct NLRP3 activation, and this 
mechanism may involve lysosomal destabilization, K+ efflux and ROS. Caspase-11 has been 
defined upstream of caspase-1 during NLRP3 inflammasome activation.
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NLRC4 Inflammasome
 NLRC4 is expressed mainly in macrophages and hematopoietic tissues and cells, and its 
expression is not believed to be upregulated upon TLR activation. Instead of the N-terminal PYD 
domain which is necessary for ASC recruitment, NLRC4 contains a CARD domain that can 
interact directly with pro-caspase-1 (Figure 1.2). A number of bacteria, including Salmonella 
typhimurium, Yersinia pseudotuberculosis, and Listeria monocytogenes, are thought to signal 
caspase-1 activation and IL-1β/IL-18 maturation via NLRC4 (Table 1.1) (Miao et al., 2008; 
Warren et al., 2008; Brodsky et al., 2010; Miao et al., 2010; Zhao et al., 2011). NLRC4 is 
specifically activated by a functional bacterial type-three or -four secretion system (T3SS/T4SS) 
or flagellin (Miao et al., 2010; Zhao et al., 2011) (Figure 1.2). S. typhimurium was one of the 
first bacterial species shown to activate caspase-1 via the NLRC4-inflammasome; and mutants of 
S. typhimurium lacking genes that encode flagellin monomers are unable to induce caspase-1 
(Miao et al., 2010). 
 Although the mechanism is still unclear, the monomers are thought to interact with 
distinct members of the NAIP (neuronal apoptosis inhibitor protein) family that act activate 
NLRC4 (Lightfield et al., 2008). NAIP5, like NLRC4, contains a NBR and LRR but it exchanges 
the C-terminal CARD for a BIR domain and can form hetero-oligomers with NLRC4 (Zamboni 
et al., 2006). NAIP2 and 6 (with 5) are involved in NLRC4 activation, providing an adapter 
service for flagellin and T3SS proteins, respectively (Kofoed and Vance, 2011). Although this 
model of ligand binding and differentiation by NAIPs is appealing, it should be pointed out that 
there is only one human NAIP protein and this has only been found to recognize the 
Chromobacterium violaceum T3SS needle protein CprI (Zhao et al., 2011). 
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 Interestingly, NLRC4/NAIP5 inflammasome activation has been directly tied to 
eicosanoid release from resident murine peritoneal macrophages (Moltke et al., 2012). Activation 
of the NLRC4 inflammasome by flagellin also causes a rapid “eicosanoid storm”, defined as a 
release of signaling lipids (prostaglandins and leukotrienes) which rapidly cause inflammation 
and vascular fluid loss in mice (Moltke et al., 2012). This response was initiated within minutes 
of flagellin detection, however, these in vivo responses were not confirmed during infection and 
the relationship to antimicrobial responses is unknown. 
 NLRC4 has been implicated in a pro-inflammatory defense mechanism in the intestine 
against foreign, but not commensal, bacteria (Franchi et al., 2012a). Intestinal mononuclear 
phagocytes (iMPs) are hyporesponsive to TLR stimulation however, they contain high basal 
levels of pro-IL-1β and NLRC4 which are activated by foreign bacteria presenting a T3SS or 
T4SS (Franchi et al., 2012a). It has been determined that NLRC4 is activated upon 
phosphorylation at Ser533 by PKCδ, which provides some insight into general NLR activation 
(Figure 1.2)(Qu et al., 2012).
NLRP12 Inflammasome
 NLRP12 was the first NLR shown in biochemical assays to interact with the adaptor 
protein ASC to form an active IL-1β-maturing inflammasome (Figure 1.2) (Wang et al., 2002). 
The role of NLRP12 in innate immunity has remained unclear as both inflammatory and 
inhibitory functions have been suggested, as has a role in hypersensitivity - though there have 
been disagreements from different groups, and from within the same group, regarding expression 
and activity of NLRP12. In 2003, Williams et al. reported NLRP12 expression in human DCs, 
monocytes, and neutrophils (Williams et al., 2003). In this study, an overexpression HeLa cell-
31
line and siRNA knockdown in monocytes were used to suggest that NLRP12 controlled MHC 
(major histocompatibility complex) I expression (Williams et al., 2003). The same group showed 
NLRP12 expression is downregulated in human primary PBMCs (peripheral blood mononuclear 
cells) or granulocytes after exposure to high levels of TLR stimulants or M. tuberculosis 
(Williams et al., 2005). In the latter study, they used overexpression and luciferase systems to 
show that a NLRP12 NBD domain associates with IRAK upon TLR stimulation resulting in 
impaired NF-κB expression downstream from MyD88 (Williams et al., 2005). Separately, 
another overexpression system in THP-1 cells was used to show that the NBD and LRR domains 
of NLPR12 associate with NIK (NF-κB inducing kinase). NIK is a kinase upstream of non-
cononical NF-κB activation resulting in the expression of pro-inflammatory cytokines which 
support ongoing immune responses, downstream from CD40 (Coope, 2002). The association of 
NLRP12 and NIK induces NIK degradation in a proteasome-dependent fashion (Lich et al., 
2007). The degradation may involve HSP90, and ATP binding (Arthur et al., 2007; Ye et al., 
2008), as in NLRP3 signaling (Mayor et al., 2007). These studies of NLRP12 describe a negative 
regulation function, but have used only overexpression and siRNA knockdown systems, which 
have sometimes been unreliable. 
 The NLRP12 KO animal was first utilized in 2010 in an allergic dermatitis model to 
show reduced swelling and cellular influx at the site of elicitation. However, this is not due to 
reduced amounts of IL-1β or other cytokines, such as TNF, as in NLRP3-deficient animals in the 
same model (Watanabe et al., 2007; Arthur et al., 2010). NLRP12-deficient animal responses are 
abrogated due to a reduction in DC and myeloid cell migration; in addition, the DCs, as well as 
neutrophils, from these animals fail to respond to chemokines in vitro (Arthur et al., 2010). 
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However, these studies do not correlate with studies from the same group as levels of NF-κB-
induced cytokines or chemokines are not increased, nor is MHCI expression altered. Moreover, 
NLRP12 expression in monocytes was not consistent with those observed in four other 
publications nor did they publish caspase-1 western blots for this model. Up to this point, the 
NLRP12 animal had not been used for any infectious disease studies, and the role of the 
NLRP12 inflammasome in infections was unknown.
 Interestingly, as with NLRP3, mutations in NLRP12 are linked to hereditary 
inflammatory disease (Jéru et al., 2008), and mutations appear to lead to increased ASC speckle 
formation and caspase-1 activity after a conserved missense-mutation (Jéru et al., 2011b), as well 
as increased NF-κB activation after a nonsense-mutation (Jéru et al., 2011a). These results 
mimicked previous observations from NLRP3 mutations (Jéru et al., 2010). It has been reported 
that patients carrying NLRP12 mutations associated with increased inflammasome activation 
have been successfully treated with anti-IL-1 therapy, similar to patients containing mutations in 
NLRP3 (Hawkins and Lachmann, 2003; Lachmann et al., 2009; Jéru et al., 2011a).
NLRP1 Inflammasome
 The original description of the inflammasome complex involved human 
NLRP1(Martinon et al., 2002), which has been shown to be expressed in most cells including 
adaptive immune cells and non-hematopoietic tissues. Human NLRP1 has a N-terminal PYD, 
central NBD, LRR, and FIIND (domain with function to find) domains, and a C-terminal CARD. 
Studies in THP1 cells showed that NLRP1 forms a complex with CARD8, ASC, caspase-5, and 
caspase-1 to subsequently process IL-1β (Martinon et al., 2002). Mice, unlike humans who have 
a single NLRP1 gene, have 3 paralogs expressing NLRP1a, NLRP1b, and NLRP1c-ps. NLRP1b, 
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the major focus of immune studies, contains a C-terminal NBD, an internal LRR, and a N-
terminal CARD domain (Figure 1.2). 
 Mouse NLRP1b has also been linked to IL-1β production by muramyl-dipeptide (MDP) 
(Bruey et al., 2007). Moreover, it has been described as a receptor for lethal toxin from Bacillus 
anthracis in the host cytosol and participates in caspase-1-mediated IL-1β production and 
pyroptosis, in vivo and in vitro (Figure 1.2) (Terra et al., 2009). The detection of lethal toxin has 
also been linked to induction of the eicosanoid response as previously described for NLRC4 
(Moltke et al., 2012). 
 Studies have determined that human NLRP1 is activated in a “two-step process”: first 
MDP binds directly or indirectly to NLRP1 and results in a conformational change that allows 
NTP (nucleotide triphosphate) to bind. This then leads to the oligamerization of NLRP1 and 
recruitment of pro-caspase-1 (Faustin et al., 2007).
NLRP6, NLRP7, and NLRC5
 NLRP6 (Figure 1.2), expressed in the gastrointestinal tract, kidney, liver, and epithelial 
cells (Elinav et al., 2011), has been reported to be involved in obesity, intestinal inflammation 
and tumorigenesis, the regulation of commensal microflora, and most recently, bacterial 
recognition (Chen et al., 2011; Elinav et al., 2011; Anand et al., 2012; Henao-Mejia et al., 2012). 
 A pro-inflammatory role for NLRP6 has been proposed since NLRP6-deficient mice 
showed altered gut microbiota (increase in normally suppressed communities) and a 
predisposition to colitis as a result of decreased levels of IL-18 secretion by intestinal epithelial 
cells (Elinav et al., 2011). However, Anand et al.  presented a novel function for NLRP6 during 
certain bacterial infections as a negative regulator of innate immunity; mice deficient for NLRP6 
were resistant to infection with L. monocytogenes, Salmonella, and E. coli (Anand et al., 2012). 
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Infection of the NLRP6 KO animal resulted in increased monocyte and neutrophil populations in 
the blood and increased NF-κB signaling (Anand et al., 2012), thereby providing evidence of 
NLRP6 in dampening inflammatory signaling, although the mechanism remains elusive.
 NLRP7 is not expressed in mice, but hNLRP7 has been linked to inflammasome function 
in response to bacterial lipopeptides (TLR2 ligands) (Figure 1.2) using a siRNA knockdown 
system (Khare et al., 2012). The NLRP7 PYD 3D structure has been solved by NMR and also 
has a six α-helical bundle fold, as in other NLR PYDs around a conserved hydrophobic core 
(Pinheiro et al., 2010). 
 The main function of another family member, NLRC5, appears to be in regulation of 
MHC class I genes (Meissner et al., 2010), although knock-down data in human cells suggest 
NLRC5 may participate in inflammasome activation during infection (Davis et al., 2011a).
AIM2 Inflammasome
 AIM2 (Absent in Melanoma 2) is a cytosolic receptor for double-stranded DNA and is 
known to form an inflammasome and activate caspase-1 in the presence of bacteria and viruses 
(Figure 1.2) (Hornung et al., 2009; Fernandes-Alnemri et al., 2010; Rathinam et al., 2010). It 
contains an N-terminal pyrin domain and a C-terminal DNA-binding HIN200 domain and is the 
only known HIN200 domain-containing protein with the ability to mature IL-1β and IL-18 via 
interactions with ASC and caspase-1 (Hornung et al., 2009). Macrophages from AIM2 KO mice 
are deficient in caspase-1, pro-IL1β, and pro-IL-18 processing after infection with L. 
monocytogenes and the F. tularensis LVS strain (Fernandes-Alnemri et al., 2010; Rathinam et al., 
2010), thus defining the importance of inflammasome activation against bacteria that replicate 
intracellularly. This anti-bacterial phenotype was recapitulated in vivo as AIM2-deficient mice 
were more susceptible to subcutaneous infection with F. tularensis LVS and resulted in reduced 
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serum IL-18 levels (Fernandes-Alnemri et al., 2010). Moreover, AIM2 plays a major role in the 
detection of cytosolic DNA viruses such as murine cytomegalovirus (MCMV). After MCMV 
infection, the IL-18 and the NK cell-dependent IFNɣ secretion were decreased and correlated to 
increased viral titers in mice deficient in AIM2 (Rathinam et al., 2010). 
 Inflammasome and Caspases
 Recent studies have shown that mouse caspase-11 contributes to caspase-1-independent 
cell death in response to a number of pathogens (Kayagaki et al., 2011; Broz et al., 2012; 
Rathinam et al., 2012b). To the great surprise of the inflammasome field, it was revealed that that 
the widely used caspase-1-deficient mice, generated on a 129 background, also lack a functional 
allele of caspase-11, and are therefore functionally caspase-1/caspase-11 double knockouts 
(Kayagaki et al., 2011). 
 Caspase-11 was found to be a key molecule in inflammasome activation by cholera toxin, 
E. coli, Vibrio cholera and Citrobacter rodentium, as well as a central mediator of LPS-induced 
lethal shock (Kayagaki et al., 2011), although caspase-11 works upstream of caspase-1 for IL-1β 
processing and independently of caspase-1 for the induction of cell death. Rathinam et al. 
subsequently found that TLR4/TRIF-dependent type I IFN production is crucial for caspase-11 
activation in response to various Gram-negative bacteria, and this licenses NLRP3-
inflammasome-induced caspase-1 processing, thus providing another link between TLR and 
NLR signaling (Rathinam et al., 2012b). Broz et al. supported this role for TRIF, and it appears 
that in the absence of caspase-1, lysis of macrophages and the release of intracellular Salmonella 
can be detrimental to the host in a caspase-11-dependent manner (Broz et al., 2012).  
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Inflammasome role in intestinal homeostasis 
NLRP3 and NLRC4
 At the mucosal intestinal surface, the immune system must limit immune responses 
against commensal flora, while protecting the barrier against foreign pathogens. The NLRP3 
inflammasome has emerged as a crucial regulator of intestinal homeostasis, and has been linked 
to inflammatory bowel disease (Zaki et al., 2011a). NLRP3-deficient animals were shown to be 
more susceptible to developing DSS (dextran sodium sulfate)-induced colitis (Zaki et al., 2010). 
The defective inflammasome activity led to loss of epithelial structure, resulting in systemic 
spread of commensal bacteria, massive leukocyte infiltration, and increased chemokine 
production in the colon (Zaki et al., 2010). This study determined that basel level IL-18 
production by the NLRP3 inflammasome in colonic epithelial cells is a critical mediator of the 
mucosal protection against DSS-induced colitis. IL-18 is involved in proliferation and repair of 
epithelial cells, which may protect against IBD and the DSS-induced colitis (Takagi et al., 2003; 
Reuter and Pizarro, 2004). However, there have been conflicting reports that NLRP3-deficient 
animals are resistant to DSS-induced colitis (Bauer et al., 2010). The study by Bauer et al. 
determined that IL-1β and IL-18 mediated inflammation in the pathogenesis of IBD, therefore 
the inability to produce of these cytokines protects the NLRP3-deficient animal. 
 Basel level inflammasome activity of NLRC4 in regulating responses against commensal 
bacteria in the intestines is described above (Franchi et al., 2012a).
NLRP6
 NLRP6 has also been linked to IBD syndromes as NLRP6-deficient mice are more 
susceptible to DSS-induced colitis, just like the NLRP3 mice (Chen et al., 2011), and another 
linked the absence of NLRP6 to reduced IL-18 levels and a deregulation of gut flora (Elinav et 
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al., 2011). It was speculated that NLRP6 in the latter model provides a steady-state level of IL-18 
production, and the reduction of this basal level provides opportunity for suppressed microbiota 
to grow.
NLRP12
 Two recent papers have highlighted the role of NLRP12 in intestinal homeostasis. 
NLRP12-deficient mice were highly susceptible, like other NLR-deficient mice, to DSS-induced 
colitis due to an increase in NF-κB activation resulting increased chemokine production (Allen et  
al., 2012). Moreover, this study found that NLRP12-deficient mice developed colitis-induced 
colon cancer presenting with an increase of target cancer genes (Allen et al., 2012). Allen et al. 
proposed a mechanism that deregulated NF-κB activation, due to NLRP12-deficiency, lead to 
these findings. This study was followed up by Zaki et al. who also found that NLRP12-deficient 
animals were more susceptible to DSS-induced colitis and colorectal tumorigenesis (Zaki et al., 
2011b). Zaki et al. noted an increase in cellular recruitment to the spleen, colon and MLN 
(mesenteric lymph nodes) in the NLRP12-deficient animals during DSS diet, as well as an 
increase in some pro-inflammatory cytokines in the colon of these animals, however, neither 
IL-1β nor caspase-1 activity was analyzed. This study also showed that macrophages lacking 
NLRP12 have an increase in NF-κB activation pathways, though only at later time points (Zaki 
et al., 2011b). Taken together, these studies show that mice lacking NLRP12 develop DSS-
induced colitis faster then WT mice, which mimmic NLRP3-deficient animals, however not 
through a inflammasome / caspase-1 mediated pathway. The latter of the two studies does notice 
a reduction of caspase-1 activity in macrophages from the NLRP12-deficient animal stimulated 
with bacteria and synthetic ligands.
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Summary of Inflammasomes in Innate Immunity
 Inflammasome activation is a key event in the response to pathogens. However, this is a 
double-edged sword as dysfunction and dysregulation can drive human inflammatory diseases, 
and there is a need for balance between resolution of infection and excessive inflammation. 
Thus, we will likely see further studies of regulators of inflammasome activity and infections 
(Rathinam et al., 2012a). It is interesting to note the relationship of the different inflammasome-
forming NLRs during the protection against colitis and bowel-inflammation versus anti-
pathogenic processes. Many of the NLRs described utilize and are involved in common 
activation and regulatory pathways. Moreover, some pathogens are capable of activating multiple 
inflammasomes, such as Y. pestis, Salmonella, and L. monocytogenes (Broz et al., 2010; Kim et 
al., 2010; Vladimer et al., 2012); and cooperation and synergism between multiple NLRs or 
AIM2 and specific caspases during infections is likely to be the focus of future research. Total 
overview of NLR activation by bacterial pathogens is in Table 1.1. Continuing investigation into 
inflammasome activation mechanisms, including proposed upstream activators such as 
cathepsins, ROS, GBP5, PKR and PKC will drive our understanding of inflammation and 
hopefully elucidate novel drug targets for both antimicrobial and anti-inflammatory uses.
Cytosolic nucleic acid recognition / RIG-Like Receptors (RLRs)
Cytosolic RNA detection
 Foreign nucleic acid within the cytosol is an extremely potent PAMP, and elicits a strong 
innate immune response. Viruses depend on the host machinery for nucleic acid replication, and 
moreover, bacterial and viral lysis causes the release of a variety of nucleic acid species 
(Hornung and Latz, 2010; Barbalat et al., 2011). Both double and single stranded DNA and 
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RNA, as well as some tertiary structures have been shown to be innate immune activators (Kato 
et al., 2006; Poeck et al., 2009; Rathinam et al., 2010; Keating et al., 2011; Sharma et al., 2011). 
 The RLR family contains two major receptors: RIG-I and MDA5 (Barbalat et al., 2011), 
which are both known to detect poly(I:C) in the cell cytoplasm (Kato et al., 2008). Longer 
polymers of poly(I:C) are preferentially recognized by MDA5, whereas smaller polymers are 
recognized by RIG-I (Kato et al., 2008). RIG-I has also been implicated in the cytosolic 
detection of short, uncapped 5’-triphosphate ssRNA (Hornung et al., 2006). Therefore, RIG-I can 
discriminate between self/nonself based on the absence of the 7-methyal-guanosine cap group on 
viral mRNA. 
 RIG-I and MDA5 signal IRF3 activation though the adapter protein MAVS 
(mitochondrial antiviral signaling) (Kawai et al., 2005). MAVS contains an N-terminal CARD 
domain that mediates the RLR/IRF3 activation axis, and is located in the mitochondrial outer 
membrane (Kawai et al., 2005). RIG-I also must also be ubiquinated by the E3 ligase TRIM25 
(tripartite motif-containing 25), in order for recruitment of MAVS and subsequent signaling 
(Gack et al., 2007). The ubiquitination of RIG-I may “prime” the receptor before binding viral 
RNA, which may work as a control mechanism. 
 As TRIM25 is upstream of RIG-I signaling, STING (stimulator of IFN gene) may be 
downstream (Ishikawa and Barber, 2008). STING is a transmembrane protein implicated in RIG-
I signaling via MAVS but not for MDA5 (Ishikawa and Barber, 2008), although the exact role for 
STING still remains controversial (Ishikawa and Barber, 2008; Ishikawa et al., 2009; Nakhaei et 
al., 2009; Barbalat et al., 2011).
Cytosolic DNA detection
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 To date, knowledge of DNA detection, excluding the discovery of AIM2 described above, 
in the cytosol is still limited. The transfection of poly(dA:dT) (poly(deoxyAdenylic-
Thymidylic)) DNA into cells activates IRF3, independently of TLRs (Stetson and Medzhitov, 
2006), but though an unknown receptor. It is known that transfected poly(dA:dT) can be 
transcribed by RNA polymerase III (PolIII) to generate 5‘cap-deficient RNAs for signaling 
though RIG-I (Hornung et al., 2006). DAI (DNA-dependent activator of IRF) has also been 
shown to bind DNA and activate IRF3 for downstream type 1 IFN production in L929 cells 
(Takaoka et al., 2007). However, DAI-deficient animals do not present a phenotype (Ishii et al., 
2008), possibly due to a redundancy of cytosolic DNA receptors.
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Yersinia pestis
Overview
 Yersinia pestis, the Gram-negative causative agent of plague, is estimated to have killed 
200 million people over three pandemics (Perry and Fetherston, 1997). Though plague outbreaks 
are rare and infections can be treated through the early use of antibiotic therapy, there is still 
great concern over the possibility of weaponized Y. pestis as a bioterrorism agent (Butler, 2009). 
Y. pestis infects via two routes: bubonic, and pneumonic, which both lead to septicemic spread 
(Perry and Fetherston, 1997); all are treatable if intervention is started within 24 hours after the 
onset of symptoms. Bubonic plague is transmitted between mammalian hosts when a flea takes a 
blood meal from an infected rodent and then another (Perry and Fetherston, 1997). The 
bacterium is then trafficked by macrophages to the draining lymph node where it escapes and 
replicates rapidly, thereby causing buboes (enlarged lymph nodes), necroses, and eventually 
death of the host (Perry and Fetherston, 1997; Guinet et al., 2008). 
 The development, and continued spread, of plague requires that Y. pestis establish a 
systemic infection characterized by very high bacteremia, exceeding 108 per ml of blood; this is 
after transfer of only a few bacteria into the intradermal skin layer delivered by a flea bite (Perry 
and Fetherston, 1997; Hinnebusch, 2005). Large foci of plague infection are usually devoid of 
inflammatory cells, therefore, plague can cause bacteremia while avoiding innate immune 
activation. Once Y. pestis has become systemic, it can colonize the lung and can spread person-
to-person via aerosol droplets, which defines Pneumonic plague (Perry and Fetherston, 1997). 
 To evade and quell local inflammation, Y. pestis uses several mechanisms that are 
necessary for virulence and the factors are encoded on three “virulence plasmids”. These factors 
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include a type III secretion system (T3SS), which delivers multiple effector proteins to the 
cytoplasm of host cells in contact with the bacteria, and Pla, an outer membrane protease with 
plasminogen activator activity (Sodeinde et al., 1992; Cornelis, 2002b). Extracellular release of 
the T3SS-associated protein LcrV has also been suggested to contribute to immune suppression 
(Pouliot et al., 2007). 
 Many Gram-negative bacteria, including Y. pseudotuberculosis, a very close ancestor of 
Y. pestis, produce a hexa-acylated lipid A and LPS, which has the potential of strongly triggering 
innate immunity via TLR4-MD2 signaling (Therisod et al., 2002; Rebeil et al., 2004; Raetz Cr, 
2007; Munford, 2008). In contrast, Y. pestis generates a tetra-acylated lipid A/LPS that poorly 
induces TLR4-mediated cellular activation (Kawahara K, 2002; Knirel et al., 2005; Montminy et 
al., 2006; Rebeil et al., 2006). We have reported that expression of E. coli lpxL in Y. pestis, which 
lacks a homolog of this gene, forces the biosynthesis of a hexa-acylated lipid A/LPS and that this 
single modification dramatically reduces virulence in wild-type mice, but not in mice lacking a 
functional TLR4 (Montminy et al., 2006). This emphasizes that avoiding activation of innate 
immunity is important for Y. pestis virulence.
 
Evolution of highly pathogenic Yersinia pestis
 The genus Yersinia contains three pathogenic species: Y. pestis, the causative agent of 
plague, and the enteric food- and water-borne pathogens Y. pseudotuberculosis and Y. 
enterocolitica, which cause self-limiting gastroenteritis. Plague is responsible for the deaths of 
approximately 200 million people in Europe and North Africa during two pandemics termed 
Justinian’s plague (541–767 A.D.) and the Black Death (1346–19th century) (Achtman et al., 
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2004). Y. pestis is classified into three biovars. Orientals, Medievalis, (estimated to be 
responsible for the Black Death), and Antiqua (DEVIGNAT, 1951; Achtman et al., 2004). The 
biovars are have distinct IS100 insertion elements, DNA islands, and multilocus variable number 
of tandem repeats (Achtman et al., 1999; Deng et al., 2002; Morelli et al., 2010). 
 Y. pestis evolutionarily emerged from Y. pseudotuberculosis approximately 2,603–28,646 
years ago, and shares strong sequence homology, making exact dating difficult (Achtman et al., 
1999; Morelli et al., 2010). Though these pathogens are so closely related, the clinical 
manifestations are dramatically different (Perry and Fetherston, 1997). There have been reports 
of sequence comparisons of Y. pseudotuberculosis to Y. pestis which identified 32 Y. pestis 
chromosomal genes and two Y. pestis specific virulence plasmids that represent the only new 
genetic material that Y. pestis acquired since the divergence (Chain, 2004). In contrast, 317 
genes, and 149 pseudogenes, from Y. pseudotuberculosis are absent from Y. pestis, indicating that 
nearly 13% of genes no longer function in Y. pestis (Chain, 2004). Chain et al. also reported 
many genomic rearrangements and reductive genetic evolution through gene loss, which resulted 
in elimination and modification of gene expression pathways. This appeared to be more 
important for plague virulence than acquisition of genes.
 Necessary to the virulence of all Yersinia is the shared requirement of a virulence plasmid 
which encodes a type III secretion system which is responsible for injecting a number of 
effectors termed Yops (Yersinia outer proteins) into host cells that inhibit bacterial phagocytosis 
and pro-inflammatory pathways (Michiels et al., 1990; Perry Rd, 1998). 
 Two additional plasmids unique to Y. pestis are necessary during tissue invasion and 
capsule formation, as well as infection of the plague flea vector(Cornelis, 2002a; Butler, 2009). 
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However, the presence of these unique plasmids by themselves cannot account for the 
remarkable increase in virulence observed in Y. pestis (Butler, 2009). 
 Phylogenetic analysis shows that Y. pestis evolved in or near China and spread to Europe, 
South America, Africa, and Southeast Asia, leading to country-specific lineages with unique 
SNPs (single nucleotide polymorphisms) (Morelli et al., 2010). Moreover, only slight genetic 
drift in important Y. pestis virulence factors have been detected in the 660 years of evolution as a 
ruthless human pathogen, suggesting that the previous increase in virulence may not only be due 
to single molecular changes, but is one component of a number of factors including population, 
living conditions, and vector dynamics which caused the major outbreaks (Bos et al., 2011).
Virulence factors of Yersinia pestis
 The success of Yersinia pestis as a human pathogen comes from its ability to promote 
bacterial survival and transmission while disrupting normal cellular function and thwarting host 
defense responses. Plague has three virulence plasmids, as previously mentioned, and a number 
of virulence factors within the genome that all play a role in pathogenesis, (outlined in Table 1.2)
(Perry and Fetherston, 1997; Kraushaar et al., 2011). 
Genome encoded virulence factors
Lipopolysaccharide and TLR4 evasion
 LPS, which decorates the outer membrane of Gram-negative bacteria and is anchored to 
the membrane by lipid A (endotoxin) (Raetz Cr, 2007), is an extremely potent immune activating 
PAMP. Lipid A is a di-glucosamine molecule covalently modified with fatty acid chains and 
phosphate groups; it is synthesized by eight enzymes encoded in the genome of Gram-negative 
bacteria (Brozek and Raetz, 1990). 
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 The eight to nine responsible enzymes are highly-conserved among Gram-negative 
bacteria, however, the composition of the acyl-chains can vary widely between different, and the 
same, bacterial species. The number of, and modifications to, acyl-chains can be effected by 
many environmental factors (Raetz Cr, 2007). The majority of Gram-negative bacteria are not 
viable when lacking early enzymes in the lipid A biosynthesis pathway, however, bacteria 
lacking the late-acyl-transferases are generally able to recover (Clementz et al., 1996; Zhou Z, 
1999; Rebeil et al., 2006). 
 The late-acyl-transferases add the secondary chains to the tetra-acylated lipid A precursor 
lipid IVA (Rebeil et al., 2006). All closely related bacterial pathogens to Y. pestis express a hexa-
acylated lipid A, which has 6 fatty acid chains. This hexa-acylated lipid A signals strongly 
through the TLR4/MD2 complex as defined above (Lien et al., 2000; Park et al., 2009). 
 Y. pestis has two variations of lipid A depending on the growth conditions (Kawahara et 
al., 2002); when grown at 26oC, Y. pestis expresses a hexa-acylated lipid A, just as its other 
relatives, above (Montminy et al., 2006). However, when grown at 37oC, Y. pestis has a tetra-
acylated lipid A, which is lacking the two secondary acyl-chains (Kawahara et al., 2002; 
Montminy et al., 2006). These two temperatures are important to the plague life-cycle as they are 
the major growth temperatures of the two hosts: flea and mammal. The lipid A that is expressed 
at 37oC is not TLR4 stimulatory, and this was described by Montminy et al. as a major virulence 
factor (Montminy et al., 2006). Moreover, purified LPS from Y. pestis grown at 37oC inhibits 
TLR4 activation by TLR4-activating LPS (Montminy et al., 2006). This lipid A phenotype is due 
to the evolutionary loss of a homolog of the E. coli LpxL, a late-acyl transferase, from Y. pestis. 
Y. pestis can express hexa-acylated lipid A at 26oC as it upregulates expression and activity of a 
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cold-shock-induced late-acyl-tranferase, LpxP. LpxL and LpxP add the second to last secondary 
acyl-chain to Lipid IVA, the last chain is added by a conserved LpxM which has temperature-
independent activity(Montminy et al., 2006; Feodorova et al., 2009). This LPS expression model 
will be referred to in the following chapters.
Iron Assimilation
 Also expressed within the genome is the ability for Y. pestis to sequester and store iron as 
a nutrient, allowing it to grow in iron-deficient environments (Perry and Fetherston, 1997). Y. 
pestis, for biosafety is classified into two groups: pigmented (Pgm+) and non-pigmented (Pgm-), 
the latter has a spontaneous 102kb deletion from its genome responsible for iron assimilation. 
The term pigmentation comes from the absorption of exogenous heme, causing pigmented 
colonies when growing on particular media (Perry and Fetherston, 1997). The Pgm- strains are 
avirulent unless hemin, ferrous sulfate, or ferric chloride is injected with the pathogen. However, 
in 2009 a naive researcher became infected and later died from bubonic plague following contact 
with a Pgm- strain due to his possible hemochromatosis-induced iron overload which was able to 
supplement the lack of virulence (Centers for Disease Control and Prevention (CDC), 2011). 
 Within the Pgm locus are the genes for hemin storage (Hms), as well as genes for iron 
uptake. Hms+ bacteria store hemin within the outer membrane when grown at 26oC and this has 
been shown to be essential for flea blockage, but its role in mammalian infection is unknown 
(Hinnebusch, 2005).
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Y pestis contains lllllllerous important vimlence factors which are encoded in the 
genome or all three vimlence plasmids . pCDl is conserved among Yersillia family members 
and pMTl and pPCPl were obtained upon evolutionary divergence from Y. 
pseudotuberculosis. 
Virulence Plasmids
 The Y. pestis derivative KIM (Kurdistan Iran Man; from where it was isolated) contains 
three virulence plasmids: pPCP1 (pesticin, coagulase, plasminogen activator), pCD1 (calcium 
dependence), and pMT1 (murine toxin) (Perry and Fetherston, 1997); only the pCD1 plasmid is 
conserved among other Yersinia species (called pYV1 in Y. pseudotuberculosis). The plasmids 
are described below from smallest to largest.
pPCP1 Plasmid
 The 9.5kb pPCP1 plasmid encodes three virulence genes. Pesticin (pst), a secreted 
bacteriocin which kills related surrounding bacteria within the same niche by hydrolyzing 
peptidoglycan (Perry and Fetherston, 1997). Y. pestis pPCP1 also expresses a pesticin immunity 
protein (pim), localized to the periplasm, which inactivates the bacteriocin thereby protecting 
itself from destruction (Pilsl et al., 1996). 
 Most importantly, pPCP1 contains the gene for the plasminogen activator, Pla, a surface 
protease and proven virulence determinant. Pla is responsible for coagulase and fibrinolytic 
activity during infection (Sodeinde et al., 1992; Perry and Fetherston, 1997). Pla-deficient 
pathogens were significantly less virulent upon subcutaneous or intranasal infection (Sodeinde et 
al., 1992; Lathem et al., 2007), but had comparable virulence when injected intravenously 
(Sodeinde et al., 1992). This lead to the hypothesis that Pla protease’s function was to promote 
bacterial dissemination from the local tissue/site of infection. 
pCD1 Plasmid, secretion system, and Yops
 The calcium dependence plasmid encodes the low-calcium response stimulon (LCRS) 
which controls the expression of the T3SS that delivers secreted effector proteins termed Yops 
(Yersinia outer proteins) to the cytosol of host cells (Michiels et al., 1990; Cornelis, 2002a). 
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Expression of pCD1 is highest at 37oC in the absence of millimolar concentrations of calcium, 
thereby expressing virulence factors at the highest level when in a mammal and close to host 
cells (Higuchi et al., 1959). 
 The Yops have multiple functions: YopB and YopD are secreted by the system and make 
up the pore in the host membrane (Neyt and Cornelis, 1999) while LcrV (V antigen) forms the 
tip of the needle apparatus (Table 1.2) (Price Sb, 1991). Seven secreted Yops have been 
identified: YopH, YopE, YopT, YpkA, YopJ, YopM, and YopK (activity outlined in Table 1.2) 
(Perry Rd, 1998). 
 Four of the Yops (YopH, YopE, YopT, and YpkA) limit phagocytosis by inhibiting 
dynamics of the cytoskeleton of macrophages and neutrophils (Perry and Fetherston, 1997; 
Andersson et al., 1999; Black et al., 2000). YopH is a tyrosine phosphatase which 
dephosphorylates focal adhesions thereby reducing phagocytosis, as well as lymphocyte 
proliferation (Black and Bliska, 1997). YopE, YopT and YpkA (Yersinia protein kinase A) act on 
monomeric GTPases of the Rho family which are anchored to the cytoplasmic face of the plasma 
membrane of host cells and control actin polymerization/depolymerization (Cornelis, 2002a). 
Specifically, YopE acts as a GTPase-activating protein which changes the GTPases on the inside 
of the plasma membrane ‘off’ by speeding up GTP hydrolysis yielding phagocytosis activity 
(Black and Bliska, 2000). YopT, a cysteine protease cleaves Rho GTPases and detaches them 
from the membrane causing actin-depolymerization (Iriarte and Cornelis, 1998; Zumbihl et al., 
1999). Lastly, YpkA, an autophosphorylating serine/threonine kinase, becomes activated after 
actin interaction and assists in actin-depolymerization and changes in cytoskeleton dynamics 
(Håkansson et al., 1996; Juris et al., 2000). 
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 YopJ can inhibit pro-inflammatory signal transduction by modifying various proteins 
upstream from the transcription factors MAPK and NF-κB, and blocking production of 
downstream cytokines (Boland and Cornelis, 1998; Orth K, 2000; Sweet et al., 2007; Paquette et 
al., 2012), though the exact mechanism is still under investigation. YopJ from Y. pestis has been 
described as a serine/threonine acetyltransferase that can modify critical residues in factors such 
as TAK1 and IKKβ upstream of MAPK and NF-κB activation (the latter in Figure 1.4) (Orth K, 
2000; Paquette et al., 2012). YopP of Y. pseudotuberculosis (the homologue of YopJ) uses the 
TAK1 acetylation to subvert NOD2 activity in the gut, leading to intestinal barrier dysfunction 
(Meinzer et al., 2012). This YopJ-induced modification competes directly with the 
phosphorylation that occurs during normal activation. Therefore, YopJ also blocks pro-survival 
signals and is considered a pro-apoptotic virulence factor (Cornelis, 2000).
 YopJ has also been described to have de-ubiquitinating function and interferes with 
TRAF6/3 signaling downstream of TLR activation, thereby blocking MAPK, NF-κB and IRF 
activation (Figure 1.4) (Sweet et al., 2007). 
 It is possible that YopJ contains both of these features and has multiple roles in halting 
pro-inflammatory cytokine translation downstream from transcription factor activation.
 Multiple groups have also shown that YopJ activity is necessary for caspase-1 activation 
and downstream pro-IL-1β and pro-IL-18 processing (Brodsky et al., 2010; Zheng et al., 2011; 
2012), although the direct mechanism has not been elucidated. It has been suggested that the 
inhibitory effect of YopJ on the NF-κB pathway leads to inflammasome activation in a NLRP3, 
ASC, and caspase-1 dependent manner, and does not necessarily activate the NLR directly 
(Zheng et al., 2011). YopJ activity was also necessary for the apoptosis of infected cells (Lilo et 
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al., 2008). The cell-death pathway activated seemed to depend on the activation state of the cells; 
activated cells died by the more pro-inflammatory pyroptosis pathway instead of apoptosis 
(Bergsbaken and Cookson, 2009; Brodsky, 2012). This YopJ-induced caspase-1 activation and 
cell death was shown to be independent of mitochondrial-directed apoptosis, but is involved in 
necrosis of infected cells (Zheng et al., 2012). YopJ has a strong role within cells in vitro; 
however, strains lacking YopJ have shown no changes in virulence during animal infections.
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Figure 1.4: Activity of Y. pestis YopJ and location of YopK
 YopJ plays a dual role inside cells during Y. pestis infection. As an acetyltransferase, YopJ 
acetylates activators, IKKβ here, of pro-inflammatory transcription factors (such as NF-κB). The 
acetyl group blocks the normal phosphorlation-dependent activation rendering the pathway off. 
YopJ has also been described to have a de-ubiquitinase function, removing the K-63 linked poly-
ubiqutin chains from TRAF proteins upstream from pro-inflammatory transcription factors. Red 
lines with arrows are YopJ function, red lines with stop arrows are blocked pathway function, 
black dotted arrows are summarized pathways,‘A’ is the acetyl group, and the gray stars are K63-
linked poly-Ub.
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 YopK, which shares no sequence identity with other known proteins, has been shown to 
play a role in Yop regulation and delivery, and possibly localizes to the tip of the T3SS with 
LcrV inside the host cell (Holmstrom et al., 1995; Holmström et al., 1997; Brodsky et al., 2010; 
Dewoody et al., 2011). YopK also has been linked to regulating inflammasome activation during 
macrophage infection with an engineered Y. pseudotuberculosis strain, as YopK-deficient strains 
cause an increased caspase-1 activity, however the mechanism of this is still unknown (Brodsky 
et al., 2010).
 The role of YopM during plague infection also has yet to be determined fully; it contains 
an N-terminal LRR which makes up most of the protein and is shaped in a TLR-like horseshoe 
structure, and possibly binds eukaryotic proteins (Evdokimov et al., 2001). YopM, after injection, 
traffics to the nucleus of macrophages in a vesicle-dependent manner (Skrzypek et al., 1998). 
Bubonic infection of C57BL/6 mice with fully virulent plague versus a strain lacking YopM 
showed markedly decreased virulence, though this was not the case during pneumonic plague 
(Ye et al., 2009). Very recently, YopM was implicated in the binding of caspase-1 and therefore 
restricting inflammasome formation (LaRock and Cookson, 2012). However, only Y. 
pseudotuberculosis infections with YopM deficient strains were performed and the relation to 
plague infection us unknown.
The pMT1 Plasmid
 pMT1 is the largest virulence plasmid, but only encodes two known virulence factors: 
murine toxin (Ymt) and the structural gene for fraction 1 (F1) protein capsule antigen (Perry and 
Fetherston, 1997). At 37oC, the F1 protein is expressed and forms a gel-like capsule responsible 
for blocking phagocytosis by macrophages, possibly by limiting receptor interaction (Perry and 
Fetherston, 1997; Du et al., 2002). Ymt refers to a protein which has β-adrenergic blocking 
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ability, and when released from lysing bacteria during systemic plague infection, causes vascular 
collapse and hypotension (Montie, 1981). However, the expression of Ymt is higher at 26oC, and 
was discovered that the expression is necessary for flea transmission (Hinnebusch et al., 2002). 
 Y. pestis replicates in the midgut of fleas and forms cohesive aggregates, eventually 
blocking normal feeding; the blockage is necessary for efficient transmission as blocked fleas 
feed more often (Perry and Fetherston, 1997). Y. pestis expressing a mutant Ymt could not cause 
flea blockage, and therefore, fleas infected with the mutant had decreased transmission rates 
(Hinnebusch et al., 2002). 
Plague Vaccines
 Yersinia pestis easily avoids innate host defenses, however, animals which survive initial 
infection effectively resist re-infection (Perry and Fetherston, 1997). The ability to resist 
infection suggests that an efficient vaccine that confers strong protection can be created. 
Formalin-killed whole bacteria were licensed and sold in the United States as a plague vaccine 
and given to members of the US military during the Vietnam War (Butler, 2009). While the 
vaccine protected against bubonic plague, it did not protect against pneumonic plague. 
Furthermore, the vaccine would cause adverse reactions after booster injections (Cavanaugh et 
al., 1974). This led to the understanding that killed whole-cell vaccines will probably not protect 
against weaponized plague. 
 Subunit vaccines targeting F1 protected mice and rats against bubonic and pneumonic 
plague (Feodorova and Corbel, 2009). However, using F1 alone does not protect against F1-
negative Y. pestis strains (Worsham et al., 1995). Single subunit vaccines using recombinant 
LcrV work well to protect against pneumonic and bubonic plague, with or without F1 capsule 
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protein (Anderson et al., 1996). However, there is evidence that plague strains express LcrV 
variants, and therefore, this subunit vaccine may not confer cross-protective immunity 
(Roggenkamp et al., 1997). Putting these two subunit vaccines together and creating an F1/LcrV 
fusion may provide greater protection against animal challenge (Williamson et al., 1995; Heath 
et al., 1998). 
 Live attenuated plague vaccines have also been developed; the use of a live and virulent 
Y. pestis expressing a TLR4 stimulating lipid A (described above) can protect against pneumonic 
and bubonic plague, however the strains described were still considered controlled pathogens 
and could pose a threat (Montminy et al., 2006).
Thesis Rationale, Objectives, and Summary
 Yersinia pestis has a dark history as an exceptionally powerful pathogen causing 
widespread death while directing centuries of cultural changes. Y. pestis kills by evading innate 
immune system activation while multiplying to almost 108 bacilli per milliliter of blood resulting 
in massive bacterial sepsis (Perry and Fetherston, 1997). Y. pestis effectors stop immune 
signaling while halting phagocytosis, dissolving clots to assist in dissemination, all while hiding 
itself from the host by expressing modified lipids on the its surface (Sodeinde et al., 1992; 
Cornelis, 2002a; Rebeil et al., 2004). The innate immune system can counteract most pathogens 
using TLR and NLR mediated surveillance to elicit an inflammatory response to assist in 
clearance, and the connection between plague, the cytosolic NLRs, and downstream pathways 
had yet to be elucidated.
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 We discovered that expressing a single gene, LpxL, resulted in a hexa-acylated lipid A on 
the surface of Y. pestis, and that this could protect mice from initial pneumonic and bubonic 
infection, as well as challenges in a TLR4-dependent manner (Montminy et al., 2006). Using this 
modified strain, which effectively activates the innate immune system, as well as wild type 
plague, we sought to elucidate the inherent control mechanism that plague can bypassed during 
infection. As an important cytosolic receptor, it was our hypothesis that the inflammasome was 
necessary for eliciting a strong inflammatory response during plague infection, and that an 
effector of Y. pestis either activated or controlled inflammasome function. Moreover, we worked 
to elucidate the evolutionary history of Y. pestis loss of LpxL and how this may have played a 
role in inflammasome signaling.
 Overall, we determined that Y. pestis, either wild type or expressing a hexa-acylated lipid 
A, activates the NLRP3, NLRC4 and NLRP12 inflammasomes in macrophages in a T3SS / YopJ 
dependent manner. These inflammasomes are necessary for animal survival during bubonic 
plague infection with the LpxL modified strain, and during pneumonic plague when infected 
with WT plague. Moreover, the downstream cytokines IL-18, IL-1β, and IFNɣ were 
extraordinarily important for protection against subcutaneous or respiratory infection. With this 
model we also determined a novel important pro-inflammatory role for the NLRP12 
inflammasome, which had not been previously elucidated.
 This work suggests that the inflammasome components are prime targets of Y. pestis 
ligands and strongly initiate important immune function for the clearance of plague. By studying 
how plague evades innate immune pathways, we can uncover more successful vaccine strategies 
and therapeutic targets, as well as novel roles for known receptors. As more and more drug 
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resistance bacterial strains emerge, the importance of having a broader range of understanding of 
how pathogens and the immune system cooperate will be more important then ever.
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CHAPTER 2 
Evolution of virulence in Yersinia pestis by loss of lipid A acyl-transferase 
LpxL: impact on NLRC4 inflammasome activation
Abstract
 Yersinia pestis has several means of evading host defenses. We propose that its inability 
to synthesize TLR4-activating hexa-acylated LPS caused by loss of lipid A biosynthesis enzyme 
LpxL was one of the key determinants for increased virulence during the evolutionary split of Y. 
pestis from the closely related Y. pseudotuberculosis. Modified Y. pestis generating a Y. 
pseudotuberculosis- or a Y. enterocolitica-like hexa-acylated lipid A are largely attenuated. Here, 
we implicate the inflammasome molecule NLRC4 in host responses against Y. pestis (and Y. 
pseudotuberculosis). NLRC4-deficient animals produced less IL-18, IL-1β and IFNγ upon 
infection with Y. pestis, and survival of animals infected with Y. pestis was NLRC4 dependent. 
We suggest an evolutionary advantage in development of high virulence for Y. pestis by 
subverting detection via TLR4, with a subsequent reduction in activation of inflammasomes.
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Introduction
 The success of Y. pestis as a pathogen comes from its ability to evade immune detection 
early during infection utilizing several virulence factors. As a result, plague is characterized by 
very high bacterial numbers during septic infection (Perry and Fetherston, 1997). Key factors for 
immune evasion include a type III section system (T3SS), a membrane bound plasminogen 
activator (Pla), and a strong iron acquisition system (Cornelis, 2002a; Lathem et al., 2007). The 
Yersinia T3SS delivers modifying proteins into the host cell cytoplasm that disrupt signaling, 
induce apoptosis, and limit immune activation functions (Cornelis, 2002a). 
 Related Gram-negative bacteria, including Y. pseudotuberculosis, the direct evolutionary 
parent of Y. pestis, and Y. enterocolitica, produce a hexa-acylated lipid A and LPS which can 
strongly trigger innate immunity via Toll-like receptor 4 (TLR4)-MD-2 signaling (Therisod et 
al., 2002; Rebeil et al., 2004; Raetz Cr, 2007; Munford, 2008). In contrast, Y. pestis generates a 
tetra-acylated lipid A-LPS that poorly induces TLR4-mediated cellular activation (Kawahara et 
al., 2002; Knirel et al., 2005; Montminy et al., 2006; Rebeil et al., 2006). This is due to the lack 
of a late lipid A acyl transferase (LpxL, also called HtrB) by Y. pestis needed to produce a hexa-
acylated LPS at mammalian body temperature. Previously we have reported that expression of E. 
coli lpxL in Y. pestis causes the biosynthesis of a hexa-acylated LPS (Montminy et al., 2006), and 
that this single addition reduces virulence of plague during bubonic and pneumonic infection in 
wild type mice, in a TLR4 dependent manner. This change in virulence highlights the importance 
of immune evasion during Y. pestis evolutionary divergence, and creates a model to study the 
immune pathways necessary for detection of bacterial pathogens. 
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 The three pathogenic Yersiniae share many virulence factors and it is reported that Y. 
pestis may have diverged from Y. pseudotuberculosis between 1,500 and 20,000 years ago 
(Achtman et al., 2004; Chain, 2004; Morelli et al., 2010). This is much more recent than the 
divergence of Y. pseudotuberculosis/Y. pestis from Y. enterocolitca estimated at 41-186 million 
years ago (Kraushaar et al., 2011). Despite the recent divergence and close similarity of Y. pestis 
and Y. pseudotuberculosis these two pathogens cause very different clinical manifestations in 
humans. Plague often results in sepsis with high mortality whereas Y. pseudotuberculosis and Y. 
enterocolitica mostly cause self-limiting gastroenteritis and mesenteric lyphadenitis. While the 
later species are transmitted orally, Y. pestis is transmitted primarily by the bite of infected fleas 
or spread of aerosol droplets. Adaptation to this mode of transmission, which imposed 
requirements for survival in the flea gut and the ability to rapid establish system infection 
following inoculation into the skin, may have driven the development of high virulence in Y. 
pestis (Hinnebusch, 2005). The production of a tetra-acylated LPS may also be an important 
factor for better enabling infection via a flea bite at a peripheral site. In this regard, it may be 
relevant that a number of gastrointestinal Gram-negative pathogens do in fact produce a hexa-
acylated LPS, whereas infection via other sites often can be associated with hypo-acylated lipid 
A (Munford et al., 1982).
 TLR signaling is critical for the sensing of pathogens, and one implication of TLR4 
engagement is the induction of the pro-forms of the central inflammatory cytokines IL-1β and 
IL-18 downstream from NF-κB activation. The cleavage of the pro-cytokines into active IL-1β 
and IL-18 is dependent upon activation of the inflammasome, a cytosolic multi-protein complex 
consisting of inactive pro-caspase-1 and members of the nucleotide-binding domain-leucine rich 
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repeat (NLR) family of immune system proteins(Stutz et al., 2009). The assembly of an 
inflammasome leads to proteolytic activation of caspase-1 which in turn cleaves pro-IL-1β and 
pro-IL-18 (Latz, 2010). The NLR family is evolutionary conserved and has more than 20 
members. Many are proposed to play a role in innate immunity, such as, NOD1/2 (recognizing 
peptidoglycan fragments), NLRP1 (which senses anthrax lethal toxin), NLRP3 (which is 
activated by alterations in membrane potential and exposure to many crystal structures and 
pathogens), NLRC4 (which senses intracellular flagellin and bacterial type III secretion rod 
proteins), NLRP6 (both inflammasome activation and a potential negative regulator of 
inflammation), NLRP12 (promotes pro-inflammatory responses against Y. pestis) and Naip5 
(which promotes Legionella pneumophila resistance) (Ye et al., 2008; Kanneganti, 2010; Chen et 
al., 2011; Horvath and Schrum, 2011; Allen et al., 2012; Anand et al., 2012; Lamkanfi and 
Kanneganti, 2012; Vladimer et al., 2012).
 Here we provide evidence for the loss of LpxL to be a major event in the divergence of Y. 
pestis from Y. pseudotuberculosis and the development of differences in virulence between the 
two pathogens. The absence of LpxL minimizes the incorporation of secondary acyl chains in Y. 
pestis lipid A. The result is a decrease in activation of NLRC4 inflammasome, and reduced 
subsequent IL-18 and IL-1β release. Our results suggest that the action of NLRC4 is effective in 
limiting Y. pestis growth in vivo. Thus, we have shown that Y. pestis is able to activate multiple 
innflammasomes - NLRP3, NLRP12 and NLRC4 - and we propose that Y. pestis needs to 
minimize strong inflammasome activation in innate immunity by lipid A modification in order to 
induce lethal bubonic plague.  
63
Results
Y. pestis LPS structure and evolution of virulence.
 At 37oC Y. pestis produces a tetra-acylated LPS with poor stimulatory activity (Kawahara 
K, 2002; Rebeil et al., 2004; Montminy Sw, 2006). We have earlier expressed E. coli LpxL in Y. 
pestis, enabling the production of a TLR4-stimulating hexa-acylated LPS at 37oC, and found that 
this single modification greatly reduces virulence (Montminy et al., 2006). A comparison of Y. 
pseudotuberculosis and Y. pestis genomes shows that lpxL is part of a block of Y. 
pseudotuberculosis genes present in Y. pseudotubercolosis that has been deleted from Y. pestis 
(Chain, 2004). We cloned lpxL from Y. pseudotuberculosis IP2666 and expressed it Y. pestis, 
under its own promoter, to to determine its effects on virulence and on the stimulation of TLR4. 
We found that Y. pestis KIM5 expressing Y. pseudotuberculosis LpxL on pBR322 (KIM5-
pYtbLpxL) produces a hexa-acylated lipid A, comparable to the lipid A from wild type (WT) Y. 
pseudotuberculosis IP2666 (referred to as IP2666) (Figure 2.1 A,B). Mass spectrometry analysis 
revealed that the lipid A composition in Y. pestis-pYtbLpxL and Y. pseudotuberculosis is 
strikingly similar, with some heterogeneity in the lipid A species present (Figure 2.2 A,B,C). 
Consequently, purified LPS from IP2666 and KIM5-pYtbLpxL have comparable abilities to 
induce cellular activation when added to human PBMC or HEK293/TLR4-MD-2 cells (Figure 
2.1 C,D), and are much more active than LPS from parental Y. pestis KIM5. The LPS failed to 
activate HEK293/TLR2 or mock transfected cells (Figure 2.2 D,E). 
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Figure 2.1: The addition of a lost late-acyl transferase increases immune 
recognition of Y. pestis
(A-B, H-I) Major lipid A structures depicted from mass spectrometry analysis of (A) Y. 
pestis KIM5, (B) Y. pestis KIM5-pYtbLpxL and Y. pseudotuberculosis, (H) Y. 
enterocolitica, and (I) Y. pestis KIM5-EntLpxL all grown at 37oC. (C-G,J) ELISA of 
supernatants after stimulation of (C) human PBMCs (D) HEK293 expressing mouse 
TLR4/MD2 (E-G, J) or BMDMs for (C) TNF, (D) IL-8, or (F-H, K) IL-1β. Cells were 
stimulated either overnight (C-D) or for 6 hours (F-H, K).
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Figure 2.2: Mass Spectrometry analysis of variations of Yersinia lipid A 
reveals the changes of the late-acyl transferase LpxL on structure
Y. pestis KIM5, KIM5-pYptbLpxL, and IP2666 were grown at 37 ºC and the lipid A 
purified from whole bacteria by Bligh-Dyer two-phase organic extraction. The lipid was 
then further purified over a DE52 column and analyzed by MALDI-TOF mass 
spectrometry. The negative ion spectra shown here are representative of multiple 
extractions. (A) Negative mode MALDI-TOF analysis of Y. pestis KIM5. Tetra acyl lipid 
A (m/z 1405) with 4 C14:0 acyl groups is the predominant lipid A species found in this 
bacterium. (B) Negative mode MALDI-TOF analysis was also conducted on Y. 
pseudotuberculosis IP2666. Three predominant species present; tetra-acyl lipid A with 
four C14:0 acyl groups (m/z 1405), a penta-acyl lipid A with an additional secondary 
C12:0 acyl chain (m/z 1587), and a hexa-acyl lipid A with two additional C12:0 acyl 
chains (m/z 1769). (C) KIM5-pYptbLpxL expresses a very similar acyl chain pattern to 
IP2666. (D-E) ELISA of IL-8 in supernatants of HEK293 cells expressing (D) mouse 
TLR2 and (E) a control plasmid; stimulation with various ligands was overnight. D-E are 
control experiments for Figure 2.1 D.
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 Purified LPS alone is unable to induce release of IL-1β, and needs addition of an 
inflammasome specific stimulator such as alum (triggering NLRP3 activation) (Figure 2.1 E) for 
IL-1β secretion, suggesting that other bacterial factors are needed for activation of the 
inflammasome. We observed that in vitro infection of cells with KIM5 induced some release of 
IL-1β, but the response was markedly increased after infection with KIM5-pYtbLpxL (Figure 
2.1 F). The experiments indicate that the increased immune response is due to the change in LPS 
structure as Y. pestis producing a hexa-acylated LPS at 37oC has normal growth in vitro and in 
vivo, preserved membrane stability, Pla activity, and type III secretion activity (data not shown). 
Thus, it appears that the presence of a potent LPS in KIM5-pYtbLpxL significantly enhanced the 
ability of the cells to produce IL-1β.   
 Analysis of known genome segments of various Yersiniae suggested that lpxL is present 
in all members of the genus except Y. pestis (Figure 2.3 A-B). As with Y. pseudotuberculosis 
LpxL, the expression of Y. enterocolitica LpxL in KIM5 (KIM5-pYeLpxL) enabled the 
production of a hexa-acylated lipid A (Figure 2.1 H-I, 2.4 A-B) and the secondary 3’ C14 acyl 
chain in lipid A from KIM5-pYeLpxL, presumably added by Y. entrocolitica LpxL, resembled 
that of wild type Y. enterocolitica (Rebeil et al., 2004). The addition of LpxL and resulting 
modification resulted in the enhanced the ability of the bacteria to induce IL-1β in mouse cells, 
compared to KIM5 (Figure 2.1 J). 
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Figure 2.3: lpxL in Yersinia
Punitive genes for lpxL were identified by BLAST analysis using E. coli K12 lpxL within 
sequenced Yersinia strains.  Punitive lpxL genes were located in all sequenced Yersinia 
with the exception of Y. pestis. (A) Clustal-W alignment of punitive lpxL genes in 
sequenced Yersinia strains.  Yellow shading denotes area of sequence homology, with the 
consensus sequence is listed above. (B) Percent identity and divergence of the lpxL 
sequences generated after clustal-W alignment. 
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Figure 2.4: Yersinia enterocolitica LpxL
(A) Mass spectra analysis of Y. enterocolitica strain 8081. The predominant species present 
are typical tetra-acyl lipid A with three C14:0 acyl groups on the digucosomine backbone and 
one secondary C14:0 acyl chain, a penta-acyl lipid A with an additional primary C14:0 acyl 
chain, and a hexa-acyl lipid A with a secondary C12:0 acyl chains. (B) Y. pestis expressing Y. 
enterocolitica  LpxL (KIM5-pYeLpxL) expresses a very similar acyl chain pattern to 8081.
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 To test pathogen virulence, mice were subjected subcutaneous (s.c.) infection with fully 
virulent Y. pestis KIM1001 or KIM1001-pYtbLpxL (or our previously published KIM1001-
EcLpxL), and observed TLR4-dependent survival in animals infected with strains expressing 
potent lipid A, whereas all mice infected with KIM1001 died (Figure 2.5 A). Along the same 
lines, the expression of Y. enterocolitica lpxL in KIM1001 also protected mice from infection 
(Figure 2.5 B). We previously published that the survival of mice infected with KIM1001-
pYtbLpxL correlated with the absence of bacteria in spleens, compared to KIM1001, indicating 
control of the pathogen before systemic spread (Vladimer et al., 2012). To further study the 
importance of lpxL expression on TLR4 engagement and cytokine production via hexa-acylated 
lipid A, we engineered a strain with a deleted lpxL gene from Y. pseudotuberculosis, generating 
IP2666ΔLpxL (Figure 2.5 C-D). HEK293 cells expressing TLR4/MD2 stimulated with the 
IP2666ΔLpxL had reduced IL-8 responses in comparison to stimulations with WT IP2666, this 
was regained after the addition of the pYtbLpxL plasmid used in KIM5 above (Figure 2.5 E). 
Although we studied present-day lpxL genes only, we propose that the loss of lpxL was a 
necessary step in the evolution of virulence from Y. pseudotuberculosis to Y. pestis, related to the 
production of a tetra-acylated LPS and the resulting evasion of TLR4 signaling.
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Figure 2.5: The Addition of LpxL protects animals from subcutaneous 
infection with Y. pestis
(A-B) Survival of animals infected subcutaneously, to mimimc bubonic plague, with fully 
virulent (A) Y. pestis KIM1001, KIM1001-pEcLpxL, or KIM1001-pYtbLpxL and (B) Y. 
pestis KIM1001 or KIM1001-pYeLpxL. (C-D) The major lipid A structures of Y. 
pseudotuberculosis IP2666 lacking LpxL, or with an LpxL addback. (E) ELISAs of 
supernatant IL-8 from HEK293 cells expressing TLR4/MD2 after stimulation for 18 hours
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Inflammasome and macrophage response to wild type and modified strains of Y. pestis and Y. 
pseudotuberculosis
 Our in vitro experiments (Figure 2.1) verified that Y. pestis induced IL-1β release, and 
this release was markedly enhanced by the expression of Y. pseudotuberculosis or Y. 
enterocolitica LpxL. Previous experiments with Y. pestis expressing E. coli and Y. 
pseudotuberculosis LpxL suggested that IL-1R and IL-18R signaling could play a more 
important role in resistance to Y. pestis strains generating a hexa-acylated lipid A/LPS than 
signaling via type I IFN, IL-12 or TNFR I signaling (Montminy et al., 2006; Vladimer et al., 
2012). We also showed that mice deficient in MyD88, an adaptor common to TLR, IL-1R and 
IL-18R signaling pathways, revealed that these mice were more susceptible to wild type Y. pestis 
KIM1001 than wild-type C57Bl/6 mice (Vladimer et al., 2012). The possible involvement of 
IL-1β and IL-18 led us to perform in vitro experiments to identify candidate inflammasome 
components that promote caspase-1 cleavage and IL-1β/IL-18 release following infection with Y. 
pestis modified strains. We have previously shown a role for NLRP12 and NLRP3 in innate 
immune responses to parental Y. pestis and strains producing a hexa-acylated LPS. Y. pestis 
harbors a type III secretion system, often associated with NLRC4 activation, and it has been 
proposed that NLRC4 participates in macrophage responses to attenuated Y. pestis strains 
(Brodsky et al., 2010). We found that NLRC4 participates in the release of IL-1β from 
macrophages infected with KIM5 and KIM5-YptbLpxL (Figure 2.6 A-B). NLRC4 deficient 
macrophages responded normally to alum/LPS but did not respond to S. typhimurium (Miao et 
al., 2010) (Figure 2.6 C). Moreover, we see the same strong IL-1β production from BMDM 
stimulated with WT IP2666 in a LpxL dependent manner (Figure 2.6 D). NLRC4 deficiency had 
no impact on TNF release when stimulated with various ligands (Figure 2.6 E). 
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Figure 2.6: Y. pestis activates the production of IL-1β in a NLRC4 dependent 
manner, upregulated by expression of LpxL
(A-E) ELISAs of supernatant from stimulated BMDM stimulated with (A-B, E) KIM5, or 
KIM5-pYtbLpxL (C) Salmonella or ALUM+KIM5pYtbLpxL LPS (D-E) IP2666, 
IP2666ΔLpxL, or IP2666ΔLpxL-pYtbLpxL to detect (A, C-D) IL-1β, (B) IL-18, or (E) TNF. 
Stimulations all lasted 6 hours, with 50µg/ml gentamycin added after 3 hours. Bacterial 
stimulations used 10cfu. 
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 We conclude that IL-1β and IL-18 release in macrophages involve multiple 
inflammasome components: caspase-1, ASC, NLRP3, NLRP12 (Vladimer et al., 2012) and 
NLRC4. Some other live pathogens are also reported to interact with different inflammasome 
NLRs, or NLRs plus AIM2 (Broz et al., 2010; Kim et al., 2010). It is at present unclear how 
these different inflammasome components cooperate in order to provide maximum protection of 
the host. Future studies may determine if multiple parallel signals generate different 
inflammasomes containing either NLRP3, NLRP12 or NLRC4, or if all signals converge into 
larger caspase-1 processing complexes simultaneously containing all these NLRs. It is of note 
that single ASC containing complexes are often observed by microscopic studies of macrophages 
infected with S. typhimurium.
NLRC4 mediates in vivo host resistance to Y. pestis infection.
 Performing in vivo infections with Y. pestis strains expressing a potent LPS using mice 
deficient in key innate immunity molecules will clarify the basis for the advantage gained by Y. 
pestis via loss of lpxL during evolution. Moreover, the strains could be used as tools to probe 
novel innate immunity pathways, as we have previously shown (Vladimer et al., 2012). We 
subjected wild type and NLRC4 KO mice to s.c. infection with Y. pestis KIM1001-pYtbLpxL. 
Mice with defects NLRC4 showed greatly increased susceptibility to the bacteria, with 
approximately 70% of the mice succumbing the bacterial challenge (Figure 2.7 A). The 
improved survival observed in animals infected with i.v. with 500 cfu of KIM1001-pYtbLpxL as 
compared to fully virulent KIM1001 at 48 hpi was correlated with significantly increased IL- 18 
and IL-1β in sera and spleens of animals (Figure 2.7 B-C). This increase was diminished in the 
NLRC4 KO mice, and their cytokine levels generally reduced (Figure 2.7 B-C).
78
 Intravenous infection revealed a significant reduction of spleen bacterial load when mice 
were infected with KIM1001-pYtbLpxL compared to wild-type KIM1001 (Figure 2.7 D), 
indicating beneficial host responses induced by the presence of the hexa-acylated LPS. However, 
these differences in systemic bacterial load between the two bacterial strains were absent in the 
NLRC4 KO mice. Furthermore, NLRC4 KO mice also had increased bacterial loads compared to 
wild type mice when infected with the virulent Y. pestis (Figure 2.7 D). 
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Figure 2.7: Y. pestis activates the production of IL-1β in a NLRC4 dependent 
manner, upregulated by expression of LpxL
(A-E) ELISAs of supernatant from stimulated BMDM stimulated with (A-B, E) KIM5, or 
KIM5-pYtbLpxL (C) Salmonella or ALUM+KIM5pYtbLpxL LPS (D-E) IP2666, 
IP2666ΔLpxL, or IP2666ΔLpxL-pYtbLpxL to detect (A, C-D) IL-1β, (B) IL-18, or (E) TNF. 
Stimulations all lasted 6 hours, with 50µg/ml gentamycin added after 3 hours. Bacterial 
stimulations used 10cfu. *p < 0.05; **p < 0.001.
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Discussion
 Y. pestis is considered the most recently evolved of the human-pathogenic Yersiniae. It is 
believed that the ancestors to present-day Y. enterocolitica and Y. pseudotuberculosis split many 
million years ago, whereas the split between Y. pestis and Y. pseudotuberculosis is much more 
recent – a few thousand years ago (Achtman et al., 2004; Chain, 2004; Zhou and Yang, 2009). 
Much interest is associated with finding critical factors that contributed to the greatly increased 
virulence in Y. pestis compared to its ancestors. 
 In this report we provide results consistent with the hypothesis that loss of LpxL, and the 
resulting inability to synthesize a potent TLR4-activating hexa-acylated LPS at 37oC, was a 
major event in the the evolution of high virulence in Y. pestis. Y. pestis expressing LpxL from Y. 
pseudotuberculosis strain produces a lipid A which is similar to that of Y. pseudotuberculosis, 
more so that the Y. pestis containing E. coli LpxL (Montminy et al., 2006). Our current data 
indicate that the production of IL-1β and IL-18 are crucial components of LPS-induced 
protection in the context of Y. pestis infection. We propose that avoiding the effects of these 
inflammatory cytokines was a major selective force driving the divergence of Y. pestis from Y. 
pseudotuberculosis. We also conclude that inflammasome activation by the bacteria is an 
effective way of limiting spread of Y. pestis in the host, thus, evading these mechanisms is key in 
the strategy of Y. pestis to limit innate immunity.
 We show that the expression of Y. pseudotuberculosis and Y. entrocolitica LpxL in Y. 
pestis enables the production of hexa-acylated LPS at 37oC, increasing TLR4-dependent release 
of potent pro-inflammatory cytokines and greater activation of the NLRC4 inflammasome. This 
increased activity correlates with increased resistance to the modified pathogen. In fact, the 
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results indicate that a major consequence of producing LPS with low TLR4-activating potential 
could be lack of priming necessary for effective synthesis of active IL-1β and IL-18. Strains 
lacking LpxL, or containing LpxL with a point mutation at a residue associated with enzymatic 
activity, had reduced release of IL-1β and IL-18 in vitro and in vivo and strongly increased 
virulence.
 Our data supports the thought that the cytosolic inflammasome complex is necessary for 
a strong host response against many pathogens. It is known that Y. pestis limits activation of NF-
kB and MAPK pathways by acetylating upstream components via a type III secretion effector 
YopJ (Mittal et al., 2006; Sweet et al., 2007; Paquette et al., 2012). We, and others have 
demonstrated YopJ can promote IL-1β release and inflammasome activation (Vladimer et al., 
2012; Zheng et al., 2012). Previous studies have shown that Y. pestis can activate the NLRP3, 
NLRP12 and now the NLRC4 inflammasome, and this suggests that NLRs may work together 
for optimal protection of the host. More work must be completed to resolve the association of all 
of the inflammatory NLRs which protect against pathogens. Greater knowledge of molecular 
relationships this will assist in determining better targeted therapeutics and vaccine candidates.
Materials and Methods
Bacterial Strains and Growth Conditions
Y. pestis KIM is originally a clinical isolate from a Kurdistan Iran man (Perry and Fetherston, 
1997). Y. pestis strains KIM5, KIM1001, KIM5-pYtbLpxL, and KIM1001-pYtbLpxL were as 
reported (Vladimer et al., 2012). Y. pseudotuberculosis IP2666 (containing a complementation of 
PhoP/PhoQ deficiency) and Y. enterocolitica 8081 were provided by J. Mecsas. Strains were 
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grown in tryptose-beef extract (TB) broth with 2.5 mM CaCl2 all by shaking at 37C.  All strains 
containing plasmids above remained tetracycline sensitive. KIM1001 (pPCP1+, pCD1+, and 
pMT1+) is highly virulent (Perry and Fetherston, 1997), whereas KIM5 bears the chromosomal 
deletion ‘‘Δpgm,’’ which substantially attenuates virulence. The pgm locus contains no genes 
thought to affect LPS biosynthesis. For the generation of IP2666-ΔLpxL, the product was cloned 
in the allelic exchange vector pRE107 in E.coli K12 strain B2155 and transferred to IP2666 by 
conjugation; recombinants were selected on TB medium containing 100 mg/ml ampicillin but no 
diaminopimelic acid. After counter selection with 5% sucrose, deletion mutants were identified 
by PCR. For in vitro infections, bacteria were grown overnight at 37oC in TB broth with or 
without ampicillin, diluted 1:4 in fresh media, and cultured for three more hours at 37oC, then 
washed three times with PBS and resuspended in DMEM or RPMI. S. enterica serovar 
typhimurium strain SL1344 was provided by M. O’Riordan.
Lipid preparations
Pyrogen-free reagents and supplies were used as much as possible during isolation of lipids. 
Lipid A and LPS were prepared as described (Montminy et al., 2006) after suspension growth of 
strains overnight at 37ºC. Briefly, LPS was prepared by hot water-phenol extractions followed by 
two phenol re-extractions, and lipid A was prepared directly from whole bacteria using a Bligh-
Dyer two-phase chloroform-methanol/water organic extraction.
Cell Stimulations
Mouse BMDMs were prepared by maturing fresh bone marrow cells for 5–7 days in the presence 
of M-CSF containing supernatant from L929 cells. Mouse BMDMs were plated at 105 per well 
in 96-well plates for ELISA or 106 per well in 12-well plates for immunoblotting. Stimulation 
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was for 6 hr and supernatants were collected for cytokine analysis. Three hours after bacterial 
infections, 50 mg/ml of gentamycin was added. Alum was from Pierce; nigericin and 
poly(dA:dT) was from Sigma. IL-1β p17 and Caspase-1 p10 immunoblots were conducted 
mainly as described (Hornung et al., 2009) with antibodies from Santa Cruz Biotechnology 
(caspase-1 p10) and R&D (IL-1β). The antibody against β-actin was from Sigma. ELISA kits for 
IL-1β, TNF-a, IL-8, CXCL12, IFN-ɣ (R&D), and IL-18 (MBL) were used for cytokine 
detection. 
Mice
All experiments involving animals were approved by the Institutional Animal Care and Use 
Committee. ASC (PYCARD) and NLRC4 (IPAF) mice were generated by Millennium 
Pharmaceuticals and were backcrossed 8–11 generations to C57BL/6 background. Mice deficient 
in TLR4 (TLR4) were from S. Akira. Wild-type, C57BL/6 (from Jackson Laboratories or bred at 
UMass) and knockout mice were infected s.c. in the nape of the neck with Y. pestis, or orally 
with IP2666, and their survival was monitored twice a day for 30 days. For cytokine and CFU 
analysis, mice were infected i.v. and sacrificed at the indicated time points. Serum was generated 
by centrifugation in microtainer tubes (BD), and spleens were homogenized in 0.5 ml PBS with a 
closed system Miltenyi gentleMACS dissociator and c-tubes to preserve intact cells; 
subsequently cells/debris were removed by centrifugation. Samples for cytokine analysis were 
subjected to protease inhibitor (Roche) treatment. Hematoxylin and eosin (H&E) staining and 
microscopy were performed as published (Montminy et al., 2006).
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CHAPTER 3: 
The NLRP12 and NLRP3 Inflammasomes Recognize Yersinia pestis During 
Bubonic Plague Infection
Abstract
 Yersinia pestis, the causative agent of plague, is able to suppress production of 
inflammatory cytokines IL-18 and IL-1β, which are generated through caspase-1-activating 
NLR-containing inflammasomes. Here, we sought to elucidate the role of NLRs and IL-18 
during bubonic plague. Lack of IL-18 signaling led to increased susceptibility to Y. pestis and Y. 
pestis expressing a modified lipid A / LPS. We found that the NLRP12 and NLRP3 
inflammasomes were important regulators controlling IL-18 and IL-1β production after Y. pestis 
infection, and inflammasome-deficient mice were more susceptible to bacterial challenge. 
NLRP12 and NLRP3 also directed interferon-γ (IFN-γ) production via induction of IL-18, but 
NLRP12 deficiency had minimal effect on NF-κB signaling. These studies reveal a novel role for 
NLRP12 in host resistance against pathogens. Minimizing NLRP12, and other, inflammasome 
activations may have been a central factor in evolution of the high virulence of Y. pestis.
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Introduction
 The NLR family has more than 20 members, and their relative roles in promoting 
resistance to infection are in many instances unclear. There is evidence supporting a function in 
bacterial recognition for several NLRs, reviewed above. The role of NLRP12 in innate immunity, 
however, has remained unclear. Both inflammatory and inhibitory functions have been 
suggested, as has a role in hypersensitivity (Wang et al., 2002; Lich et al., 2007; Lich and Ting, 
2007; Arthur et al., 2010; Zaki et al., 2011b). Interestingly, like for NLRP3, mutations in 
NLRP12 are linked to hereditary inflammatory disease (Jéru et al., 2008). It has been reported 
that patients carrying NLRP12 mutations associated with increased inflammasome activation 
have been successfully treated with anti-IL-1 therapy, similar to patients containing mutations in 
NLRP3  (Hawkins and Lachmann, 2003; Lachmann et al., 2009; Jéru et al., 2011a). No previous 
studies have addressed the role of NLRP12 in host resistance to infectious agents.
 Evading innate immunity early in infection plays a key role in virulence of many 
microorganisms including the plague bacillus Yersinia pestis (Perry and Fetherston, 1997; 
Cornelis, 2000; Stenseth et al., 2008). This pathogen has several means of minimizing immune 
activation (Sodeinde et al., 1992; Monack et al., 1997; Zhou et al., 2005; Mukherjee et al., 2006; 
Lathem et al., 2007), with the effect that bacterial replication can proceed with minimal 
interference by the immune system. As a result, plague is often characterized by very high 
bacterial numbers in patient sera and organs (Perry and Fetherston, 1997). Major factors 
neutralizing host defenses by active means include a complex type III secretion system (T3SS) 
(Perry and Fetherston, 1997; Cornelis, 2002a), the plasminogen activator Pla (Sodeinde et al., 
1992; Lathem et al., 2007), and a high-affinity iron acquisition system (Perry and Fetherston, 
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1997). The Yersinia T3SS delivers effector proteins, which disrupt signaling within the host cell 
to prevent phagocytosis, induce apoptosis, and evade the immune response (Cornelis, 2002a). 
Many Gram-negative bacteria, including Y. pseudotuberculosis, a very close ancestor of Y. pestis, 
produce a hexa-acylated lipid A-LPS which has the potential of strongly triggering innate 
immunity via Toll-like receptor 4 (TLR4)-MD-2 signaling (Therisod et al., 2002; Rebeil et al., 
2004; Raetz Cr, 2007; Munford, 2008). In contrast, Y. pestis generates a tetra-acylated lipid A/
LPS that poorly induces TLR4-mediated cellular activation (Kawahara et al., 2002; Knirel et al., 
2005; Montminy et al., 2006; Rebeil et al., 2006). We have reported that expression of E. coli 
LpxL in Y. pestis, which lacks a homologue of this gene, forces the biosynthesis of a hexa-
acylated LPS (Montminy et al., 2006), and that this single modification dramatically reduces 
virulence in wild type mice, but not in mice lacking a functional TLR4. This emphasizes that 
avoiding activation of innate immunity is important for Y. pestis virulence. It also provides a 
model in which survival is strongly dependent on innate immune defenses, presenting a unique 
opportunity for evaluating relative importance of innate immunity signals in protection against 
bacterial infection. 
 One implication of TLR4 engagement is the induction of the immature forms of the 
central pro-inflammatory cytokines IL-1β and IL-18. TLR4 signaling can also promote 
expression of inflammasome components such as NLRP3 (Bauernfeind et al., 2009). This 
establishes links between TLR4 activation and the inflammasome pathways. In this study we 
have used wild type Y. pestis and attenuated strains expressing a strong TLR4-activating hexa-
acylated LPS as a model system to investigate the involvement of NLRP12 in pathogen 
recognition and IL-18/IL-1β release.
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 Here we show that NLRP12 is an inflammasome component that is central in the 
recognition of Y. pestis and that IL-18 signaling substantially contributes to resistance against 
bacteria. Compared to wild type mice, NLRP12 deficient animals had higher mortality and 
increased bacterial loads following infection, correlated with lower levels of IL-18, IL-1β and 
IFNγ. We propose a role for NLRP12 in the sensing of microbial pathogens.
Results
IL-18 signaling is essential for resistance to attenuated Y. pestis 
 We have found that all members of the genus Yersinia other than Y. pestis, and including 
the very closely related Y. pseudotuberculosis, contain the lpxL gene (Chapter 2, unpublished). 
Absence of lpxL and the resulting production of a tetra-acylated LPS was proposed to be 
essential for Y. pestis virulence (Montminy et al., 2006). To study the evasion of TLR4 signaling 
in an evolutionary perspective, we cloned lpxL from the closely related Y. pseudotuberculosis and 
expressed it in Y. pestis, generating Y. pestis-pYtbLpxL, to determine its effects on virulence. Y. 
pestis grown at 37oC has a tetra-acylated lipid A (Figure 3.1 A) (Montminy et al., 2006) whereas 
Y. pseudotuberculosis and Y. pestis-pYtbLpxL have a hexa-acylated lipid A (Figure 2.1 B). Mice 
infected s.c. (subcutaneously) with 500 c.f.u. (colony forming units) of highly virulent Y. pestis 
KIM1001 rapidly succumb to infection (Figure 3.2 A). All wild-type mice infected with 
KIM1001-pYtbLpxL expressing a hexa-acylated Y. pseudotuberculosis-like lipid A survived 
(Figure 3.2 A), and the animals were protected towards challenge with virulent KIM1001 (Table 
3.1). Survival of mice was strongly TLR4 dependent (Figure 3.2 A). To determine the pathways 
responsible for in vivo clearance, mice from several strains deficient in inflammatory cytokines 
or cytokine receptors were infected s.c. with 500 c.f.u. of KIM1001-pYtbLpxL (Figure 3.2 B). 
Interestingly, 100% of the animals lacking IL-18 and IL-18R died, as did the TLR4 KO mice and 
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70% of the IL- lRI KO mice. Weaker effects were observed in animals lacking IFNapR, TNFRl , 
or IL-12p40 (Figure 3.2 B). 
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Figure 3.2: Infection of Mice with Y. pestis-pYtbLpxL Is Controlled by IL-18
(A) Survival of mice infected s.c. with 500 CFUs of Y. pestis KIM1001 (C57Bl/6: n = 8) or 
KIM1001-pYtbLpxL (C57Bl/6 and Tlr4-/-[TLR4 KO]: n = 10) bacteria. (B) Mortality of 
animals infected s.c. with 500 CFUs of KIM1001-pYtbLpxL (n = 7 for Ifnar-/-[IFNabR KO], 
8 for Il12b -/-[IL-12p40 KO], 10 for C57Bl/6, Il1r1 -/-[IL-1R1 KO], Il18r1 -/-[IL-18R KO], 
Il18 -/-[IL-18 KO], and TLR4 KO). Statistical differences in TLR4, IL-18, or IL-18R versus 
IL-1R and other strains: p < 0.002. Statistical differences in IL-12p40, IL-18, IL-18R, and 
TLR4 versus C57Bl/6: p < 0.001. (C and D) Survival of mice deficient in (C) IL-1β (Il1β-/-, 
IL1β KO) and IL-1R and (D) IL-18 infected s.c. with 500 CFUs of KIM1001-pYtbLpxL (n = 
10 of each genotype). (E and F) Concentrations of spleen IL-1β and IL-18 from C57BL/6 
mice infected i.v. with 500 CFU of KIM1001 or KIM1001-pYtbLpxL for 44 hr.(G) IL-1β in 
supernatants from BMDM stimulated with 10 multiplicity of infection (m.o.i.) of KIM5 or 
KIM5-pYtbLpxL for 6 hr, 50 mg/ml of gentamicin was added to wells after 3 hr.p.i.; error 
bars represent the SD. (H) Immunoblot of IL-1β in the combined lysates and supernatants of 
BMDMs stimulated with 10 m.o.i. of Y. pestis KIM5, KIM5-pEcLpxL, and KIM5-
pYtbLpxL and 1 m.o.i. of Salmonella typhimurium. Both pro-IL-1β (upper band) and mature 
IL-1β (lower band) are shown. Shown is representative of three to five performed 
experiments. *p < 0.05; **p < 0.01; ***p < 0.001
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Table 3.1: Mice immunized with Y. pestis KIM1001-pYtbLpxL are resistant to 
challenge with KIM1001
Survival of wild type mice vaccinated subcutaneously with Y. pestis KIM1001-pYptbLpxL 
and naive mice (None) after subsequent subcutaneous challenge with Y. pestis KIM1001, 
presented as surviving mice of total mice. Data representative of two to three experiments.
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Resistance to infection in IL-1β and IL-1R1 deficient animals was reduced to a similar degree, 
with approximately 30% of animals surviving (Figure 3.2 C). However, IL-18 was critically 
important for resistance to infection in this model, as IL-18 and IL-18R deficient mice developed 
all symptoms of bubonic plague, and rapidly succumbed to disease when infected with 
KIM1001-pYtbLpxL (Figure 3.2 B and 3.2 D). As inflammasomes are responsible for 
processing of IL-18 and IL-1β into mature forms, this result indicates that this infection model is 
well-suited for the study of inflammasome mechanisms and implications of IL-18 release. Mice 
deficient in MyD88, an adaptor molecule common to TLR, IL-1R and IL-18R signaling 
pathways were more susceptible to wild type Y. pestis KIM1001 than wild-type C57Bl/6 mice 
(Figure 3.1 C) and are also highly susceptible to strains expressing LpxL (Montminy et al., 
2006). Intravenous (i.v.) infection causes systemic infection even when attenuated bacterial 
strains are used, hence the inflammatory capacity in tissues for various bacterial strains can 
better be compared using this route of delivery. We found elevated levels of spleen IL-1β and 
IL-18 during i.v. infection with Y. pestis, and fully virulent KIM1001 induced lower cytokine 
levels as compared to KIM1001-pYtbLpxL producing the potent LPS (Figure 3.2 E-F). A 
similar release pattern could also be seen in vitro using bone marrow derived macrophages 
(BMDM) (Figure 3.2 G) after stimulation with KIM5 (a pgm mutant attenuated strain used for 
in vitro experiments) or KIM5-pYtbLpxL. Western blot analysis (Figure 3.2 H) indicated that 
pro-IL-1β was indeed cleaved into mature IL-1β following infection with Y. pestis strains, a sign 
of inflammasome action. Infection with the Y. pestis-YtbLpxL strain markedly increased levels 
of pro- and cleaved IL-1β. These results indicate that minimizing inflammasome priming may 
94
have been an important implication of lpxL loss during evolution of Y. pestis from Y. 
pseudotuberculosis. 
NLRP12 is involved in recognition of Y. pestis
 We next wanted to determine which NLRs were involved in resistance to Y. pestis strains 
and in IL-18 and IL-1β release. NLRP12 and NLRP3 have both been shown to interact with ASC 
in generating an IL-1β processing inflamammasome (Manji et al., 2002; Wang et al., 2002; 
Agostini et al., 2004), but little is known of the role of NLRP12 during infection. We infected 
NLRP3 KO and NLRP12 KO mice (Figure 3.3 A-B) s.c. with 500 c.f.u. of KIM1001-
pYtbLpxL, and found that only 20% of NLRP12 KO and 50% of NLRP3 KO mice survived. 
This suggests that NLRP12 plays an important role in host defense against some bacterial 
pathogens. In contrast, NLRP12 KO mice were resistant to infection with S. typhimurium, 
whereas TLR4 KO mice all succumbed to the infectious challenge (Figure 3.3 C). 
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Figure 3.3: NLRP12 Is Involved in Host Resistance to Attenuated Y. pestis
(A and B) Survival of C57Bl/6 (circles), (A) Nlrp3-/-(NLRP3 KO, squares), and (B) Nlrp12 -/-
(NLRP12 KO, squares) mice infected s.c. with 500s CFU of KIM1001-pYtbLpxL. (C) 
Survival of C57BL/6 (circles), NLRP12 KO (squares), or TLR4 KO (triangle) mice infected 
i.p. with 500 CFUs of S. typhimurium; p < 0.003 (NLRP12 KO or WT versus TLR4 KO).
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This indicates that NLRP12 deficient animals are not universally more sensitive to infections. 
The function of NLRP12 is not well understood, but mRNA is detectable in several organs and 
immune cells (Figure 3.4 A-B), including macrophages, although prolonged macrophage 
maturation led to a decrease in NLRP12 levels (Figure 3.4 C). NLRP12 KO mice (Figure 3.4 D) 
had a normal composition of cell populations in spleen and bone marrow (Figure 3.4 E). The 
possible involvement of NLRP12 in maturation of IL-1β and IL-18 led us to perform in vitro 
experiments with mouse cells to study inflammasome components that promote caspase-1 
cleavage and IL-1β/IL-18 release following infection with Y. pestis and modified strains. 
Neutrophils express more NLRP12 than macrophages (Figure 3.4 B), but the role of 
inflammasomes in pathogen-induced neutrophil release of IL-1β and IL-18 is not yet studied in 
detail for many microbes. We found that thioglycollate-elicited neutrophil-enriched peritoneal 
cells released IL-1β after Y. pestis infection (Figure 3.5 A). When compared to cells from wild-
type mice, the amounts of IL-1β, but not TNF (Figure 3.6 A) released from the NLRP12 KO 
neutrophils were significantly reduced after stimulation with Y.pestis strains. Moreover, infected 
neutrophils from the caspase-1 KO mice lack IL-1β in the supernatant, suggesting that Y. pestis-
induced neutrophil IL-1β release involves caspase-1 inflammasomes, although we cannot rule 
out a role for other neutrophil proteases (Netea et al., 2010). It is also unclear which role 
caspase-11 plays relative to caspase-1 in Y. pestis-induced inflammasome activation, as the 
caspase-1 deficient mice utilized in this study contain the same truncated and apparently non-
functional caspase-11 as previously published (Kayagaki et al., 2011). Macrophages deficient in 
NLRP12 or NLRP3 also had a reduced ability to release both IL-18 and IL-1β after infection 
with parental Y. pestis and Y.pestis-pYtbLpxL (Figure 3.5 B-C). 
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Figure 3.4: Characterizing the NLRP12 KO mouse
(A-C) Nlrp12 mRNA measured by qPCR using cDNA (A) from multiple tissues, or (B-C) 
reverse transcribed cell lysate RNA, results are given as arbitrary units. Samples were 
normalized towards β-actin. (C) Lysates from bone marrow, freshly harvested or matured 
with M CSF (in L929 supernatant) for 5 or 12 days, were used for generating mRNA (D) RT-
PCR from NLRP12 genotyping of a NLRP12-KO mouse (left lane), a +/- heterozygous 
animal (het - middle) and a wild-type C57Bl/6 mouse (right). DNA was extracted from tail 
clippings. (E) Flow cytometric analysis of F4/80 positive macrophages, CD11c positive 
dendritic cells, Ly6G positive granulocytes, and CD19 positive B cells in spleen cell 
suspensions or bone marrow of C57BL/6 and NLPR12 KO uninfected mice. Blue lines show 
specific stain, red lines show isotope controls. Cell populations in WT and NLRP12 KO 
spleens and bone marrows are comparable. Results are representative out of at least three 
experiments.
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Figure 3.5: NLRP12 Mediates Y. pestis-Induced Release of IL-1β and IL-18
(A) IL-1β released from neutrophil-enriched peritoneal cells from C57BL/6 (black bars), 
NLRP12 KO (gray bars), and Casp1-/-(Caspase-1 KO, white bars) mice. (B–I) IL-18 (B), 
IL-1β (C and E–I) and TNF (D and G) released from C57BL/6, NLRP12 KO, NLRP3 KO, 
ASC KO, and caspase-1 KO BMDM (B–D); C57BL/6 and NLRP12 KO BMDM (E); 
C57BL/6 BMDM (F and G); or C57BL/6 and TLR4 KO BMDMs (I). Infection with Yersinia 
strains occurred for 6 hr, with an addition of 50 mg/ml gentamicin to limit bacterial growth 
after 3 hr. Yersinia strains were added at 10 m.o.i., S. typhimurium at 1 m.o.i. Alum (130 mg/
ml) stimulations (C and I) lasted 6 hr after priming for 3 hr with 10 ng/ml KIM5-YtbLpxL 
LPS. Shown are mean for triplicate cultures (with SD) in representative experiments out of 
three to ten performed. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 3.6: WT and NLRP12 KO BMDM have comparable non-inflammasome 
phenotypes
(A-C) ELISA of (A,B right) TNF or (B left, C) in the supernatants of (A) WT, NLRP12 KO 
or Caspase-1 KO peritoneal cells enriched for neutrophils or (B) WT or NLRP12 BMDM 
after 6 hours stimulation (including a gentamicin of infected wells at 3hpi) with (A) KIM5, 
KIM5-pYtbLpxL (MOI=10) or Alum following a three hour LPS priming, (B) KIM5 pre-
grown at 26oC, for 6 hours as above; Nigericin was used for 1 hour after LPS priming, or (C) 
poly(dA:dT) 1 µg/ml (transfected with Genejuice) for 3 hours after LPS prime. (D) 
Expression level of 31 genes related to innate immunity and inflammatory responses from 
RNA of C57BL/6 and NLRP12-deficient BMDM. Cells were infected with KIM5-
pYtbLpxL (MOI=10) for 4 hours or left unstimulated, and gentamicin was added after 2 hrs 
to limit bacterial growth. RNA samples were subject to analysis by Nanostring nCounter 
instrumentation using a custom multiplex codeset. Values are given as arbitrary units, 
normalized to internal standards: GAPDH and HPRT1 and reflect non-amplified transcript 
levels. Shown is one representative experiment out of two performed. (E) Kinase Assay (top) 
detecting IKK kinase activity was performed using lysates from WT or NLRP12 KO BMDM 
infected with KIM5 or KIM5-pYtbLpxL for 1 hour (MOI=10), or treated with recombinant 
mouse TNFα for 10 minutes. BMDM lysates were subject to IP with anti-IKKɣ/NEMO and 
then incubation with purified GST-IκBα and ɣ- p32 labeled ATP. Loading controls (middle) 
show coomassie blue staining of total loaded protein after the IP, and (bottom) IKKb WB 
shows that the NEMO IPs co-IP’d similar amounts of the kinase subunit. (F) Western blot of 
lysates using (top) anti-IκBα from BMDM stimulated as in Figure S3E, loading control 
(bottom) showing β-actin. (G- H) ELISA for (G) TNFα or (H) IL-18 in supernatants of (G) 
WT or NLRP12 KO BMDM (H) WT and TLR4 KO BMDM stimulated with (G) Y. 
enterocolitica and Y. pseudotuberculosis (10 m.o.i.) or (H) KIM5 and KIM5-pYbLpxL for 6 
hours, bothwith a gentamicin (50 µg/ml) treatment at 3hpi. Cytokines were measured by 
ELISA in one representative experiment out of three.
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These observations are consistent with the survival data (Figure 3.3), which indicated that host 
recognition of Y. pestis involves NLRP12. Cells deficient in ASC and caspase-1 also had 
decreased IL-18 and IL-1β release (Figure 3.5 B-C). Thus, NLRP12 signaling may occur 
parallel to or in cooperation with additional inflammasome components, as NLRP12 deficiency 
did not completely block cytokine release. NLRP12 KO macrophages responded normally to 
alum, S. typhimurium (Figure 3.5 C), nigericin and poly(dA:dT) (Figure 3.6 B-C) suggesting 
that NLRP12 may not participate in NLRP3, AIM2 or NLRC4 inflammasomes formed in 
response to those stimuli. None of the inflammasome proteins had an impact on TNF release 
(Figure 3.5 D, Figure 3.6 A). Furthermore, NLRP12 deficiency had little impact on the 
expression of 31 selected macrophage genes, including IL-1β, in the absence or presence of 
bacteria (Figure 3.6 C). Many of those genes are controlled by NF-kB and/or MAPK. In a more 
detailed study, NF-kB signaling measured by IKK kinase assay and IkB degradation was also 
largely preserved in NLRP12 deficient cells (Figure 3.6 D-E). Y. pestis pre-grown at 26ºC 
naturally expresses a hexa-acylated LPS (Montminy et al., 2006), and release of IL-1β in 
response to infection by 26ºC-grown bacteria was also influenced by NLRP12 (Figure 3.6 B). 
Upon infection of wild-type and NLRP12 KO BMDM with the human pathogens Y. 
pseudotuberculosis and Y. enterocolitica, ancestors of Y. pestis (Chain, 2004), we observed a 
reduction in secreted IL-1β from the cells lacking NLRP12 (Figure 3.5 E) while TNF release 
was normal (Figure 3.6 F). By using KIM6, a derivative of KIM5 that lacks the pCD1 virulence 
plasmid containing genes for the T3SS (Perry and Fetherston, 1997), we found that the secretion 
system was necessary for stimulating IL-1β release, even in the presence of a highly stimulatory 
LPS as found in KIM6-pYtbLpxL (Figure 3.5 F). YopJ may participate in inflammasome 
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activation (Zheng et al., 2011) and the deletion of YopJ or the T3SS translocon protein YopB 
reduced IL-1β release (Figure 3.5 G). Experiments performed using a strain with the expression 
of LpxL on a YopJ mutant background suggested that YopJ is a key player controlling IL-1β 
release, even in the presence of a stimulatory LPS (Figure 3.5 H), although other T3SS-
dependent factors may also regulate IL-1β (Brodsky et al., 2010). The data suggest that the 
ligand(s) responsible for NLRP12 activation are dependent on the Yersinia T3SS. TLR4 plays a 
critical role in the IL-1β and IL-18 production after infection of the mouse macrophages (Figure 
3.5 I, and Figure 3.6 G), although the relative importance of mouse vs. human TLR4/MD-2 in 
inducing Y. pestis responses may differ. Rodent cells have higher ability to recognize hypo-
acylated lipid A (Lien et al., 2000; Montminy et al., 2006). This may be influenced by a shallow 
positioning of the hypoacylated lipid A in mouse MD-2 compared to human MD-2, and the 
enabling of enhanced ionic interactions between hypoacylated lipid A and mouse TLR4, 
facilitating receptor cluster dimerization and signaling (Park et al., 2009). Our results indicate a 
role for both TLR4 and NLRP12 in the pro-inflammatory macrophage response against Y. pestis 
strains.
NLRP12 is an inflammasome component
 Upregulation of NLRP3 has been suggested to positively affect the activity of the NLRP3 
inflammasome (Bauernfeind et al., 2009). We therefore studied expression levels of NLRP12 and 
NLRP3 (Figure 3.7 A-B) after infection of macrophages with KIM5 or KIM5-pYtbLpxL. 
Expression of NLRP12 in BMDM was markedly increased after infection with Y. pestis strains 
and this may boost host responses to an infection. Treatment with LPS alone upregulated 
NLRP12 levels (Figure 3.8 A). 
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Figure 3.7: NLRP12 Is Necessary for Optimal Maturation of IL-1β and 
Caspase-1 after Infection with Y. pestis
(A, B, and G) Q-PCR of (A) Nlrp12, (B) Nlrp3, or (G) Il1b from BMDMs infected with 10 
m.o.i. of Y. pestis KIM5 or KIM5-pYtbLpxL for (G) 4 hr or (A and B) 6 hr, with gentamicin 
addition after 3 hr. Error bars represent the SD. (C–F) FACS histograms (C and E) showing 
active caspase-1 after FLICA reagent staining with corresponding (D and F) percent positive 
cells of (C and D) bone marrow cells after 6 hr of challenge with 10 m.o.i. of Y. pestis strains 
(gentamicin added after 3 hr) or (E and F) Ly6G- or F4/80-positive splenocytes from mice 
infected with 500 CFUs of KIM1001 or KIM1001-pYtbLpxL for 24 hr. Values from 
unstimulated cells are subtracted in (D). LPS primed cells treated with nigericin (10 mM) 
served as a control (C and D). Error bars in (D) and (F) represent the SD.
(H) Immunoblot for caspase-1 p10 or IL-1b p17 in supernatant or cell lysate from BMDMs 
exposed for 10 hr to poly(dA:dT) (LPS primed as in Figure 3), KIM5, or KIM5-pYtbLpxL. 
Shown is a representative of two (E–G) or three to five (A–D, H, and I) experiments. *p < 
0.05; **p < 0.01; ***p < 0.001. Also see Figure S4.
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Figure 3.8: NLRP12 is Upregulated After Stimulation and Plays a Role in 
Caspase-1 Activation, but not in Cell Death
Figure S4: (A) Nlpr12 q-PCR of cDNA from RNA purified from WT BMDM stimulated 
with KIM5, KIM5- pYtbLpxL, LPS (100ng/ml) or KIM5 after 3 hours of LPS priming (100 
ng/ml). (B) Caspase-1 and IL-1β maturation following infection of BMDM for 10 hrs with 
high MOI of the given bacterial strains, 10ng/ml LPS and 2,6 ug/ml of poly dA:dT was used 
as a control stimulation. (C) Cell death in C57Bl/6 and NLRP12 KO BMDM, 6 hrs after 
infection of 20 c.f.u. of KIM5 bacteria and centrifugation, measured by calcein stain. 
Gentamicin was added to a total concentration of (50 µg/ml) 1 hour into the infection. 
Results are representative out of at least three experiments.
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Furthermore, Y. pestis-induced formation of cleaved and active caspase-1, as measured by an 
assay showing binding of active caspase-1 to a fluorescent substrate, was also impaired in 
NLRP12-deficient cells, providing evidence for NLRP12-dependent inflammasome function 
(Figure 3.7 C-D). Caspase-1 cleavage measured by this assay is also decreased in spleen 
macrophages or neutrophils from NLRP12 KO mice 24 hours after infection with KIM1001 or 
KIM1001-pYtbLpxL (Figure 3.7 E-F). IL-1β gene expression was similar in infected wild type 
cells and NLRP12 KO cells infected with Y. pestis (Figure 3.7 G, and Figure 3.8 D). The 
macrophages infected in vitro showed a reduction in caspase-1 and IL-1β processing by western 
blot (Figure 3.7 H), also cells infected at a higher MOI (Figure 3.8 B). Thus, several lines of 
evidence support the hypothesis that NLRP12 is a component of inflammasomes formed after Y. 
pestis infection. Macrophage cell death induced by Y. pestis has been reported to be caspase-1 
independent (Lilo et al., 2008). We confirmed those data (not shown), and in line with this 
observation, NLRP12 deficient cells did not show an altered cell death in response to Y. pestis 
infection (Figure 3.8 C). Cell death may be induced by other mechanisms than pyroptosis in 
macrophages infected with Y. pestis.
NLRP12 and IL-18 mediate host resistance to Y. pestis infection
 As shown in Figures 3.2 and 3.3, NLRP12 KO and IL-18 KO mice are more susceptible 
than wild-type mice to infection with Y. pestis-pYtbLpxL. To monitor changes in IL-18 and 
IL-1β in tissues during systemic disease, we subjected WT and NLRP12 mice to i.v. infection 
with fully virulent or attenuated Y. pestis (KIM1001 or KIM1001-pYtbLpxL). At 44 hours post 
infection with KIM1001, IL-18 cytokine levels were significantly lower in the NLRP12 KO 
mice, expressed as both cytokine normalized to the spleen bacterial load in each particular 
animal (Figure 3.9 A) or simply as cytokine concentration in homogenate (Figure 3.10 A). 
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Figure 3.9: NLRP12 and IL-18 Control Infection with Y. pestis In Vivo
(A) IL-18 in serum (ng/ml) of C57Bl/6 or NLRP12 KO mice infected i.v. with 500 CFU Y. 
pestis KIM1001 for 44 hr, normalized by bacterial loads (for each animal); n = 5. (B–D) 
IL-18 or IL-1β in (B and C) spleen or (D) serum of WT or NLRP12 KO mice infected i.v. 
with 500 CFU KIM1001-pYtbLpxL for 44 hr. In (B) and (C), uninfected mice: n = 3; 
infected animals: n = 8. In (D), uninfected mice: n = 4; infected mice: n = 5. (E) Spleen 
CFUs of mice infected i.v. with either KIM1001 or KIM1001-pYtbLpxL (n = 5). Horizontal 
lines indicate mean values. (F) Histology of fixed H&E stained liver sections from (top) WT, 
(middle) NLRP12 KO, or (bottom) IL-18R KO mice infected i.v. with (left) KIM1001 or 
(right) KIM1001-pYtbLpxL for 44 hr. Asterisks represent bacterial clusters; arrows represent 
foci of inflammatory cells, primarily neutrophils. (G) Survival of C57Bl/6 (n = 10), IL-18 
KO, and NLRP12 KO (n = 8) mice with 10 CFU s.c. of KIM1001. (H and I) Spleen CFU (H) 
or spleen IL-1b (I) of C57Bl/6 and NLRP3 KO mice infected for 44 hr with 500 CFU i.v. of 
KIM1001-pYtbLpxL. Shown is a representative of three performed experiments. *p < 0.05; 
**p < 0.001. Also see Figure S5.
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A decrease of IL-18 and IL-1β in the spleen (Figure 3.9 B-C) and serum (Figure 3.9 D-E) was 
also observed after KIM1001-pYtbLpxL infection in the NLRP12 KO mice as compared to wild-
type mice. Experiments with IL-1R KO, IL-1β KO and IL-18R KO suggested that IL-18 
signaling had the greatest impact on resistance to Y. pestis-pYtbLpxL, as 100% of IL-18 and 
IL-18R KO animals died after infection (Figures 3.2 B and 3.2 D). IL-18R KO mice had 
reduced levels of IL-18 and IL-1β in the spleens compared to wt mice after infection with 
KIM1001-pYtbLpxL (Figure 3.10 B), suggesting a positive feed-back loop via IL-18R for IL-1β 
and IL-18 production. 
 A reduction of several orders of magnitude in spleen bacterial load was seen when mice 
were infected i.v. with KIM1001-pYtbLpxL compared to wild-type KIM1001 (Figure 3.9 E), 
indicating beneficial host responses induced by the presence of the hexa-acylated LPS. These 
differences in systemic bacterial load between the two bacterial strains were absent in NLRP12 
KO and IL-18R KO mice. NLRP12 KO and IL-18R KO mice also had increased bacterial loads 
compared to wild-type mice when infected with the virulent Y. pestis KIM1001 (Figure 3.9 E, 
p=0.01, WT vs. NLRP12 KO; p<0.001, wt vs. IL-18R KO). This is important in that it shows 
that NLRP12 and IL-18 participate in host resistance in vivo towards both virulent and 
attenuated strains of Y. pestis. Thus, it appears that Y. pestis has an inherent ability to activate 
NLRP12-dependent recognition, and that the potent LPS found in strains expressing LpxL 
increases the formation of pro-forms and subsequently mature forms of inflammasome-
controlled cytokines such as IL-1β (Figures 3.2 G and 3.5 C). Livers from animals infected with 
wild type Y. pestis have large extracellular clusters of bacteria (Figure 3.9 F, left panels, marked 
with *) and remarkably few signs of inflammation, likely reflecting active suppression of 
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immunity combined with stealth via limited initiation of TLR4 signaling. Livers from animals 
infected with Y. pestis-pYtbLpxL display foci consisting of inflammatory cells (Figure 3.9 F, 
upper right, arrows) and absence of visible bacterial masses, suggesting that recruitment of 
phagocytes limits bacterial growth (Montminy et al., 2006). Livers from NLRP12 KO infected 
with KIM1001-pYtbLpxL had recruitment of inflammatory cells (Figure 3.9 F, arrows). Such 
masses of inflammatory cells typically contain large number of neutrophils and some 
mononuclear cells (Montminy et al., 2006), and a calculation of number of recruited cells 
showed no significant difference between infected wild type versus NLRP12 KO livers (Figure 
3.10 C). However, this cell recruitment did not correlate with suppression of bacterial growth, as 
bacterial masses were visible (Figure 3.9 F). These results suggest that NLRP12 may not play a 
major role in the attraction of phagocytes to infected sites in the liver; but is central to the 
effective anti-bacterial actions they perform. Few, if any inflammatory cells were visible in livers 
of IL-18R KO mice (Figure 3.9 F), indicating failures of both cell recruitment and anti-bacterial 
defenses.
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Figure 3.10: NLRP12 is upstream from IL-18 and IL-1β production after Y. 
pestis infection while recruitment is unchanged.
(A) IL-18 in spleen homogenates from C57Bl/6 or NLRP12 KO, infected for 44 hrs with 
KIM1001 (500 c.f.u. i.v.). (B) IL-18 or IL-1β in spleen homogenates of WT or IL-18R KO 
mice infected i.v. with 500 c.f.u. of KIM1001 or KIM1001-pYtbLpxL and sacrificed after 48 
hours post infection. (C) Inflammatory cells, mainly neutrophils, were counted in 
microscopic fields (100x) from different mice (C57Bl/6 or NLRP12 KO) infected with 500 
c.f.u. of KIM1001-pYtbLpxL. (D) Baseline serum levels of (left) TNFα or (right) CXCL12 
from uninfected mice. (E-F) Serum levels of (E) TNFα or (F) CXCL12 from mice infected 
i.v. with 500 c.f.u. of KIM1001-pYtbLxpL, sacrificed at 44 hrs post infection. (G) Levels of 
IL-18, IL-1β, TNFα, or CXCL12 in the serum of mice either naive or 4h after i.p. injection of 
200µg alum pre-mixed with 100 ng KIM5-pYtbLpxL LPS in PBS of WT (black bar) and 
NLRP12 KO (white bar) mice. (H) Mice were injected with 1 ml of thioglycollate i.p., 4 hrs 
later peritoneal lavage was performed and neutrophil recruitment assessed. (J) Spleen 
suspensions from mice infected with 500 c.f.u. of KIM1001-pYtbLpxL were analyzed for 
CD11c+ DC contents by FACS.
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Taken together, the results suggest that NLRP12 and IL-18 contribute to host resistance against 
Y. pestis and Y. pestis-pYtbLpxL. We also found that NLRP12 KO mice infected with KIM1001-
pYtbLpxL had reduced levels of TNF and the chemokine CXCL12 compared to C57Bl/6 
(Figure 3.10 D-F), possibly secondary effects of reduced IL-1β and IL-18 levels, as primary 
NLRP12 KO cells in culture did not display decreased TNF release (Figure 3.3). In contrast, 
NLRP12 KO mice injected with an alum/LPS mixture did not show decreased serum levels of 
IL-1β, IL-18, TNFα and CXCL12 (Figure 3.10 G). Furthermore, we found similar recruitment 
of neutrophils to the peritoneum of wild type mice or NLRP12 deficient mice injected i.p. with 
sterile thioglycollate (Figure 3.10 H). Movement of neutrophils (Figure 3.9 F, Figure 3.10 C) 
and DC (Figure 3.10 I) during infection of NLRP12 KO may be largely preserved. Differences 
in survival between NLRP12 KO or IL-18 KO mice and wild-type mice after s.c. infection with 
only 10 c.f.u. of fully virulent KIM1001 were not significant (Figure 3.9 G). This result is of 
uncertain importance because the very low LD50 of Y. pestis (less than 10 c.f.u.) makes it 
difficult to demonstrate reductions in host resistance impacting survival without the use of very 
large numbers of animals. Tissue bacterial loads (Figure 2.9 E) appear to be more sensitive 
assays for analyzing host resistance to Y. pestis.
 NLRP3 has also been proposed as an inflammasome component recognizing Y. pestis 
(Zheng et al., 2011) (Figure 3.3, Figure 3.5). NLRP3-deficient animals also were less resistant 
to infection by KIM1001-pYtbLpxL, in that they displayed increased bacterial loads in the 
spleen (Figure 3.9 H) that correlated with reduced spleen cytokine levels (Figure 3.9 I). To sum 
up, NLRP12 and NLRP3 both contribute to the host resistance towards Y. pestis strains.
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NLRP12, NLRP3 and IL-18 signaling induce IFNγ that limits infection
IL-18 is a known inducer of IFNγ (Okamura et al., 1995), a key protein in many host responses 
to pathogens. This suggests that signaling via NLRP12, NLRP3, and the IL-18R, resulting in the 
release of IFNγ, could mediate resistance to Y. pestis-pYtbLpxL. We infected IFNαβR x IFNγR 
double KO (dKO) animals with KIM1001-pYtbLpxL s.c., and we found that all the dKO animals 
succumbed to the infection (Figure 3.11 A). This phenomenon was largely attributed to IFNγR 
signaling, as only a few IFNαβR single KO died upon infection, whereas almost all IFNγR single 
KO succumbed (Figure 3.11 B). No differences in IFNγ levels were observed between spleens 
of uninfected wt, NLRP12 KO, NLRP3 KO and IL18R KO mice (Figure 3.11 C-D). However, 
the IFNγ levels in spleens from KIM1001-pYtbLpxL infected NLRP12 KO and NLRP3 KO 
mice compared to wild-type were drastically reduced (Figure 3.11 D), as was also true for the 
IL-18R KO mice (Figure 3.11 D). Thus, we propose a novel cascade of signals from NLRP12 
and NLRP3 to IL-18 maturation that in turn mediates IFNγ release following infection with Y. 
pestis strains. 
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Figure 3.11: NLRP12 Induces IFN-g via IL-18 Signaling
(A and B) Survival of mice: in (A), C57Bl/6: n = 10 and Ifnar1-/-, 3 Ifngr1-/- (IFNabR 3 IFN-
gR DKO; triangles): n = 8, and in (B), C57Bl/6 (squares): n = 10, IFNabR KO: n = 8, and 
IFN-ɣR KO: n = 7, infected s.c. with 500 CFUs of KIM1001-pYtbLpxL. (C and D) IFN-ɣ in 
spleen homogenates from C57BL/6 and NLRP12 KO mice infected i.v. with 500 CFU of 
KIM1001-pYtbLpxL. Uninfected mice: n = 3; in- fected mice: n = 8 (C) and n = 5 (D). 
Samples were harvested 46 hr after infection. Horizontal lines indicate median values. 
Experiments shown are representative out of three performed. *p < 0.05; **p < 0.001.
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Discussion
 We propose that recognition of Y. pestis expressing a stimulatory LPS by TLR4 leads to 
upregulation of NLRP12 and pro-inflammatory cytokines such as IL-18 and IL-1β. NLRP12 
then recognizes a ligand produced upon Y. pestis infection and assembles into an inflammasome 
that processes IL-18 and IL-1β. Although the precise nature of the true NLRP12 ligand is 
unknown, and may be a host or bacterial protein, the generation of the ligand appears to require 
the virulence-associated T3SS of Yersinia. Models for activation may include possibilities that 
cells sense membrane damage associated with the T3SS, secreted effectors or other molecules 
channeled by the T3SS, and modified host proteins. NLRP3 also contributes to IL-18/IL-1β 
release. IL-18 seems to be more critical than IL-1β, and plays a key role in induction of IFNγ.
 Most importantly, we show that NLRP12 is an inflammasome component recognizing Y. 
pestis, and contributes to in vivo resistance to infection with Y. pestis strains, as do NLRP3 
inflammasomes. This is the first demonstration of a clear role for NLRP12 in resistance to 
infection. Our data suggest an inflammasome role for NLRP12 in pathogen recognition, and that 
the NLRP12 - IL-18 - IFNγ axis is effective in limiting infection with Y. pestis-pYtbLpxL. We 
also show that the expression of Y. pseudotuberculosis LpxL in Y. pestis increases TLR4-
dependent release of IL-18 and IL-1β. This increase correlates with increased resistance to the 
modified pathogen. In fact, the results indicate that a major consequence of producing LPS with 
low TLR4-activating potential could be lack of priming necessary for effective synthesis of 
active IL-1β and IL-18.Therefore, Y. pestis is able to utilize inflammasome-activating 
components like the T3SS to neutralize the immune response without an effective activation of 
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an inflammatory response. This phenomenon may have played a role in evolution of high 
virulence in Y. pestis.
 These findings support the view that inflammasomes, the cellular protein complexes 
cleaving IL-18 and IL-1β into mature forms, are fundamental components of the host response to 
many pathogens. Indeed, several viral, bacterial and fungal microbes have strongly increased 
ability to induce disease in the absence of IL-1β, IL-18 and inflammasome components (Hise et 
al., 2009; Lamkanfi and Dixit, 2009; Broz et al., 2010; Rathinam et al., 2010; Davis et al., 
2011b). In spite of this, only a few mammalian NLRs out of a family of more than 20 members 
have currently been shown to directly participate in host defenses. Here we are the first to show 
that NLRP12 participates in host responses to wild type Y. pestis and modified Y. pestis strains 
expressing a potent LPS, although the factor(s) in Y. pestis responsible for directly activating the 
NLRP12 inflammasome are still unknown.
 NLRP12 may also be involved in resisting infections caused by other human pathogens. 
It is unclear how NLRP12 may interact with other inflammasome components. NLRP12 
deficiency did not cause a complete reduction in ability to release IL-18 and IL-1β following 
exposure to Y. pestis and Y. pestis-pYtbLpxL infection (Figure 3.5 and 3.7). Also, the increased 
mortality observed in NLRP12-deficient mice did not appear as great as observed in IL-18 
deficient animals (Figures 3.2, 3.3), and NLRP3 also play a role in host defenses (Figures 3.3, 
3.7). Redundancy between NLRs may occur, and other NLRs may also participate in optimal 
responses to infection. This may support the idea that NLRs work together for optimal protection 
of the host (Broz et al., 2010). The generation of animals with combined deficiencies in NLRP12 
and other NLRs may clarify how NLRP12 functions in cooperation with other signaling 
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components. NF-κB signaling following bacterial challenge appeared normal in NLRP12-
deficient cells (Figure 3.4). 
 IL-18, IL-1β and IFNγ are all cytokines active at the interface between innate and 
adaptive immunity. We have found that Y. pestis strains generating a hexa-acylated LPS could 
function as effective live vaccines (Montminy et al., 2006). It would be of interest to investigate 
the role of NLRP12 in promoting the development of adaptive immunity and protection 
following vaccination with both live and subunit/adjuvant vaccines.
 The emerging role of inflammasomes as key players in host defenses during many 
infections makes them desirable targets for therapeutic intervention and drug development. We 
note that alum, one of the first components known to activate specific inflammasomes, already is 
in widespread use as one of the few vaccine adjuvants licensed for human use. However, a 
delicate balance between pathological effects and enhanced host defenses arising from 
inflammasome-stimulating treatments will be necessary. Mutations in NLRs are linked to 
inflammatory diseases (Hawkins and Lachmann, 2003; Jéru et al., 2011a), and anti-IL-1 
treatment does in fact reduce symptoms in many such patients. More knowledge on the role of 
NLRs in inflammation and homeostasis is needed in order to fine-tune future NLR-based 
therapies.
Material and Methods
Bacterial strains and growth conditions 
Y. pestis KIM is originally a clinical isolate from a Kurdistan Iran man (Brubaker, 1970; Perry 
and Fetherston, 1997). Y. pestis strains KIM5, KIM5-pEcLpxL (containing E. coli LpxL, earlier 
called pLpxL) and KIM1001 were as reported (Montminy et al., 2006). Y. pseudotuberculosis 
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IP2666 (containing a complementation of PhoP/PhoQ deficiency) and Y. enterocolitica 8081 
were provided by Joan Mecsas. Strains were grown in tryptose-beef extract (TB) broth with 
2.5mM CaCl2 all by shaking at 37°C. lpxL of Y. pseudotuberculosis IP2666 including 480 
basepairs upstream and 266 basepairs downstream from coding region was cloned using Pfu 
Ultra (Stratagene) and was ligated into the BamHI and SalI sites of pBR322, creating 
pSP::YtbLpxL (or ‘pYtbLpxL’). The resulting plasmid was electroproated into Y. pestis KIM5 
(Goguen et al., 1984) or Y. pestis KIM1001 (Sodeinde et al., 1992) and bacteria were selected by 
growth on TB agar supplemented with 2.5mM CaCl2 in the presence of 100µg/ml of ampicillin. 
All strains containing plasmids above remained tetracycline sensitive. KIM1001 (pPCP1+, 
pCD1+, pMT1+) is highly virulent (Perry and Fetherston, 1997) whereas, KIM5 bears the 
chromosomal deletion ‘Δpgm’ which substantially attenuates virulence. The pgm locus contains 
no genes thought to affect LPS biosynthesis. KIM6 is a KIM5 derivative lacking the T3SS-
containing pCD1 virulence plasmid . KIM5-ΔYopB was provided by Greg Plano (Torruellas J, 
2005). For the generation of KIM5-ΔYopJ, the following method was used. An in-frame deletion 
removing codons 4-287 was created via allelic exchange. PCR products made with primer sets A 
(ATAGAGCTCCACTACTGATTCAACTTGGACG), B 
(TCCGATCATTTATTTATCCTTATTCA) and C 
(TGAATAAGGATAAATAAATGATCGGATAATGTATTTTGGAAATCTTGCT), D 
(GGGTCTAGACTGATGTCGTTTATTTCTGGGTAT), respectfully, were used to make a fused 
product by overlap PCR using primers A and D. This product was cloned in the allelic exchange 
vector pRE107 in E.coli K12 strain B2155, transferred to Y. pestis by conjugation, and 
recombinants selected on TB medium containing 100µg/ml ampicillin but no diaminopimelic 
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acid. Following counter selection with 5% sucrose, deletion mutants were identified by PCR. For 
in vitro infections, bacteria were grown overnight at 37oC in TB broth with or without ampicillin, 
diluted 1:4 in fresh media and cultured for three more hours at 37ºC, then washed three times 
with PBS and resuspended in DMEM or RPMI. S. enterica serovar typhimurium strain SL1344 
was provided by Mary O’Riordan, and strain M525P by Clare Bryant.
Cell stimulations 
Mouse BMDM were prepared by maturing fresh bone marrow cells for 5-7 days in the presence 
of M-CSF containing supernatant from L929 cells. Mouse neutrophils were enriched by injecting 
1ml of thioglycolate i.p., peritoneal cells (typically >80% Ly6G-positive cells, (Nilsen N, 2004) 
cells were harvested 4 hrs later after flushing with RPMI. Mouse BMDMs were plated at 2x105 
per well in 96-well plates for ELISA or 2x106 per well in 12-well plates for western blot. 
Stimulation was for 6 hours and supernatants were collected for cytokine analysis. Three hours 
after bacterial infections, 50µg/ml of gentamycin was added. Alum was from Pierce, nigericin 
and poly(dA:dT) was from Sigma. IL-1β p17 and Caspase-1 p10 western blots were conducted 
mainly as described (Hornung et al., 2008) using antibodies from Santa Cruz Biotechnology 
(caspase-1 p10) and R&D (IL-1β). The antibody against β-actin was from Sigma. Q-PCR for 
NLRP12 and NLRP3 in resting or infected BMDM or magnetic bead (StemCell Technologies)-
isolated neutrophils was performed by RNeasy Mini Kit (Qiagen), and iScript cDNA Synthesis 
Kit (BioRad). PCR was performed on transcribed cDNA or mouse tissue cDNA (Clontech) with 
primers for detection of mouse NLPR12 (5’-TGCAAGCTTCGAGTCCTGT-3’, 5’-
CCTGGTCGGCTTCATTCTG-3’), NLRP3 (5’ AACCAATGCGAGATCCTGAC 3’, 5’ 
ATGCTGCTTCGACATCTCCT 3’), or pro-IL-1β (5’-GCCCATCCTCTGTGACTCAT-3’, 5’-
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AGGCCACAGGTATTTTGTCG-3’) using SYBR green (BioRad) according to the 
manufacturer’s instructions. ELISA kits for IL-1β, TNFα, IL-8, CXCL12, IFNγ (R&D) and 
IL-18 (MBL) were used for cytokine detection. Reagents for FACS detection of active and 
cleaved caspase-1 by FLICA/FITC substrate were from Immunochemistry Technologies.
Mice 
All experiments involving live animals were approved by the Institutional Animal Care and Use 
Committee. ASC (Pycard-/-), NLRP6, NLRP3 (Nlrp3-/- ), and NLRP12-deficient (Nlrp12-/-) 
mice were generated by Millennium Pharmaceuticals and were backcrossed eight to eleven 
generations to C57BL/6 background. Mice deficient in TLR4 (TLR4-/-) and MyD88 (Myd88-/-) 
were from S. Akira, and mice lacking caspase-1 (Casp1-/-) were from Michael Starnbach. 
C57BL/6 and mice deficient in IL-1R1 (Il1r1-/-), IL-18R (Il18r1-/-), IL-18 (Il18-/-), TNFR1 
(Tnfr1-/-), IL-12p40 (Il12b-/-), and IFNγR (Ifngr1-/-) were all from Jackson Laboratories. J. 
Sprent (The Scripps Research Institute) provided the IFNαβR1 (Ifnar1-/-) and IFNγR1 x 
IFNαβR1 doubly deficient mice. IL-1β (Il1b-/-) deficient mice were provided by Y. Iwakura. 
Wild-type (from Jackson Laboratories or bred at UMass) or knock-out mice were infected s.c. in 
the nape of the neck with Y. pestis and their survival monitored twice a day for 30 days. Infection 
with S. typhimurium: mice were infected with 1000 CFU of M525P i.p. and survival was 
monitored as described above. For cytokine and CFU analysis, mice were infected either s.c. or 
i.v. and sacrificed at the indicated time points. Serum was generated by centrifugation in 
microtainer tubes (BD), and spleens were homogenized in 0.5 ml PBS using a closed system 
Miltenyi gentleMACS dissociator and c-tubes to preserve intact cells, subsequently cells/debris 
were removed by centrifugation. Samples for cytokine analysis were subjected to protease 
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inhibitor (Roche) treatment. Cytokine levels corrected by bacterial loads were calculated by 
dividing IL-18 levels (ng/ml) by the bacterial load (CFU x 108) for each animal. Hematoxylin 
and eosin (H&E) staining and microscopy was performed as published (Montminy et al., 2006). 
In vivo caspase-1 cleavage analysis: mice were infected with 500 CFU of Y. pestis i.p. After 24 
hrs, spleens were harvested, homogenized and cell suspensions were stained with caspase-1 
FLICA reagent. Wild type and NLRP12 KO mice were injected i.p. with pre- mixed Y. pestis 
KIM5-pYtbLpxL LPS (100 ng per mouse) and alum (Imject, Thermo Scientific, 200 µg/mouse) 
as indicated. Blood was harvested 4 hrs post- injection and serum cytokines were analyzed by 
ELISA.
Statistical analysis
In vitro cytokine release was analyzed by two-way ANOVA with Bonferroni post-test. 
Differences in spleen and serum cytokine concentrations were analyzed by the unpaired t-test. 
Differences in survival were studied using Kaplan-Meyer analysis and the logrank test. 
Differences in spleen CFU or cytokine/CFU values between genotypes of mice were evaluated 
with the Mann-Whitney test, or in more complex comparisons involving multiple mouse 
genotypes, with a generalized linear regression model of cubic transformed log CFU values 
(95% confidence interval) to meet normality assumptions. P values <0.05 were considered 
significant.
Lipid A analysis 
Lipid A from Y. pestis KIM5, KIM5-pYtbLpxL and Y. pseudotuberculosis IP2666 were isolated 
as described (Montminy et al., 2006) and analyzed by MALDI-TOF mass spectrometry (Paquette 
et al. unpublished).
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Q-PCR analysis of Nlrp12 expression in mouse tissues 
Multiple tissue cDNA panel was from Clontech Laboratories.
Genotyping of NLRP12 deficient mice
 RT-PCR genotyping of NLRP12 KO mice was performed using the primers 
GCAGCGCATCGCCTTCTATC (neo) combined with GAAGCAACCTCCGAATCAGAC and 
CCCACAAAGTGATGTTGGACTG, using 35 cycles at 94-62-74°C.
Gene expression analysis by NanoString 
nCounter CodeSets were constructed to detect genes of interest and control genes. WT and 
NLRP12 KO BMDM were plated at 2x106 cells per well in a 12-well plate and were incubated 
for 4 hours with or without KIM5-pYtbLpxL at MOI=10. At 2 hours post infection, 50µg/ml 
gentamicin was added to culture. Total RNA was purified using the Qiagen RNeasy mini kit per 
manufactures directions. Normalized total RNA was hybridized overnight to the CodeSet and 
then loaded into the nCounter Prep Station followed by assessment by the nCounter Digital 
Analyzer, following the manufactures directions. nCounter data was normalized first for 
processing efficiency by standardizing measurements of all samples to positive controls included 
by the nCounter during analysis. Second, we normalized expression levels to two control genes 
(Gapdh and Hprt). These gene transcript levels did not vary between experimental conditions. 
The weighted average of the mRNA counts of the control genes were used to normalize every 
sample’s values by multiplying each transcript count by the weighted average of the controls. 
Neutrophil recruitment 
1 ml of 3% thioglycollate was injected i.p. into mice. Four hours later, peritoneal lavage cells 
were harvested, counted, and % Ly6G/Ly6C double positive cells were determined.
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Cell death 
Cell death was evaluated 6 hrs after infection of BMDM with KIM5 (MOI 40, bacteria were 
centrifuged onto the cells) by using calcein stain (Invitrogen). 100% lysis was obtained by 
treatment of cells with water.
IKK kinase assay 
Cells were lysed in whole cell lysis Buffer (10% Glycerol, 20 mM Tris-HCL pH 7.4, 150 mM 
NaCL, 2 mM EDTA, 1% Triton X-100, 25 mM beta-glycerophosphoate, 1 mM dithiotreitol, 1 
mM sodium orthovanadate, and mammalian protease inhibitor cocktail from Sigma-Aldrich (cat 
# P8340). Lysates were cleared by centrifugation (16000 rpm, 12 min). Protein concentrations 
were determined by Bradford assay. 200 µg of whole cell lysate was incubated with anti-IKKγ/
NEMO (Santa Cruz # 8330) for 1.5 hours at 4oC followed by addition of protein A beads (Pierce 
# A23330). After overnight incubation at 4oC, IPs were washed twice in lysis buffer and twice in 
kinase buffer (20 mM HEPES pH 7.6, 20 mM beta-glycerophosphate, 10 mM Magnesium 
Chloride, 50 mM Sodium Chloride, and 1 mM diothreitol). IP beads were split into two aliquots: 
one aliquot was subjected to SDS-PAGE followed by immuno-blotting for IKKβ (Santa Cruz # 
56918) and the other aliquot was incubated with purified GST-IkBα N-term (0.5 µg), ATP (100 
µM), and gamma-P32-labeled ATP (5 µCi) for 30 minutes at 30oC. Reactions were stopped by 
the addition of 3X sample buffer containing 20 mM EDTA. Reactions were immediately boiled, 
subjected to 10% SDS-PAGE, and visualized by autoradiography.
IkB degradation 
Cell lysates were prepared essentially as for kinase assays described above and subjected to 10% 
SDS-PAGE. Gels were transferred to PVDF membranes, followed by western blotting using 
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antibodies against IkBa (Cell Signaling) and secondary antibodies (anti-rabbit IgG HRP) from 
Bio-Rad.
Flow Cytometry 
Bone marrow or homogenized spleen cells suspensions (fixed for infected animals) from mice 
were stained with antibodies against F4/80 (clone BM8, PerCP-Cy5.5), CD11c (N418, 
eFluor®450) (eBiosciences), Ly6G (1A8, PE), Ly6C (AL-21, FITC), and CD19 (1D3, Pe-Cy7) 
(BD). Cells were treated with Fc block (clone 93, rat anti CD16/CD32, eBiosciences) 15 minutes 
prior to stain. Cells were analyzed using a LSRII instrument (BD), with Diva and FlowJo 
software.
Calculation of neutrophil recruitment to infected organs 
Inflammatory cell infiltration, largely consisting of neutrophils, in livers from mice infected with 
500 c.f.u. of KIM1001-pYtbLpxL was assessed by analyzing HE-stained sections. 10 
microscopic fields were analyzed from different mice and inflammatory cell influx was counted.
Vaccination 
C57Bl/6 mice were vaccinated s.c. with 1000 CFU of Y. pestis KIM1001- pYtbLpxL. Thirty 
days later, vaccinated or naive mice were challenged s.c. with fully virulent Y. pestis KIM1001 
and survival was monitored up to 28 days.
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CHAPTER 4: 
Innate immune responses via NLRP12, NLRP3, and IL-18 Control 
Pneumonic Plague Infection
Abstract
 Pneumonic plague caused by Yersinia pestis can reach 100% mortality if intervention is 
not started within 24 hours. The initial immune response activated against Y. pestis in the lungs 
has yet to be determined, though we know it is able to suppress production of many host 
inflammatory factors during primary infection allowing it to become systemic and expand to an 
extremely high concentration in tissues. Here, we sought to elucidate the role of the 
inflammasome and the pro-inflammatory cytokine IL-18 during pneumonic plague. We found 
IL-18 to be necessary in limiting the initial pathogen spread, and IL-18-deficient mice had 
increased susceptibility to Y. pestis. Moreover, the NLRP12 and NLRP3 inflammasome were 
important regulators controlling IL-18 production after Y. pestis infection in the airway, and mice 
lacking these inflammasomes had decreased IL-18 responses, cellular recruitment to the lungs, 
and were more susceptible to bacterial challenge. This is the first evidence of NLR-mediated 
protection against Y. pestis lung infection and could be key to understanding the how plague 
virulence determinants differ during peripheral vs airway infection.
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Introduction
 Yersinia pestis, the causative agent of plague, is typically transmitted by a the flea vector 
from infected rodents to humans causing bubonic disease, or directly between individuals as 
pneumonic plague (Perry and Fetherston, 1997; Hinnebusch, 2005). Following systemic spread 
of bacteria during bubonic plague, pulmonary infection can develop resulting in secondary 
pneumonic plague. Primary pneumonic plague also occurs, which can involve spread from 
person to person via infectious respiratory droplets. Currently, there is no licensed vaccine 
effective against pneumonic plague even though it is the expected disease form to result from a 
Y. pestis based biowarfare attack. 
 Pulmonary Y.pestis infection has a rapid onset and high mortality - close to 100% if not 
treated (Perry and Fetherston, 1997; Perry Ja, 2005; Butler, 2009). Initial pneumonic plague 
infection may differ from many pulmonary infections as the first 36 hours are characterized by 
rapid bacterial replication during which infected animals may display a muted pro-inflammatory 
response (Lathem et al., 2005). This may allow Y. pestis to expand exponentially in the lungs and 
other organs before the immune system is able to contain the infection. In spite of the violent 
nature of pneumonic plague, several lines of evidence suggest that the bacteria is less able to 
mount a deadly infection via the airways than via the skin. Pneumonic plague is much less 
common, as 80-90% of natural cases of Y. pestis infections are bubonic plague (Perry and 
Fetherston, 1997), although some pneumonic plague epidemics have been described (Stenseth et 
al., 2008). Early studies of human transmission suggested that preventive measures such as 
simple surgical masks could prevent infection (Kool and Weinstein, 2005). A close contact 
between subjects resulting in inhalation of large respiratory droplets and likely transmission of 
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larger amount of bacteria was also believed to be necessary for transmission (Kool and 
Weinstein, 2005). 
 Finally, the LD50 for Y. pestis infection in mouse models via the pulmonary route is 
reported to be around 500 CFU. This is indeed 50-100 times higher than for infection via the 
peripheral route - subcutaneous (s.c.) or intradermal (i.d.) delivery with LD50 of less than 10 
bacteria, modeling spread of bubonic plague via flea bites into the skin. This is in contrast to 
another highly virulent bacteria, Francisella tularensis type A, where LD50 via pulmonary and 
peripheral routes are both very low (estimated to less than 10 CFU). Many studies of Y. pestis 
focus on its ability to evade host immunity (Smiley, 2008) and less attention has been paid to the 
initial protective innate immune responses limiting pneumonic plague . The observations 
indicated above may suggest that innate immune responses could contribute to limiting 
development of pneumonic plague, and that a higher amount of bacteria is needed to overcome 
these initial responses during lung infection than via the peripheral route, to generate a 
productive infection. Thus, the immune response may still be significant enough in the airways 
to mediate some level of protection to limit pneumonic plague. The description of the innate 
immune responses contributing to limiting airway infection could lead to the development of 
additional therapeutic options and also guide in finding optimal vaccines against pneumonic 
plague.
 Y. pestis virulence depends on multiple factors including a plasmid-encoded T3SS (type 
III secretion system) that injects effector proteins called Yops into host cells to alter cell 
functions such as signaling pathways and phagocytosis (Cornelis, 2002a). The T3SS is strongly 
conserved among all human-pathogenic Yersinia species, although other members of this family 
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(Y. pseudotuberculosis and Y. entrocolitica) typically cause self-limiting gastroenteritis compared 
to the serious infection caused by Y. pestis (Perry and Fetherston, 1997). Therefore, differences in 
the T3SS cannot explain the major increase in virulence during evolution of Y. pestis. Acquisition 
of the surface protease Pla (Sodeinde et al., 1992; Lathem et al., 2007) and loss of ability to 
potently trigger TLR4 signaling by production of a tetra-acylatedlipid A/LPS in Y. pestis may 
have contributed to dramatically increased ability to cause systemic disease in the evolutionary 
split from Y. pseudotuberculosis (Kawahara K, 2002; Montminy et al., 2006; Vladimer et al., 
2012)(Vladimer et al unpublished.)
 Previously, we have implicated the pro-inflammatory cytokines IL-1β and, more 
importantly, IL-18 in host resistance to disease induced by subcutaneous infection of virulent and 
attenuated strains of Y. pestis expressing a modified lipid A/LPS (Vladimer et al., 2012) (and 
Vladimer et al. unpublished.) We determined that high levels of IL-18 and IL-1β in the serum 
and the spleen following i.v. infection were dependent on the inflammasome forming nucleotide-
binding domain and leucine-rich repeat containing (NLRs) NLRP3, NLRP12. Moreover, mice 
deficient in these NLRs, as well as NLRC4-deficient animals, had reduced host resistance 
against Y. pestis induced delivered via the peripheral route. We hypothesized that inflammasome 
signaling and IL-18 production in the lung may be key factors during the primary immune 
response during pneumonic plague. Here, we propose a mechanism for how inflammasome 
function and downstream cytokines during pneumonic plague infection mediate protection by 
controlling anti-bacterial defenses, inflammation,  and cellular recruitment. Thus, the 
inflammasome-directed production of IL-18 after transmission of bacteria may limit spread of 
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infection during early stages of pneumonic plague, and therefore also limit the spread of 
pneumonic plague during epidemics.
Results
Pneumonic plague infection is controlled by IL-18 early in infection
 Y. pestis rapidly disseminates into the lymphatic system of mice after a s.c./i.d. infection 
while yielding immune response activation and pro-inflammatory responses, leading to bubonic 
plague. The model has an LD50 of less than 10 CFU (Perry and Fetherston, 1997; Vladimer et 
al., 2012). In contrast, when mice are infected via the pulmonary route (intratracheal, i.t.) an 
increase in the LD50 to approximately 500 CFU is observed (Figure 4.1A). This suggests that 
plague may be more susceptible to the early innate immune response in the airway compared to 
the dermal tissues. Normally, Y. pestis produces a tetra-acylated lipid A/LPS at 37oC with 
reduced ability to activate TLR4 signaling. Previously, we characterized modified strains of 
plague which generate a hexa-acylated, potent, TLR4-activating lipid A / LPS after expression of 
lpxL, a “late” acyl-transferase which was deleted during evolution of Y. pestis from Y. 
pseudotuberculosis. The Y. pestis strain expressing Y. pseudotuberculosis LpxL is called Y. pestis-
pYtbLpxL (Montminy et al., 2006; Vladimer et al., 2012). This strain induces increased immune 
responses via TLR4, and allowed us to study signaling pathways effective in increasing 
resistance to Y. pestis infections (Vladimer et al., 2012). Indeed, when we infected mice i.t. with 
5000 CFU of KIM1001-pYtbLpxL or KIM1001 i.t., we found that the mortality of animals is 
strongly reduced when bacteria produce a potent LPS (Figure 4.1B). This provides evidence that 
protection from pulmonary infection can be increased by boosting the immune response though 
activation of TLR4. It also means that an efficient innate immune response could limit Y. pestis 
infection via the airways. Thus, we hypothesized that early cytokine production is necessary for 
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controlling the lung infection. We have previously proposed the pro-inflammatory cytokine, 
IL-18, as an important mediator in resistance to bubonic plague (Vladimer et al., 2012). This 
cytokine is protective for pneumonic plague as mice deficient in IL-18 die rapidly after infection 
with 500 CFU i.t. of fully virulent Y. pestis (strain KIM1001) (Figure 4.1C). Furthermore, IL-18 
is important in controlling bacterial replication very early during pneumonic plague infection as 
IL-18 KO animals have significantly increased bacterial loads in lung homogenates at 24 and 
48hpi, compared to WT animals (Figure 4.1D). Once primary pneumonic plague has colonized 
the alveoli, it can spread to the bloodstream and to other organs and tissues via the circulatory 
system (Perry and Fetherston, 1997). At 24hpi, we observe Y. pestis in the spleens of IL-18-
deficient animals infected Y. pestis, in comparison, there are no detectable bacteria with spleens 
in WT mice (Figure 4.1E). Thus IL-18 contributes to limiting early spread of plague from the 
primary site of infection in the lung to other organs. Degree of pneumonia can be measured by 
tracking elevated lung weight as fluid retention increases (Figure 4.2A); IL-18 also contributes 
to reduce pneumonia by this measure as lungs from IL-18 KO mice have increased weights 
compared to C57BL/6 controls (Figure 4.1F).
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Figure 4.1: IL-18 contributes to control of pneumonic plague early in infection
(A-C) Survival of animals infected (A) s.c. or i.t. or (B-C) i.t. with (A,C) 500 CFU KIM1001 
or (B) 5000 CFU KIM1001 or KIM1001-pYtbLpxL. (A) groups contained n=10, (B-C) n=5. 
(D-E) CFU in (D) lung or (E) spleen homogenates from WT or IL-18 KO infected i.t. with 
1000 CFU KIM1001 and sacrificed at indicated time. (F) Weights of lungs from WT or IL-18 
KO animals infected i.t. with 1000 CFU KIM1001. *p < 0.05; **p < 0.001.
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Figure 4.2: Progression of pneumonia can be tracked by lung weight
(A) Weights of lungs from C57BL/6 animals infected i.t. with 1000 CFU KIM1001; entire 
lungs were extracted while minimizing blood contamination on organ. **p < 0.001.
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The NLRP12 and NLRP3 participate in controlling IL-18 release in the lung and pneumonic 
plague
 IL-18 and IL-1β are proteolytically matured by caspase-1 following inflammasome 
activation (as reviewed in Vladimer et al., 2013.) We have proposed an important role for 
inflammasomes involving NLRP12, NLRP3 (Vladimer et al., 2012) and NLRC4 (Vladimer et al. 
unpublished, see chapter 2) in the protection to Y. pestis strains after s.c. and i.v. injection. We 
hypothesized that NLRP12 and NLRP3 could mediate IL-18 and IL-1β release and subsequent 
protection during early events in pneumonic plague. We infected NLRP12- and NLRP3-deficient 
animals with fully virulent Y. pestis KIM1001 i.t. and found that those mice are more susceptible 
to pneumonic plague than WT control mice (Figure 4.3A,B). The NLR-deficient animals 
infected i.t. with 350 CFU of WT plague succumb to the infection to a greater extent than 
C57BL/6 animals indicating that these NLRs play a role in protection from pneumonic plague 
within the airways. Further investigation of the BAL (bronchoalveolar lavage) fluid at 48hpi 
from animals infected with KIM1001 i.t. shows a significant decrease of IL-1β  (Figure 4.3C) 
and IL-18 (D) in NLRP12-, but not NLRP3-, deficient animals. Furthermore, we compared BAL 
samples to lung homogenates from WT, NLRP12-, or NLRP3-deficient animals infected with 
KIM1001 i.t.; IL-18 (Figure 4.3E) and IL-1β (F) levels were decreased in both NLR-deficient 
animals indicating possible differences in temporal or spatial roles for these NLRs during 
protection. In contrast, IL-6, released after activation of inflammasome-independent pathways, is 
detected at similar levels in lung homogenates from WT or the NLR-deficient animals (Figure 
4.4A). NLRP12- and NLRP3-deficient animals also have a higher bacterial load in the lungs at 
48hpi in comparison to WT animals (Figure 4.3G) infected i.t. with 5000 CFU of KIM1001. 
Inflammasome activation can be directly visualized by detecting the processing of caspase-1 
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(Martinon et al., 2002). Western blots for caspase-1 and IL-1β in lung lysates from NLRP12- and 
NLRP3-deficient animals show reduced inflammasome activation and cytokine processing 
compared to lysates of WT animals infected i.t. with 5000CFU KIM1001 at 48hpi (Figure 
4.3H). Lastly, to determine the cellular expression of NLRP12 and NLRP3 in uninfected lungs 
we analyzed the gene expression from sorted resident Ly6G+ neutrophils and F4/80+, CD11C+ 
alveolar macrophages (Figure 4.4B) in C57BL/6 mice. Neutrophils in resting-state lungs express 
both NLRP3 and NLRP12 along with both pro-IL-1β  and pro-IL-18. In comparison the alveolar 
macrophages only express NLRP3 and pro-IL-18 (Figure 4.4B) suggesting a possible cell-type 
specific innate immune response after lung infection. However, we have previous described an 
increase of NLRP12 gene expression in BMDM stimulated with Y. pestis (Vladimer et al., 2012), 
therefore, the expression profiles of these cells may change during pneumonic infection. 
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Figure 4.3: NLRP12 and NLRP3 control IL-18 and IL-1β in the lungs
(A-B) Survival of C57Bl/6 and (A) NLRP12 KO or (B) NLRP3 KO animals infected i.t. with 
500 CFU KIM1001. Data shown are pooled from two to four experiments. (C-F) 
Concentrations of (C,E) IL-18 or (D,F) IL-1β in (C-D) BAL or (E-F) lung homogenates of 
mice infected i.t. with (C-D) 5000 CFU or (E-F) 500 CFU KIM1001, measured by ELISA. 
(G) CFU in lung homogenates after i.t. infection with 5000 CFU KIM1001. (H) Western blot 
of lung lysates for pro- and mature-caspase-1 and IL-1β at 48hpi after 5000CFU infection of 
KIM1001 i.t. Animals in C-H were sacrificed at 48hpi Groups contain (A) C57BL/6 n=25, 
NLRP12 n=12 (B) NLRP3 n=19, (C-D) n=5, (E-G) n=7, (H) n=1. BAL was collected by 
washing the aveolar space 1x with 1ml PBS via the mouse trachea.
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Figure 4.4: NLRP12 and NLRP3 in lungs of C57BL/6 mice
(A) Concentration of IL-6 in lung homogenates of mice infected i.t. with 500 CFU KIM1001 
for 48 hours, n=7 for each genotype. (B) Q-PCR for mRNA detection of pro-cytokines or 
inflammasome components in FACS sorted neutrophils (Ly6G+) or alveolar macrophages 
(CD11C+, F4/80+) cells pooled lung homogenates of three uninfected C57BL/6 mice.
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Tissue destruction can be visualized by H&E staining of sections from infected lung harvested at 
48hpi (Figure 4.5A). The analysis of lungs from WT mice compared to those from the 
NLRP3KO and NLRP12KO animals infected with 500 CFU KIM1001 i.t. (second row) shows 
decreased alveolar hemorrhage (arrows, and Figure 4.6A) and decreased fibrosis (marked by x). 
Staining of lung tissue samples infected with 5000 CFU i.t. at 4x and 20x show (third and forth 
rows) shows an increase destruction of alveoli and an increased loss of normal lung architecture 
in the NLR-deficient animals as compared to uninfected controls (first row). This can be 
measured as a loss of airway space (Figure 4.6B). Examination of the loci of infection at 40x 
(Figure 4.5A) shows increased cell-recruitment and inflammation and the absence of visible 
bacteria in WT lungs (forth row, left panel, marked by >) and mild fibrosis (marked by a x), 
whereas, NLRP12 KO and NLRP3 KO lungs (forth row, middle and right panel) shows areas 
with visible bacterial clusters (marked with a *), diminished cellular recruitment, greater fibrosis, 
and edema (marked by a #). This data indicates that NLRP12 and NLRP3 play an important role 
in the early detection and amelioration of pneumonic plague by production of potent pro-
inflammatory cytokines IL-18 and IL-1β in a possible cell-recruitment dependent manner.
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Figure 4.5: Lung histology suggests increased lung disease in NLR-deficient 
animals
(A) Histology analysis of fixed H&E stained lung sections from (left) WT, (middle) NLRP12 
KO, or (right) NLRP3 KO mice (top row) uninfected or infected i.t. with (second row) 500 
CFU or (third and fourth row) 5000 CFU of KIM1001 for 48 hr. Arrows (second row only) 
represent alveolar hemorrhage, X marks fibrosis, open arrow heads show loci of 
inflammatory cells, primarily neutrophils, asterisks show bacterial clusters (bottom row 
only).
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Figure 4.6: Loss of normal alveolar architecture during pneumonic infection in 
NLR-deficient animals 
(A-B) Measurement of area (in pixles2) of (A) aveolar hemorrhage and (B) loss of open 
airways 48hpi after 500 CPU infection i.t. with 500 CPU KIMlOOl. (A) Area was measured 
by specifically selecting red targets in H&E stained fixed hmg sections and (B) by measuring 
arOlmd loci of cellular recruitment at 5x magnification. 0=5 for each group and images used 
were representative of multiple experiments . • p < 0.05; •• p < 0.001. 
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NLRP12 and NLRP3 control cellular recruitment and immune activation in infected lungs
 The strong IL-1β and IL-18 production resulting from inflammasome activation has been 
shown to drive production of other cytokine (such as IFNɣ) and chemokine, and recruitment of 
other pro-inflammatory cells. Inflammasome deficiencies have resulted in impaired chemokine 
production and neutrophil recruitment during bacterial lung infection and murine gout (Tiemi 
Shio et al., 2009; Amaral et al., 2012) and have been linked to decreased dendritic and myeloid 
cell recruitment (Arthur et al., 2010). Here we show limited neutrophil recruitment to alveoli of 
NLRP12- and NLRP3-deficient animals compared to WT mice after infection with 5000cfu of 
KIM1001 i.t. (Figure 4.7A), possibly resulting from the decrease in IL-1β and IL-18. In contrast, 
the CD11c+, F4/80+ alveolar macrophage population, as measured by % of total cells, is 
unchanged (Figure 4.7B.) However, the induction of IFNɣ provides an activation feed-back to 
macrophages; macrophage activation can be tracked by decreased surface expression of F4/80 
(Ezekowitz and Gordon, 1982). After pneumonic infection with 500cfu of KIM1001, the 
Geometric Mean of the Mean Fluorescence Intensity (MFI) level of F4/80 on macrophages 
(F4/80+, CD11C-) is higher compared to WT animals (Figure 4.7C) suggesting that there is less 
cellular activation. The NLRP12-deficient animals have comparable baseline composition of 
Ly6G+ neutrophils and F4/80+, CD11C+ alveolar macrophages in lung tissue to C57BL/6 (Figure 
4.8A-B). Therefore, the lack of pro-inflammatory activation by NLRP12 and NLRP3 not only 
limits cytokine production locally, but also cellular recruitment and activation at the site of 
infection, likely contributing to reduced resistance against pneumonic plague.
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Figure 4.7: NLRP12 and NLRP3 KO animals have deficiencies in cellular 
recruitment and activation during pneumonic plague.
FACS of BAL fluid from animals infected i.t. with (A-B) 5000 CFU or (C) 500 CFU of 
KIM1001 after 24 hours. Population percentages for (A) Ly6G+ neutrophils, (B) CD11C+, or 
F4/80+ resident macrophages were determined. (C) Geometric mean of F4/80 staining on 
F4/80+, CD11C- cells was determined by averaging each event and averaging the samples 
together. n=5 (C57BL/6), 4 (NLRP12 and NLRP3). *p < 0.05; **p < 0.001.
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Figure 4.8: C57BL/6 and NLRP12 KO mice have comparable baseline cellular 
levels in lung homogenates
(A-B) Percent of (A) Ly6G+ neutrophils and (B) CD11C+, F4/80+ alveolar macrophages 
present in lung homoginates of uninfected C57BL/6 or NLRP12 KO mice. n=3 C57Bl/6, 2 
NLRP12 KO. 
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Discussion
 Pneumonic plague is the most likely form of the disease to result from a bioterrorist
 attack, and also the most deadly form with rapid onset pneumonia that reaches 100% fatality if 
not treated within 24 hours (Perry and Fetherston, 1997; Butler, 2009). Little was known about 
the initial immune response early during pneumonic plague infection, in fact it was was 
previously thought that the immune response in the lung was limited during the first stages of 
pneumonic infection, suppressed by the pathogen virulence factors (Bubeck et al., 2007; Smiley, 
2008). However, we have elucidated roles of the inflammasome forming NLRs NLRP12 and 
NLRP3, as well as pro-inflammatory cytokines IL-18 and IL-1β within the lung that assist in 
controlling early pneumonic Y. pestis infection. These pathways had yet to be described in the 
lung during pneumonic plague infection and are important for the survival of infected mice.
 We previously described NLRP12 and NLRP3 in protection of mice against both WT and 
an LPS-modified strain of Y. pestis; here, we use WT Y. pestis to begin to understand the 
significant differences of LD50 exist between the peripheral and pneumonic routes. The LD50 
for i.t. plague infection with KIM1001 in mice is approximately 500CFU compared to less than 
approximately 10CFU s.c. The subversion of NLR activation after bubonic plague infection is 
possibly due to the fast decimation of plague or a lack of resident expression in comparison to 
the lung, which could be responsible for the changes in protection and the much lower LD50. 
Moreover, the differences in NLRP12 and NLRP3 dependence in lung homogenate vs BAL fluid 
could be due to resident cellular population and expression differences at baseline before 
infection. We have published the upregulation of NLRs after macrophage stimulation with Y. 
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pestis (Vladimer et al., 2012) and believe the same is occurring in the resident macrophages in 
the BAL.
 Previous studies have shown that NLRP3 is responsible for complete cellular recruitment 
to the lung after influenza infection (Allen et al., 2009) as well, NLRP12-deficiencies resulted in 
decreased cell recruitment due to contact hypersensitivity (Arthur et al., 2010). We have not only 
shown that NLRP3 and 12 are important for cellular recruitment to the lung during pneumonic 
plague infection, but this is the first study that links NLRs to cellular immune activation in the 
airway.
 Together, this study has shown that NLR driven IL-18 production in the lung is necessary 
and to and can protect against pneumonic plague infection in mice; and inflammasome activation 
may result in the higher LD50 necessary to cause infection. This is also the second study to show 
an important role for the novel inflammasome NLRP12 in the protection against a gram-negative  
bacterial infection. The NLRs are emerging as important mediators of innate immunology and 
more work must be done to elucidate their exact role for possible therapy and vaccine targets.
 
Materials and Methods
Bacterial Strains and Growth Conditions
Y. pestis KIM is originally a clinical isolate from a Kurdistan Iran man (Perry and Fetherston, 
1997). Y. pestis strains KIM1001 and KIM1001-pYtbLpxL were as reported (Vladimer et al., 
2012). Strains were grown in tryptose-beef extract (TB) broth with 2.5 mM CaCl2 all by shaking 
at 37C. All strains containing plasmids above remained tetracycline sensitive. KIM1001 
(pPCP1+, pCD1+, and pMT1+) is highly virulent Y. pestis (Perry and Fetherston, 1997).
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Mice
All experiments involving animals were approved by the Institutional Animal Care and Use 
Committee. All work involving virulent pathogens was performed in a secure ABL3 facility 
approved by the Center for Disease Control, protocols were approve by the Institutional 
Biosafety Committee. NLRP3- (Nlrp3-/-) and NLRP12-deficient (Nlrp12-/-) mice were generated 
by Millennium Pharmaceuticals and were backcrossed 8–11 generations to C57BL/6 
background. C57BL/6 mice were bread in-house, and mice deficient in IL-1R1 (Il1r1-/-), and 
IL-18 (Il18-/-) were all from Jackson Laboratories. IL-1b (Il1b-/-)-deficient mice were provided by 
Y. Iwakura. Wild-type and knockout mice were infected i.t. by pipetting 50µl of PBS containing 
Y. pestis into the mouth after sub-lethal isoflurane administration, and performing a “tongue-
pull” to prevent swallowing of the pathogen until breathing was sufficient for full infection to the 
respiratory tract. Survival was monitored twice a day for 30 days. For cytokine and CFU 
analysis, mice were infected i.t. and sacrificed at the indicated time points. Lungs and spleens 
were homogenized in 0.5 ml PBS with a closed system Miltenyi gentleMACS dissociator; 
subsequently cells/debris were removed by centrifugation. Lungs were washed with 1ml of PBS 
(including void-volume) though the trachea of sacrificed animals to collect BAL samples. 
Samples for cytokine analysis were subjected to protease inhibitor (Roche) treatment. 
Hematoxylin and eosin (H&E) staining and microscopy were performed as published (Montminy  
et al., 2006). Microscopy was analyzed with ImageJ software. Analysis of alveolar hemorrhage 
was measured by color selecting the RBCs in 5 10x fields per genotype and then measuring the 
area of selected color. Loss of airway space was measured by selecting the loci of infection and 
measuring the area from 5 20x fields per genotype, then subtracting the area of the whole field.
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ELISA, Flow Cytometry, and Q-PCR
Q-PCR for Nlrp12, Nlrp3, and Il1b performed on cell-suspensions of naive C57BL/6 lungs after 
cell-sorting by BD biosciences FACSAria II. Cells were stained with antibodies against F4/80 
(clone BM8, PerCP-Cy5.5), CD11c (N418, eFluor®450) (eBiosciences) and Ly6G (1A8, PE) 
(BD). Cells were treated with Fc block (clone 93, rat anti CD16/32, eBiosciences) 15 minutes 
prior to staining, on ice. Alveolar macrophages are CD11C+, F4/80+. Primers for detection of 
mouse Nlpr12, mouse Nlrp3, and mouse Il1b were as described (Vladimer et al., 2012) with 
SYBR green (BioRad) in accordance with the manufacturer’s instructions. ELISA kits for IL-1b, 
IL-6, (R&D), and IL-18 (MBL) were used for cytokine detection. BAL cells were stained for 
Flow Cytometry with antibodies above and with CD4, CD8, CD19, CD69, MHCII... BAL 
populations were analyzed using a LSRII (BD) with Diva and Flowjo Software. MFI was 
calculated by taking the sum of florescent intensity of each event and the geometric mean of each 
samples sum. 
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Chapter 5: Discussion
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 This thesis research has focused on the evolution of Y. pestis virulence, as well as 
furthered the understanding of innate immune pathways that limit plague early in infection. 
Beginning with elucidating the pathogenesis of Y. pestis after the loss of LpxL, a key factor in the 
increased virulence from Y. pseudotuberculosis, this work implicates the cytosolic, multi-protein 
complex, the inflammasome, as key in controlling plague infections. Together, this information 
can aid in creating a useful vaccine against a pathogen that has caused worldwide pandemics, 
and persists as a constant biowarfare threat.
 Y. pestis uses multiple factors to efficiently, and concurrently, suppress many innate 
immune pathways to quell local inflammatory responses and cause systemic infection. Y. pestis 
also has the unique ability to evade immune recognition by TLR4 thereby limiting initial 
response. We previously found that the expression of a poorly stimulatory lipid A/LPS was 
necessary to cause bubonic plague (Montminy et al., 2006). Here, we continued to clarify the 
importance of the evolutionary loss of LpxL on Y. pestis virulence by noting that all closely 
related Yersiniae bacteria with known sequences of the relevant chromosome segments contain 
the lpxL gene (Figure 2.3). Moreover, adding back lpxL genes from several evolutionary 
ancestors results in significant loss of virulence in vivo (Figure 2.5 A-B) while cellular 
stimulations result in a notable increase in cytokine production.
 The study and creation of these modified strains of plague gives us the ability to evaluate 
various components that assist in controlling bubonic plague infection that would have otherwise 
been unknown. Bubonic plague has an estimated LD50 of less than 10 CFU in mouse models, 
therefore, infection is difficult to control, and increased susceptibility in mice is also challenging 
to monitor. In comparison, the LD50 of a strain of Y. pestis expressing a stimulatory LPS is 
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greater than 1x107 (Montminy et al., 2006). Using this strain, we determined an important role 
for the pro-inflammatory cytokines IL-1β and IL-18 in the protection of mice against bubonic 
plague as mice deficient in these cytokines and their receptors succumb to infection in much 
higher rates (Figure 2.3 B-D). Furthermore, mice deficient in the adapter protein MyD88 are 
also very susceptible to the modified plague strain (Montminy et al., 2006). MyD88 KO mice are 
the only immune deficient animals who die faster than C57BL/6 mice after bubonic plague 
infection with fully virulent strain of Y. pestis (Figure 3.1C). This provides evidence that MyD88 
could be an important adapter in multiple pathways of innate immune responses to WT plague: 
TLR4 signaling as well as IL-1β/IL-18 signaling. 
 We investigated mechanisms upstream of the cytokine production and determined the 
NLRP3, NLRP12, and NLRC4 inflammasomes to be protecting mice from infection (Figure 
2.7A, 3.3A-B). We also provided evidence that these NLRs are responsible for circulating IL-1β/
IL-18 cytokines during septicemic plague infection with both WT and modified hexa-acylated 
LPS-producing Y. pestis. Most importantly, we show that NLRP12 is an inflammasome 
component recognizing Y. pestis, and this is the first clear role for NLRP12 in resistance to 
infection. Our data suggests the NLRP12/IL-18/IFNɣ axis is effective at limiting infection with a 
modified Y. pestis strain.
 Though bubonic plague is the most prevalent form of the natural disease worldwide, 
pneumonic plague has higher mortality, and is the most likely form that would result from the 
use of Y. pestis by bioterrorism. Moreover, the role of innate immunity, inflammasomes, and 
inflammasome-dependent cytokine production in the lung during Y. pestis infection is not fully 
understood. We determined that NLRP12 and, to a lesser extent, NLRP3, are responsible for 
154
IL-18 and IL-1β during the initial disease progression. Moreover, we have shown that these 
NLRs affect both cellular recruitment and activation, which is in agreement with published data 
on NLRP12 and NLRP3 (Allen et al., 2009; Arthur et al., 2010). The differences in NLR-
dependence may be due to expression of each protein in different cells, present at different times 
during the infection. This evidence defines the role for the inflammasome complex in both local 
inflammasome as well as elicit activation of the innate immune system.
 Inflammasome formation culminates in caspase-1 activation to mature the inactive pro-
IL-18 and IL-1β. This study has shown that survival following infection of mice is dependent on 
multiple inflammasome forming NLRs as well as caspase-1 dependent pro-inflammatory 
cytokines. However, we have observed that caspase-1-deficient animals (caspase-1/caspase-11 
functional dKO) do not succumb to infection at all (s.c. infection of 500 CFU of KIM1001-
pYtbLpxL), or have not significantly difference in survival compared to C57BL/6 mice (500 cfu 
KIM1001 i.t.), respectively (Figure 5.1 A-B.) This is curious as several other mouse strains 
deficient in genes in this pathway cannot control Y. pestis infection. It is possible that, in vivo, 
there are redundant inflammatory caspases, such as caspase-8 (Kang et al., 2012) maturing pro-
IL-1β and pro-IL-18 that are also NLR activation dependent. Evidence of non-caspase pro-IL-1β 
maturation also exists, for example in neutrophils (Netea et al., 2010), perhaps mediated by 
enzymes such as cathepsins, elastase, and PR3. Our observed caspase-1 independence could be a 
partially neutrophil driven phenotype via action of these enzymes. Moreover, the differences in 
caspase-1 mediated survival could be greatly be dependent on route of primary infection and 
may explain some of the LD50 differences. More work must be done to elucidate the dependence 
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of caspase-1,caspase-11 and other IL-1β/IL-18 processing enzymes on cell death and 
inflammation during plague infection.
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 We and others have proposed a role for the conserved Yersiniae effector protein YopJ 
(YopP in Y. enterocolitica) in promoting inflammasome activation (Figure 3.5H, Figure 5.1), 
data not shown, and (Brodsky et al., 2010; Zheng et al., 2012). This indicates that all the 
pathogenic Yersiniae can promote YopJ-mediated inflammasome function and caspase-1 activity, 
in spite of the detrimental effects this could have on the infection. YopJ was conserved during the 
evolution of Y. pestis from Y. pseudotuberculosis, thereby conveying the important role it plays to 
promote infection, other than inflammasome activation. 
 Though the mechanism is unknown, it is speculated that YopJ may directly acetylate an 
NLR, or an NLR detects inappropriately-acylated host proteins (vis-a-vie plant R-proteins), 
leading to inflammasome activation (Figure 5.2). As well, studies in the intestinal lumen after 
oral Y. pseudotuberculosis infection show YopJ’s role in barrier disruption (Jung et al., 2012; 
Meinzer et al., 2012). Interestingly, the balance of YopJ cytokine-blocking and cell death-
induction is necessary for optimal pathogenesis as Y. pseudotuberculosis strains lacking YopJ fail 
to induce cell-death, cytokine down-regulation, and dissemination from a oral infection model. 
However, Y. pseudotuberculosis expressing hypercytotoxic YopP (from Y. entrocolitica), which 
enables stronger inhibition of cytokine production and more cell death, are also attenuated in 
vivo. 
 Other Yersiniae Yops were found to play roles during inflammasome activation: YopM 
was recently described to perhaps bind caspase-1 and sequester it into the nucleus, thereby 
halting pro-IL-1β/pro-IL-18 maturation (LaRock and Cookson, 2012). Interestingly, caspase-1 
KO animals succumb quickly to infection with the YopM deficient Y. pseudotuberculosis, 
demonstrating the importance of caspase-1 to mediate infection. We however have found that 
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caspase-1 animals (caspase-1/caspase-11 dKO mutants) do not succumb to Y. pestis KIM1001-
pYtbLpxL s.c. infection, and only trending (non-significant) towards more susceptibility to 
KIM1001 i.t. infection, therefore, the route of infection or bacterial strains used may determine 
caspase-1 importance. YopM may also have other host targets other than caspase-1 and also 
Yersinia YopM may have variations like YopJ has in Y. pestis strains.
 YopK mutants strongly activated the inflammasome complex, thereby hinting at a role of 
YopK in regulating NLR function (Brodsky et al., 2010) (and Vladimer et al., data not shown, 
Figure 5.1.) The direct pathway of YopK mediated inflammasome control is not clear, though 
there is evidence that YopK regulates Yop delivery and therefore the overabundance of Yops 
could be driving inflammasome formation (Figure 5.1) (Dewoody et al., 2012). 
 No connection has yet to be made of YopE and YopT to inflammasome activation, but we 
can hypothesize that their activity on cell-structure could lead to an increase in cellular danger 
signals, which would drive the NLRP3 inflammasome. Studies of the roles of Yersiniae Yops in 
cell-death, pro- or anti-inflammatory activity, and phagocytosis is important in discovering novel 
microbial-therapies. However, it seems likely that it is the balance of Yop expression and activity  
that regulates their overall function during pathogenesis and findings from single Yop-mutant 
bacteria probably do not represent the overall function. Yops must be studied in the context of the 
others, and more studies reviewing the disregulation of Yop delivery must be done to understand 
their role during infection.
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Figure 5.2: Multiple Inflammasome-Forming NLRs are Activated by Y. pestis.
NLRP12, NLRP3 and NLRC4 are all activated by Y. pestis and are necessary in controlling 
plague infection. Multiple Yersiniae virulence factors regulate inflammasome function such 
as YopJ (modification of host proteins and down-regulation of Nf-kB indused pro-cytokines), 
YopK (inflammasome control, possibly directly or by regulation of other Yop delivery to the 
cytoplasm), and YopM (binding and sequestering pro- and active-caspase-1.) Dashed lines 
are hypothetical pathways, solid lines are summarized pathways.
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 We believe the loss of lpxL was necessary to limit pro-IL-1β and pro-IL-18 production 
downstream from NF-κB. By limiting the caspase-1 dependent cytokine substrates, activation of 
many inflammasomes (NLRP12, NLRP3, and NLRC4) has no anti-microbial effects on the Y. 
pestis infection. 
 Y. pestis, which we have shown to activate three known inflammasomes, is a convenient 
model system in determining the relationship of NLRP12, NLRP3, and NLRC4 during anti-
microbial responses. Published evidence shows only one inflammasome per cell, therefore, we 
would assume that the multiple activated NLRs would hetero-, rather then homooligomerize 
upon activation. 
 All known inflammasomes, other then AIM2, contain a NACHT domain where 
oligomerization may occur. FRET, or IP studies could be done to further analyze the relationship 
of the separate NLRs. The model for single-inflammasomes per cell is based off of visualizing 
ASC speckles in activated cells under a fluorescence microscope. It is possible that the 
sensitivity of microscopes is not great enough to detect multiple individual inflammasomes - 
which could be evidence of single/homooligomerized inflammasome complexes. Moreover, this 
work indicates that knocking out single NLRs does not completely abrogate cytokine production, 
therefore, overlapping and redundant pathways of the multiple activated NLRs may exist.
 NLRP12 has been described previously in anti-inflammatory roles regulating colitis and 
NF-κB driven responses (Lich et al., 2007; Zaki et al., 2011b; Allen et al., 2012), however, in this 
pestis model, we see no effects on NF-κB in the NLRP12-deficient animal or cells (Figure 3.5A, 
3.6 A-B,G, 3.10 E-F, Figure 4.4A). This could be due to the regulatory effects of YopJ on NF-
κB and MAPK, thereby, regulating the loss of NLRP12 controlled activation of these 
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transcription factors (Sweet et al., 2007; Paquette et al., 2012). Though YopJ plays many roles of 
immune-suppression and inflammasome activation in vitro, the role of YopJ in vivo remains 
somewhat controversial (described above in Chapter 1.) The variations in published work could 
be due to route of infection or pathogen preparation prior to infection (bubonic vs pneumonic 
plague, and growth temperature and characteristics.) We see C57BL/6 animals survive challenge 
with a YopJ-deficient strain of KIM1001 after i.t. injection, but not s.c. (data not shown). We 
believe YopJ may act in a tissue-specific manner.
 In contrast to Y. pestis, which has an LD50 of less than 10 CFU for s.c. infection but an 
LD50 of approximately 500 CFU for i.t. infection, F. tularensis, has an LD50 of less than 10 
CFU for both routes. This drastic difference in virulence could be due to limited inflammasome 
activation in the lungs during tularemia as F. tularensis primarily signals though AIM2 
(Fernandes-Alnemri et al., 2010), which pestis does not (data not shown.) This could be due to 
AIM2-differential expression in the lung vs other tissues, and the lack of peripheral spread of F. 
tularensis in comparison to Y. pestis. The drastic difference of NLR success in controlling plague 
infection after intratracheal (pneumonic) infection compared to subcutaneous (bubonic) infection 
may be due to resident cellular expression of localized cells in tissues. Moreover, the Yersinia Pla 
protease promotes rapid decimation of the pathogen though the tissue, limiting the time the 
pathogen spends in the dermis.
 These studies reveal a role for multiple inflammasomes in host resistance against 
pathogens, and minimizing inflammasome activation may have been a central factor in evolution 
of the high virulence of Y. pestis. This is also the first study to elucidate a pro-inflammatory role 
for NLRP12 during bacterial infection. Our work has identified signaling pathways, that once 
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activated, could assist in limiting and controlling plague infection. Intervention must typically be 
started within 24 hours of the first onset of plague symptoms to limit the pathogen spread and 
increase chances of survival. With the increased challenges of treating antibiotic resistant 
bacteria, targeting NLRs to produce greater amounts of IL-18 could be an effective treatment for 
plague and other bacterial infections within an expanded post-symptom window. Lastly, by 
studying the immune mediating effect of Yersiniae Yops, more knowledge about their ability to 
activate and inhibit certain signaling pathways could lead to the development of treatments for 
modulating local inflammation.
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